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ABSTRACT 
Regenerative Medicine is a well-established field of science that aims to replace, engineer 
and regenerate human cells, damaged tissues or organs to restore their normal function. 
This branch of translational research finds a deep interest in the Science of Biomaterials; 
indeed, the knowledge acquired in that field goes proportionally with the development of 
novel biomaterials. There is a great need in developing advanced biomaterials capable to 
fulfil the requirements of stability and bioactivity for their application in biomedicine. 
Moreover, considering the complexity of the human body, this system needs a certain 
rate of versatility in order to be tailored to a specific area of application. For all these 
reasons, recombinant proteins are an interesting approach, in which, elastin-like 
recombinamers (ELRs) represent one of the most promising biomaterials. ELRs are 
obtained through DNA recombinant technology, which allows the precise control at the 
genetic level, affording exquisite control over final protein functionality. ELRs are protein-
based polypeptides that comprise repetitive units of the Val−Pro−Gly−X−Gly (VPGXG)n 
pentapeptide, in which X (guest residue) could be any amino acid except L-proline. In 
terms of biomaterial design, ELRs show several outstanding properties. ELRs are inspired 
by elastin, which is a component of natural extracellular matrix (ECM), showing excellent 
biocompatibility. One of the most important features of ELRs is that they exhibit thermo-
responsiveness; this is due to the change of protein conformation above the so-called 
transition temperature (Tt), which depends on the amino acid composition of the 
polymer. Moreover, according to the ELRs design, they can be processed as several 
supramolecular structures, such as micelles, nanoparticles, films, and hydrogels. The large 
variety of ELRs, both in terms of structures and bioactivity, permits the application of 
these protein-based biomaterials to diverse biomedical applications.  
This Thesis represents a sort of journey towards the exploration of the evolution of ELRs 
as a powerful tool with great potential in the biomedical field. The first part of this Thesis 
is dedicated to the description of the history of ELRs from their ancient chemical origin as 
ELPs (Elastin-like Polypeptides) to the most cutting-edge bioproduction techniques 
becoming into ELRs. Moreover, it is reported an exhaustive explanation of how ELRs can 
be processed in many forms (aggregates, fibers, layers, nanoparticles, or hydrogels), 
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giving examples of their great potential in many fields, including drug delivery, tissue 
engineering, protein purification, anticancer gene therapies, and nanovaccines. 
Moreover, considering their large interest, one chapter of this Thesis is dedicated to the 
ELRs as biomaterial forming hydrogels for tissue regeneration and repair. The different 
mechanisms of gelation are reported, and it is given an overview of the possible 
applications in tissue engineering, such as osteochondral application, (cardio-)vascular 
tissue regeneration, and ocular prostheses. 
The first experimental work of this Thesis is dedicated to the development of novel ELRs-
based hydrogel for cartilage repair. Tissue engineering for cartilage repair requires 
biomaterials that show rapid gelation and adequate mechanical properties. Although the 
use of hydrogel is the most promising biomaterial, it often lacks in rigidity and anchorage 
of cells when they are surrounded by synovial fluid while they are subjected to heavy 
loads. In this work, it has been developed and produced the Silk Elastin-Like co-
Recombinamer (SELR), which contains both the physical interaction from elastin motifs 
and from silk motifs. In the first part of this study, it was set up and optimized a pre-
annealing treatment based on the evolution of silk motifs into β-sheet structures in order 
to fulfil the required mechanical properties of hydrogels for cartilage repair. The new pre-
annealed SELRs (pA(EIS)2-(I5R)6) were characterized with the combination of several 
experimental techniques (CD, TEM, SEM, and rheology) to provide a deep insight into the 
material features. Finally, the regeneration properties of the pA(EIS)2-(I5R)6 hydrogel 
embedded with chondrocytes were evaluated. After 4 weeks of culturing in a 
standardized and representative ex vivo model, the biochemical and histological analysis 
revealed the production of glycosaminoglycans and collagen. Finally, the 
immunohistochemistry showed the absence of fibro-cartilage and the presence of hyaline 
cartilage, which leads to the successful regeneration of hyaline cartilage in an ex vivo 
model. 
Not only the physically cross-linked hydrogels have been investigated; indeed, an in situ 
chemically cross-linked hydrogels have been developed for osteochondral repair. 
Moreover, another bioactive composition of this biomaterial has been tested; this ELRs-
based hydrogel has been designed containing bioactive sequences, such as the well knows 
adhesion sequences RGD and REDV, and the elastase target domain VGVAPG that 
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provides proteolytic sensitivity to the biomaterial. Compared to the previous study 
reported in this Thesis, where the ex vivo platform was used, the regeneration properties 
of the chemically cross-linked ELRs hydrogel were evaluated with an in vivo study. 
Furthermore, it has been made a comparison between the usage of that biomaterial itself, 
and the biomaterial embedded with cells (tissue engineering). Both the ELR-based 
hydrogel alone and the ELR-based hydrogel embedded with rabbit Mesenchymal Stem 
Cells (rMSCs) were tested for the regeneration of critical subchondral defects in 10 New 
Zealand rabbits. Thus, cylindrical osteochondral defects were filled with an aqueous 
solution of ELRs. The animals were sacrificed at 4 months for histological and gross 
evaluation of features of biomaterial performance, including integration, cellular 
infiltration, surrounding matrix quality and evaluation of the new matrix in the defects. 
Although both groups helped cartilage regeneration, the results suggest that the specific 
composition of the rMSCs-containing hydrogel permitted adequate bone regeneration, 
whereas the ELR-based hydrogel alone led to an excellent regeneration of hyaline 
cartilage. In conclusion, the ELR cross-linker solution can be easily delivered and forms a 
stable, well-integrated hydrogel that supports infiltration and de novo matrix synthesis. 
As it has been reported above, the aim of this Thesis is to explore the possibilities of ELRs 
as a powerful tool capable of containing various bioactivities with great potential in the 
biomedical field. As a further step in the evolutional process towards advanced bioactive 
ELRs, one objective of this Thesis is to combine these two diametrically opposed 
approaches in a new hybrid biomaterial. Biomaterial design in tissue engineering aims to 
identify appropriate cellular microenvironments in which cells can grow and guide new 
tissue formation. Despite the large diversity of synthetic polymers available for 
regenerative medicine, most of them fail to fully match the functional properties of their 
native counterparts. In this work, we have combined the strategy of synthetic peptides 
with the DNA recombinant techniques generating a new hybrid biomaterial. Human 
umbilical vein endothelial cells (HUVECs) adhesion and proliferation were studied over 
the ELRs covalently functionalized with each three high-affinity and selectivity αvβ3- and 
α5β1-binding bicyclic RGD peptides. Next, to the bicycles, ELRs were also functionalized 
with various integrin-binding benchmark peptides, i.e. knottin-RGD, cyclo-[KRGDf] and 
GRGDS, allowing for better classification of the obtained results. Covalent 
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functionalization with the RGD peptides, as validated by MALDI-TOF analysis, guarantees 
flexibility and a minimal steric hindrance for interactions with cellular integrins. In addition 
to the covalently modified RGD-ELRs, it was also synthesized another benchmark ELR 
comprising RGD as part of the backbone. HUVECs adhesion and proliferation analysis 
using the PicoGreen® assay revealed a higher short-term adhesion and proliferative 
capacity of cells on ELR surfaces functionalized with high affinity, integrin-binding bicyclic 
RGD-peptides compared with the ELRs containing RGD in the backbone. 
Finally, in order to move forward the evolution of ELRs as advanced biomaterial showing 
multiple modular behaviours, it has been developed a new smart ELRs with the aim of 
targeting complex biomedical system. Taking advantages by the recombinant DNA 
techniques, it has been developed a smart biomaterial based on Elastin-like 
Recombinamers with allosteric control of RNase A activity.  The ELRs design comprised 
bioactive sequences sensible to external stimuli; It was designed containing ten consensus 
sequence phosphorylation sites regularly distributed along the ELR, and by the 
Ribonuclease A active sequence (RNase A). According to the position of RNase A relative 
to the ELR backbone, several variants of the smart-ELR have been produced. The smart-
ELRs were further characterized by several experimental techniques (SDS-PAGE, FTIR and 
HPLC-HR-MS), showing the capacity to be fully phosphorylated and further de-
phosphorylated. This reversible system was then investigated by turbidity analysis, 
demonstrating an evident shift in Temperature transition (Tt) value due to the (de-
)phosphorylation. Finally, the allosteric control of the RNase A catalytic activity was 
evaluated for all the different variants of the smart-ELR. The allosteric control of RNase A 
activity by the selective phosphorylation was demonstrated. Moreover, the different 
designs of the smart-ELRs exhibited different catalytic activity, showing the importance of 
the RNase A position according to the ELR backbone. 
In summary, the works reported in this Thesis provides an overview of the ELRs as 
engineering responsive and biomimetic material for the biomedical application. 
Specifically, it describes in the first part the base knowledge of this class of recombinant 
protein, focussing on the different structures that can be formed and their great potential 
in many biomedical fields. Furthermore, special interest has been dedicated to the 
potential of ELRs as biomaterial forming hydrogels for tissue regeneration and repair. 
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Following this trend, for osteochondral repair application, two types of ELRs based 
hydrogel showing different bioactivities and gelation mechanisms have been developed 
and tested with an ex vivo and an in vivo study. Finally, taking advantages from the DNA 
recombinant technology which allows the precise control at the genetic level, news 
advanced ELRs have been developed. A new class of hybrid ELRs combining the synthetic 
synthesis of peptides with the DNA recombinant techniques has been designed, and a 
new generation of smart-ELRs with allosteric control has been obtained.  
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INTRODUCTION 
The worship for the “universe” that surrounds the human body, both spiritual and physical 
found manifest (in ancient times) in religions and cultural myths and more recently in 
Medicine and Science. Since the beginning of time, Mankind has used his intelligence to 
find solutions to all the different diseases and aging effects that affect the human body. 
The knowledge and possibilities to “repair” the ultra-complex human-body machine has 
increased with technology. This branch of translational research is called Regenerative 
Medicine. It seeks to repair or replace tissues and organs that have been damaged; one 
approach considers an external substance implanted in the area affected by disease or 
trauma (1). Many different types of materials have been used along with the history of 
humanity, from wood to ceramics passing through scaffolds based on metals (2). As the 
competences of intervention on the human body have improved, also the materials have 
evolved towards various approaches with the aim of imitating the complex system for 
which they are though (Biomaterials). The science of biomaterials has evolved along the 
years exploring several types of solutions from natural sources, such as alginate (3) and 
collagen (4) to synthetic polymers such as polyethylene glycol (PEG) (5) and Poly(N-
isopropylacrylamide) (PNIPAAm) (6,7) among others. The indispensable feature of a 
biomaterial is the biocompatibility, namely the ability of a material to perform with an 
appropriate host response in a specific application (8). Indeed, it is necessary that the 
material used in surgical implants does not show cause any harmful or toxic reaction to 
living tissue. Moreover, simultaneously to the knowledge gained over the complexity of 
the different tissues of the human body, advanced biomaterials with different 
compositions have been developed for the different areas of application. In that sense, 
recombinant proteins represent a powerful tool in the field of biomaterials. Among all the 
advantages of this class of proteins, the biggest one is the precise control over the design 
and the composition of the biomaterial. Indeed, this capacity allows to obtain tailored 
biomaterials, targeting the different tissue applications.  
Elastin-like recombinamers (ELRs) 
Over the last decades, recombinant DNA techniques have proven to be very powerful 
tools for the development of novel protein-based biomaterials. This class includes elastin-
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like recombinamers (ELRs), which are protein-based polypeptides that comprise repetitive 
units of the Val−Pro−Gly−X−Gly (VPGXG)n pentapeptide, in which X (guest residue) could 
be any amino acid except L-proline (9). ELRs shows several advantages of designing 
biomaterials. They are inspired by elastin, which is a component of natural extracellular 
matrix (ECM), showing excellent biocompatibility (10,11). One of the most important 
features of ELRs, is that they exhibit thermo-responsiveness in acqueous media; this is 
due to the change of protein conformation above the so-called transition temperature 
(Tt), which itself depends on the amino acid composition of the polymer (12). Moreover, 
according to the ELRs design, it can be obtained several supramolecular structures, such 
as micelles, nanoparticles, films and hydrogels (13). Furthermore, as it will be described 
ahead, due to the DNA recombinant technology it is possible to include bioactive 
sequences in the final composition of the protein (14). An extended explanation about the 
thermo-sensitiveness property of ELRs and their capacity to self-assembly in several 
supramolecular structures can be found in Chapter 1. 
Hydrogel-based on ELRs  
As it has been extensively studied, hydrogels have become a popular option for 
regenerative medicine applications (15). The use of hydrogels as a scaffold to regenerate 
damaged tissues could provide both basic support, in case of hydrogel itself, and could 
promote an added repopulation contribution when embedded with cells. ELRs allows to 
obtain several types of biomaterial for a broad variety of applications. According to the 
amino acid composition, several structures can be formed, such as particles, micelles or 
hydrogels (13). Regarding the hydrogel structure, in this Thesis, two different gelation 
mechanisms have been explored: chemically & physically cross-linked hydrogels. 
Following the evolution of biomaterials, this is a clear example of how it is necessary to 
find out new solutions to more precise requests. In the case of chemically cross-linked 
hydrogels, the ELR sequence comprises amino acids having a functional group on the side 
chain, which, could be modified in order to confer a sort of reactivity; such as lysine that 
contains ε-amino. This ε-amino group from lysine can be chemically functionalized to 
provide a concrete reactivity to the ELRs molecule. In our case, we will take advantage of 
the 1-3 Huisgen cycloaddition to perform a crosslinking between ELRs molecules. The 
chemical cross-link can occur by catalyst-free click chemistry, allowing immediate gelation 
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of the hydrogel even at a small concentration (16). On the other hand, according to the 
amino acid composition of the polymer, ELRs exhibit thermo-responsiveness, indeed, 
above the Tt the protein conformation is translated into a hydrophobically driven self-
assembly of the molecules toward supramolecular hydrogels (17). Moreover, it has been 
already demonstrated that the amino acid sequences GAGAGS hexapeptide (G: Glycine, 
A: Alanine, S: Serine) found in Bombyx mori silk fibroin, can be included in the ELR 
sequence by DNA recombinant technique. It has been found that this silk domain is 
responsible for the supramolecular rearrangement into β-sheets, giving stability to the 
hydrogel (18). In the light of the definition of Tissue Engineering, as the combination of 
cells with engineered materials to improve or replace biological functions, these two 
different mechanisms of gelation represent two different approaches for the tissue repair 
application. As it is reported above, ELR-based hydrogels are one of the most promising 
solutions for Tissue Engineering, along the last decades they have gained interest in the 
most challenging fields of tissue regeneration (19). Chapter 2 of this Thesis is an 
exhaustive overview of the possible applications of the ELRs in Tissue Engineering field. 
Both approaches reported above (chemically & physically cross-linked hydrogels) have 
been investigated in this Thesis; two comprehensive examples of physically and 
chemically cross-linked hydrogels for osteochondral repair can be found in Chapter 3 and 
Chapter 4.  
Advanced ELRs with gained bioactivity 
The evolution of ELRs as a versatile solution for biomedical application passes through the 
ability to form different supramolecular structures according to the designed composition 
of the polymer. The capacity of comprehending any sort of bioactivity represents another 
important milestone towards advanced materials that can be tailored for certain 
applications. The capacity to confer bioactivity is possible thanks to the DNA recombinant 
technology that allows the fusion of the desired sequences with the ELR counterpart (20). 
As it is reported in the literature, many ELRs containing diverse bioactive sequences have 
been investigated (21,22). In terms of adhesion capacities of the biomaterial, one of the 
most extensively used bioactive sequences is the triple peptide Arginine - Glycine - 
Aspartic acid (RGD), which supports cell adhesion via integrins (23). Another bioactive 
sequence that provides cell adhesion is the CS5 human fibronectin REDV (Arginine - 
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Glutamic acid – Aspartic acid - Valine) which improve the selectivity for endothelial cells 
(24). At the same time, the design of ELRs comprising the elastase target domain (human 
leukocyte elastase I) VGVAPG (L-Valine – Glycine - L-Valine - L-Alanine - L-Proline - Glycine) 
provides proteolytic sensitivity to the biomaterial (25). In this Thesis is reported the 
development of novel biomaterials based on ELRs containing the listed sequence in order 
to evaluate their effectiveness in the most emerging fields. Moreover, generally speaking, 
it has to be taken into consideration that combining opposite approaches may 
compensate the drawbacks shown by each one if taken individually. For example, the 
recombinant synthesis has limitations on the incorporation of non-canonical amino acids 
and does not allow the formation of cyclized peptides (26). In that sense, the recombinant 
technique of ELR can be combined with the strategy of designing novel and efficient 
peptides (27). As a further step in the evolutional process towards advanced bioactive 
ELRs, one objective of this Thesis is to combine these two diametrically opposed 
approaches in a new hybrid biomaterial. In Chapter 5 is reported the combination of 
synthetic peptides with the ELR backbone that can be obtained using copper-free click 
chemistry (15).  
A new frontier of ELRs 
Target complex systems require new approaches capable to combine modular features in 
multi-capable material. Due to its potentiality, smart materials have gained widespread 
interest in material science (28). Smart (or stimuli-responsive material) derived from the 
development of materials that show large conformational changes in response to small 
environmental stimuli such as temperature, ionic strength, solvent polarity, 
electric/magnetic field, or light (29). In that sense, ELRs represent a promising tool for the 
generation of a new frontier of biomaterials. As it has been reported above, the ELRs 
exhibit several advantages as biomaterials, such as their compatibility, and their thermo-
sensitivity; however, the most important remains the precise control at the genetic level, 
affording exquisite control over final protein functionality. There are many examples of 
smart biomaterials based on ELR (smart-ELR); for biomedical and biomimetic applications 
(30-34). Moreover, recent works have explored a new type of ELRs, which are not only 
enzyme-responsive but also contain their own activity due to the fusion of selected 
catalytic domains at the genetic level (35,36). Following this strategy, another aim of the 
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Thesis was to explore a new generation of ELRs. In Chapter 6 is reported the experimental 
work regarding the design of a new smart ELR containing consensus sequences for 
enzymatic responsiveness and a catalytic domain for allosteric control.  
The common ground of this Thesis is the ELRs technology with its outstanding properties; 
the leitmotiv is represented by the development of engineering material in a sort of 
journey towards the exploration of new possibilities, mashing approaches and crossing 
boundaries. 
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PROBLEM STATEMENT AND HYPOTHESIS 
The Biomaterial field is a branch of translational research that evolves with technology. 
Many types of technology have a crucial impact in this scientific field, both for the 
development of biomaterials and for the application of those biomaterials in the 
biomedical field. Along the last decades, the scientific community came up with several 
types of biomaterials from natural sources to synthetic polymers. Despite the large variety 
of biomaterials, only a few of them are able to show adequate properties of bioactivity 
and versatility for being applied to different biomedical applications. Nowadays, a partial 
wrong approach is the tendency to use a “one-type” biomaterial to address diverse 
biomedical issues. The strategy of developing one type of biomaterial for a large variety 
of biomedical applications may results successful for some, but unsuccessful for the 
others. Every issue in the biomedical field needs to be targeted with tailored therapies. 
One of the biggest challenges of today is to develop tailored biomaterials for specific 
applications. In this Thesis, we propose to explore the potential of Elastin-like 
Recombinamers (ELRs) as an engineering responsive and biomimetic material, towards 
the development and the optimization of tailored solutions for specific biomedical 
applications. 
The following points represent the hypothesis of the research planning of this Thesis:  
 
- Considering that the DNA recombinant technique allows an exquisite control at 
the genetic level, we hypothesize to generate several ELRs comprising diverse 
combinations of bioactive domains. Furthermore, we aim to bio-produced the 
designed ELRs in Escherichia coli taking advantage of their thermo-responsiveness 
whereby depending on the composition of the ELRs several structures could be 
formed. 
 
- It is well known that hydrogels based on specifically designed ELRs can be formed 
by different gelation mechanisms and that these mechanisms influence the 
mechanical properties of the hydrogels. We hypothesize that the different 
gelation mechanism (chemical or physical cross-linking) has a crucial influence for 
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the generation of a 3D hydrogel embedded with cells as a successful scaffold for 
osteochondral repair. 
 
- It is well described in the literature that ELR can be modified in order to be reactive 
for click chemistry reaction. We hypothesized that the strategy of copper-free click 
chemistry allows the incorporation of non-canonical amino acids and the 
formation of cyclized peptides, (which represents a limitation shown by the 
recombinant synthesis) in order to generate a new class of hybrid biomaterials. 
 
- The consensus sequence sensible for the kinase/phosphorylase can be included in 
the ELR composition in combination with the RNAse A catalytic domain in order to 
verify the allosteric domain regulation. Indeed, new combinations of ELR with 
bioactive sequences can be explored.   
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OBJECTIVES 
 The main purpose of this Thesis is to develop engineered responsive materials 
capable to overcome some limitations shown by the existing solutions for 
biomedical applications. Our research focuses on the potentiality of using elastin-
like recombinamers (ELRs) as the common ground for the development of 
different biomimetic materials. Different aspects will be touched within this 
Thesis, lining up a sort of evolution in the complexity of the ELR-based 
biomaterials.  
 
 The first concrete scope of the Thesis is to design and produce bioactive hydrogels 
for Tissue Engineering (TE) application. Specifically, the goal is to develop bioactive 
hydrogels for osteochondral repair. The need to include bioactive domains in the 
ELR’s composition will be investigated focussing on different bioactive domains 
such as adhesion sequence and proteases sensitiveness, we aim to find the right 
ratio of bioactive sequences in order to permit the replacement of the scaffold for 
the regenerated tissue. ELRs containing tailored bioactive motifs will be obtained 
through recombinant DNA technology. Moreover, two different gelation 
mechanisms of hydrogels by chemical (covalent bonds) or by physical cross-linking 
will be investigated and characterized by different methods such as rheology and 
Scanning Electronic Microscopy (SEM).  
 
 Secondly, the cyto-compatibility of the designed hydrogels will be assessed by in 
vitro analysis. Moreover, the effective regeneration enhancement of the designed 
ELR-based hydrogels for osteochondral application will be evaluated by ex vivo and 
in vivo studies. In the first case, the study will be carried forward in collaboration 
with LifeTec Group, using an ex vivo platform for cartilage repair. On the other 
hand, we intend to assess the osteochondral regeneration of a critical defect with 
animal study trials. In both cases, the regeneration rate will be evaluated with 
different techniques, such as histology and immunohistochemistry (IHC). 
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 Furthermore, a new hybrid ELRs containing bioactive sequences will be generated 
combining the recombinant technique of the elastin-like recombinamers with the 
strategy of designing novel and more efficient synthetic peptides (in collaboration 
with PepScan). The potentiality of combining these two diametrically opposed 
approaches in a new hybrid biomaterial for broad biomedical application will be 
explored. Indeed, the adhesion capacity of the new material will be evaluated by 
different techniques such as DNA quantification and Morphological analysis for 
HUVECs. Thereby, we intend to discover the enhanced adhesion capacity of the 
hybrid material at short-term or long term, and that may be used as a new tool for 
biomedical applications.  
 
 Finally, a new class of smart-ELRs with an allosteric domain will be investigated. 
We will take advantages from the recombinant technique of ELRs to include 
bioactive consensus sequences and enzymatic activity. A new smart-ELR 
containing the Kinase/Phosphatase consensus sequence will be produced, and the 
thermo-sensitiveness modulation will be evaluated according to the 
phosphorylation/de-phosphorylation of the smart-ELRs. Moreover, in order to aim 
the allosteric control of the smart-ELR, different variants of smart-ELR having fused 
the RNase A catalytic domain will be produced. Then, the smart-ELRs will be 
characterized by several techniques such as mass analysis and turbidity; 
furthermore, the allosteric control of the RNase A catalytic will be assessed by RNA 
quantification analysis.  
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1. INTRODUCTION 
Etymologically, the term protein comes from the Greek proteios, which means “holding 
first place”, or could come from the god Proteus which name suggests “primal”, 
“firstborn” and it is associated to the facility of this God to change his form and opinion. 
The name itself indicates the crucial role that proteins have in the living beings and the 
diverse forms in which we can find them in nature. If the importance of water is well 
known in the composition of the human beings, around 60% in adult males (1), proteins 
are not less important. In fact, more than 50% of the dry weight of our bodies is formed 
by proteins. They may have very different functionalities in the living systems, and some 
of them are large molecules that help to form the structure of our tissues irrespective of 
their location. In this way, we can find them forming really hard structures like bones, 
nails, horns or scales but they are also present in softer tissues like liver, muscles or 
connective tissue. Furthermore, proteins are not only involved in these structural tasks 
but they play a paramount role in the activation or deactivation of gene expression, or 
having regulatory functions helping to organize several processes or regulating 
metabolism or even taking part in muscle contractions. 
Among these proteins, elastin is one of the most important proteins that can be found 
composing the extracellular matrix (ECM) which provides structural integrity to the organs 
and tissues in the living beings. Elastin is not only an important protein within the 
composition of the ECM, but it also possesses certain features that make it unique. For 
instance, it is extremely durable and with a very low turnover in healthy tissues, the 
estimated half-life of this protein is around 70 years (2). Elastin confers elasticity and 
resilience to many tissues like ligaments, tendons, arteries or lungs among others (3). This 
elasticity is given by the presence of hydrophobic regions within the structure of the 
monomers of elastin that tend to aggregate and self-assemble contributing to the 
polymeric organization of the elastin (4). Along the last decades of the 20th century not 
few researchers were interested in this self-assemble property and started to explore the 
synthesis and production of artificial polypeptides based on these hydrophobic domains 
that conferred such properties to the elastin molecule (5-8). They found that the most 
frequent fragment of pentapeptides in the structure of the natural elastin was the 
sequence VPGVG, appearing up to 50 times in a single elastin molecule. It was discovered 
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that synthetic polymers of (VPGVG)n (n ≤ 150) were soluble in water below 25°C but they 
aggregated suffering a phase transition above this temperature (8). This change in the 
conformation of the protein leads to a viscoelastic state in which the amount of polymer 
is around 50% and the other 50% is water. This process is common to all the elastin-like 
polymers (ELPs) and it is accompanied by a halving of the length of the polymer and a 
release of a great amount of energy (9). All this process is driven by a change in the 
structure of the ELP, from an extended conformation below the transition temperature 
(Tt), to a β-spiral with three units of the basic pentamer VPGVG, forming a type II β-turn 
per turn of the spiral, above the Tt (5) (Figure 1). The Tt can be tuned by changing the 
fourth amino acid of the pentamer VPGXG, where X could be any amino acid except 
proline, because its structure destabilizes the β-turn impeding the correct packing of the 
chains of the polymer. The Tt of an ELP is clearly influenced by the nature of the guest 
amino acid on the X position in the sequence (VPGXG)n (apolar residues decrease the Tt, 
while polar ones increase the value of the Tt) and by the overall polymer length (n). The 
effect of these two parameters has been deeply investigated and described by Urry and 
coworkers (10). Moreover, the Tt is sensitive to other external factors as for instance ionic 
strength, pH, pressure, light or chemical modifications (9). 
 
Figure 1. Schematic representation of the conformational change of the ELP and ELR backbone 
depending on the temperature. 
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Chemical synthesis of various polypeptides based on elastin were successfully obtained 
by using standard chemical processes as demonstrated by Urry, Prasad and others (11,12), 
but some problems arise when more complex structures or simply larger polymers want 
to be synthetized, like problems in purification and polydispersity and, even if these 
amounts of mixture of products are obtained in small quantities, they can drastically affect 
the physical properties of the final product (13). The arrival of the recombinant DNA 
technology opened a new way to design and produce synthetic proteins. The old 
nomenclature of ELPs was changed to ELRs (elastin-like recombinamers) pointing out the 
recombinant origin of this new family of elastin-based polymers. With this new approach, 
some of the problems derived from the old chemical synthesis, like polydispersity, need 
for organic solvents and the further elimination of their residues, were overcome while a 
higher control over the amino acid sequence was obtained. Moreover, the purification 
process changed from classical chemical purification pathways to one based exclusively 
on the thermal behavior of the ELRs. After some inverse transition cycles (ITC), which 
imply heating and cooling of the suspension containing ELRs above and below their 
inverse temperature transition (ITT), they can be easily purified without the need of the 
addition of chemical agents or solvents that should be removed afterwards. During the 
last decade, a better control over the recombinant techniques and the use of more 
specific and accurate enzymes has led to the precise biotechnological processes that are 
nowadays applied in the production of the ELRs. 
ELRs are biological polymers that due to their flexibility in the design, their self-assembly 
properties, easy chemical modification allowing the introduction of many interesting 
functionalities, versatility to be processed in many forms (aggregates, fibers, layers, nano-
particles or hydrogels) and excellent cyto- and biocompatibility, have a high potential in 
many fields, from drug-delivery to tissue engineering, including others such as protein 
purification, anti-cancer gene therapies or nano-vaccines. 
In the next pages, we will explore the evolution of ELRs from their ancient chemical origin 
to the most cutting-edge bioproduction techniques, exploring the several hosts that can 
be used to bioproduce them and their versatility in the design. We will also immerse in 
the several structures that ELRs can form and their possibilities in the numerous medical 
fields where they can be applied. 
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2. ELASTIN-LIKE RECOMBINAMERs ENGINEERING, 
BIOPRODUCTION AND DESIGN 
2.1. History and evolution of the synthesis of elastin-like 
recombinamers 
1.3.1. Ancient times (the “chemistry ages”) 
The finding of repetitive sequences in porcine elastin by Gray et al., in 1973 (14), led to 
the chemical synthesis of different versions of some of these oligopeptides, being one of 
them the pentapeptide Val-Pro-Gly-Val-Gly (VPGVG in single-letter amino acid code). 
There was a lot of enthusiasm to study the conformational properties of these peptides 
in an attempt to shed light into the features of natural elastin, a polymeric protein that 
gathered a lot of attention due to its relationship with several diseases (15,16). Hence, 
Urry’s laboratory began synthetizing elastin-derived peptides and soon became one of the 
leading research groups in this field. However, the synthetic strategies required complex 
methods including the use of diverse precursors and solvents, while the overall yield and 
the length of the polypeptide were very limited (17). Despite the limitations, these 
synthetic approaches allowed the attaining of VPGVG (poly)pentapeptides to perform 
conformational studies (17,18), even by covalent cross-linking of these peptides, which 
also led to morphological studies by scanning electron microscopy (SEM) and to the 
determination of stress-strain curves (19). Finally, all these early studies resulted in the 
development of molecular dynamics calculations which gave more information about the 
secondary structure of the protein and about the backbone torsion angles ψ and φ of the 
amino acid residues in the polypeptide, both in its relaxed and extended state (20). 
2.1.2. Modern times (the “recombinant ages”) 
By that time, the last years of the 80´s, recombinant DNA technology had arisen as a very 
promising tool for the biotechnological synthesis of proteins in heterologous hosts, mainly 
Escherichia coli. Therefore, researchers started to use this technology for the expression 
of polymeric proteins to overcome the disadvantages of both chemical synthesis and 
extraction from natural sources. The first biosynthetic strategy for the production of ELRs, 
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in this case fused to silk-like sequences (repetitions of the GAGAGS hexapeptide), was 
reported by Cappello et al. in 1990 (21). Nevertheless, the molecular biology methods that 
led to the obtaining of the elastin-like gene were described two years before in a patent 
by Ferrari et al. (22). This document explains the head-to-tail concatemerization of the 
elastin-like gene by self-ligation of cohesive DNA ends leading to a final gene encoding the 
amino acid sequence (VPGVG)160. Hence, this self-ligation method allowed the synthesis 
of ELR genes with different lengths, although in an uncontrolled manner and without the 
guarantee of achieving a gene with the desired length. This process was further explained 
by Tirrell et al. for the genetic engineering and expression of protein polymers in general, 
also discussing the potential issues derived from the use of the recombinant DNA 
technology (23). 
2.1.3. Contemporary times (the “seamless recursive ages”) 
After these first steps towards genetic engineering of ELRs, new methods were developed 
to overcome some disadvantages, like the low number of endonucleases recognizing non-
palindromic cleavage sites needed for the self-ligation in a correct head-to-tail 
orientation. Hence, some procedures described for general cloning were used in the 
context of ELRs. This is the case of the “seamless cloning” technique that allowed the 
cleavage of DNA outside the recognition sequence by the use of the type IIs restriction 
endonuclease Eam1104I and, therefore, avoided the introduction of extraneous 
nucleotides (nts) in the cloned sequence (23). This method was first used successfully by 
Conticello and co-workers for the synthesis of ELR genes, suggesting that it could be a 
more rapid and efficient system for the bioproduction of protein polymers (25). 
Nonetheless, they still relied in concatemerization to achieve the desired length of the 
gene. To overcome this limitation, Meyer and Chilkoti proposed a new method termed 
“recursive directional ligation” (RDL) (26). In their work, they described the use of two 
different restriction endonucleases with well-defined features, namely PflMI and BglI, to 
synthetize ELR genes. These two restriction enzymes leave single-stranded DNA ends 
upon cleavage that are cohesive one with the other, so one of them can be used to extract 
the ELR insert, while the other one is used to linearize the cloning vector. Both molecules 
were then mixed together for ligation to achieve the final construction. The plasmid vector 
was designed so the restriction sites were maintained after each cloning step, allowing 
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subsequent insertions of ELR-coding genes. As an evolution of this method, Chilkoti and 
co-workers described a new RDL strategy termed plasmid reconstruction (PRe)-RDL (27). 
In this case, they introduced type IIs restriction endonucleases to RDL for a more efficient 
seamless cloning. Moreover, it avoided self-ligation of the vector and nonproductive 
circularization of the insert by cutting both the insert-donor plasmid and the receptor 
vector in halves with two different type IIs endonucleases that leave non-complementary 
overhangs. Therefore, a circular plasmid is only achieved when both insert and vector 
have been ligated. 
Despite the great improvement in the genetic engineering of ELRs reached so far, there 
were still some limitations that should be overcome, like complexity in plasmid design. In 
this regard, Rodríguez-Cabello et al. described a new method for the easy and rapid 
generation of ELR gene constructs and their expression in heterologous hosts (28). For 
this purpose, they relied on the seamless cloning approach through two type IIs 
endonucleases, namely the aforementioned Eam1104I and SapI. The only difference 
between them is that SapI recognizes a 7-nt sequence, while Eam1104I recognizes a 6-nt 
one (GCTCTTC and CTCTTC, respectively), being the latter included in the SapI one. With 
this strategy, it is possible to engineer a plasmid so it can include two Eam1104I restriction 
sites, being one of them also a SapI recognition sequence. For this purpose, two 
commercially available plasmids, one being the pDrive cloning vector and the other one 
the pET-25b(+) expression vector, were modified by site-directed mutagenesis to exclude 
inherent Eam1104I and SapI restriction sites and only include the desired ones. On the 
other hand, it allows controlled concatemerization following the previous guidelines for 
RDL. Furthermore, it avoids self-ligation in a very simple way by treating the receptor 
plasmid with a shrimp alkaline phosphatase, hence eluding the need of cutting plasmids 
in halves as described above. This procedure, named iterative-recursive method, is a good 
example of how molecular biology methods can be fine-tuned to achieve well-defined 
repetitive genes coding for protein polymer sequences very efficiently. 
A schematic representation of the multiple options in ELR design and genetic engineering 
can be observed in Figure 2. 
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Figure 2. Schematic representation of the different approaches for the design and genetic 
engineering of protein polymers in general and ELRs in particular. Adapted with permission from 
(29). 
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2.2. Hosts for the expression of elastin-like 
recombinamers 
2.2.1. Prokaryotic hosts 
2.2.2.1 The gold standard: Escherichia coli 
Like in the case of many other proteins produced by recombinant DNA technology, E. coli 
was used for the heterologous expression of ELRs in the first place, as is the case for all 
the works commented above. This is mainly due to the well-studied metabolism and 
culture conditions of this Enterobacteriaceae. Furthermore, ELRs do not undergo post-
translational modifications and their folding is correctly achieved without the mediation 
of eukaryotic chaperones or any similar system. Hence, E. coli arose from the beginning 
as a good host to achieve an optimal expression and yield of ELR biosynthesis. However, 
although expression was easily achieved for short (30) and long ELRs (31), there was still 
plenty of room for optimization. First, Guda et al. compared the expression of the gene 
coding for G-(VPGVG)119-VPGV in Luria Broth (LB) culture medium following induction 
with isopropylthio-β-D-galactoside (IPTG) and Terrific Broth (TB) without induction (32), 
and they found that the expression was very much higher in the case of TB culture after 
24 hours. This TB medium had shown before a favorable effect on plasmid stability, while 
the use of lactose in TB made it a good auto-induction medium (33). 
Other approaches regarding the optimization of ELR bioproduction explored the 
supplementation of E. coli culture medium with amino acids that are highly repeated in 
the ELR sequence: glycine, valine, proline, and alanine. In this way, depletion of 
intracellular amino acid pools in E. coli could be avoided. Therefore, Chow et al. studied 
the expression of ELR and the final yield in terms of grams of ELR per liter of culture, both 
with LB culture medium followed by IPTG induction, and with TB medium (34). In this 
work, the authors showed that the use of glycerol, phosphate buffer and proline as 
supplements of TB medium enhanced 6-fold the ELR yield compared to the basal TB, from 
an initial 0.27 g/L to 1.6 g/L, with the subsequent reduction in cost. Furthermore, their 
results suggest that, surprisingly, supplementation of amino acids other than those 
abundant in ELRs (asparagine, aspartic acid, glutamine and glutamic acid) also enhanced 
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protein yields, indicating that regulatory mechanisms in the control of intracellular amino 
acid pools that are more complicated than it could be expected in the first place may exist. 
Other works have reported a high-level expression of ELRs fused to silk-like domains, 
hence making silk-elastin-like recombinamers (SELRs). Machado et al. showed a 
volumetric yield of 150 mg/L, being 6-fold higher than previously reported productivities, 
just by using auto-induction TB medium supplemented with lactose and controlling the 
temperature at 37°C (35). However, cell densities were too low compared with lactose 
supplemented TB at the same conditions, so the process could still be optimized. 
Furthermore, it was a low-scale batch production and some parameters influencing 
bacterial culture were uncontrolled. Henceforth, a comprehensive and detailed study was 
carried out by Collins et al., even though it was performed again in low-scale fermentation 
systems (shake flasks) (35). Cultures were performed at different conditions by changing 
medium and medium composition, initial pH, incubation temperature, flask volume to 
culture volume ratio, agitation rate, IPTG induction concentration, elapsed fermentation 
time at induction and induction period. Though the chosen approach was ‘one-factor-at-
a-time’ and therefore the study had some limitations. Despite these limitations, it was 
found that the best yield of 500 mg/L is achieved at 37°C with TB at pH 6-7.5, a 10:1 flask 
volume: culture volume ratio, agitation speed of 200 rpm and induction at the beginning 
of the stationary phase with 0.5 mM IPTG for 4 hours. Further studies were performed by 
the same group, in this case using a fed-batch approach and a 3 L bioreactor, allowing a 
more powerful and deeper experimental design (36). Then, they evaluated the effect of 
the pre-induction and post-induction growth rates, dissolved oxygen concentration, dry 
cell weight at induction, and IPTG concentration for induction. Furthermore, they could 
control pH, O2 concentration and feeding of a glucose solution during all the fermentation 
process. With this experimental setting, they showed that they obtained a yield of 4.3 g/L 
of SELR in the best conditions. This is 9-fold higher than the data previously reported by 
them. 
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2.2.2. Eukaryotic hosts 
2.2.2.1 Aspergillus nidulans fungus 
One of the first attempts to produce ELRs in eukaryotic hosts was made by Herzog et al. 
in Aspergillus nidulans (A. nidulans) fungus (37). They inserted the gene encoding for G-
(VPGVG)119-VPGV mentioned above into an expression vector designed for A. nidulans 
under the control of a constitutive promoter. Their results showed that they were able to 
isolate different fungus colonies that integrated the plasmid with varying copies into their 
own genome. However, the translational efficiency was low, and they suggest that this 
effect could be due to some codons found in the ELR gene (cloned from an E. coli-
optimized plasmid) that are rarely used in A. nidulans. Despite the proposal made by the 
authors towards the optimization of ELR bioproduction through A. nidulans, no other 
examples have been found in the literature. 
2.2.2.2 Yeast 
On the other hand, the well-studied Pichia pastoris (P. pastoris) yeast has become a model 
eukaryotic organism for recombinant protein expression and there are some examples in 
the literature in which it has been chosen for the biosynthesis of ELRs. In the first case 
reported, Schipperus et al. produced secreted ELRs in P. pastoris with a yield of 255 mg of 
ELR per liter of culture medium (38). They suggest that this low-scale system is completely 
scalable, easily purifying ELRs without the need of cell disruption, even though times for 
culturing and inducing expression in yeast are substantially longer than in the case of E. 
coli. Furthermore, this expression host allows glycosylation and/or formation of disulfide 
bonds, so it is proposed as a good system for the expression of ELR fusion proteins that 
may undergo any of these post-translational modifications. Almost at the same time, 
Sallach et al. described the expression in P. pastoris of non-repetitive ELR genes with 
identical amino acid sequences, taking advantage of the degenerate genetic code (39). 
They propose the same advantages than the previous work, but they also emphasize that 
in a yeast expression system there is no need to remove bacterial lipopolysaccharide, 
achieving an endotoxin-free product after simple ITC purification. In another study by 
Schipperus et al. comparing the secretion of ELRs with different transition temperatures 
(Tt) by P. pastoris, they found that higher yields are obtained for shorter and more 
hydrophilic ELRs (39). Therefore, they suggest that below Tt the ELRs are soluble and more 
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easily secreted. However, the conclusion to this work seems too ambitious since only 
three ELRs were designed and produced for the comparison, and none of them was 
strongly hydrophilic. 
2.2.2.3 Plants 
As regards other expression systems, recombinant protein production in plants has been 
widely developed since the beginning of the recombinant DNA era and, hence, ELRs have 
been produced in this system too. In the first work describing ELR production in plant cells, 
Zhang et al. transformed tobacco cells physically by particle bombardment (biolistics) for 
the expression of the gene encoding (GVGVP)121 (41). They showed the integration of the 
ELR gene in the genome of the cells (2-5 copies) and expression of the elastomeric protein, 
although at very low quantities. As a next step, the following article by this group showed 
the feasibility to express the same ELR in transgenic tobacco (Nicotiana tabacum) plants 
(42). Nonetheless, only 0.5 to 5 µg per g of fresh weight of leaf tissues were obtained, 
being approximately 0.003 to 0.03% of total soluble proteins, while 0.01 to 0.05% was 
observed by Western blot prior to purification. Even though there are many other 
examples of expression of ELRs in transgenic plants, they mostly use them as fusion tags 
to improve the stability of the expression and the purification efficiency of different 
recombinant proteins, which will be briefly described below. However, there is a very 
recent work by Heppner et al. that describes the bioproduction of a fusion protein 
comprising spider silk and ELR sequences in tobacco leaves (43). The spider silk block is 
not excised from the whole protein after purification, so it can be taken as an example of 
ELR expression in plants. Authors showed a yield of 400 mg per 6 kg of leaves (66.7 mg/kg 
or µg/g) which is more than a 13-fold increase when compared to the results commented 
above, although the comparison is limited because in this last case ELR is fused to spider 
silk. The expression of ELRs in all the heterologous hosts described in this section is 
summarized in Table 1. 
 
 
 
60 
 
Host (VPGXG)n composition Main achievements Refs. 
Prokaryotic Escherichia 
coli 
(VPGVG)160 First recombinant 
production of an ELR 
combined with silk-like 
sequences 
(22) 
(VPGVG)20 First biotechnological 
production of an ELR by 
itself 
(30) 
(VPGVG)251 First reported expression 
of extremely long ELRs (31) 
(VPGVG)120 Comparison between 
culture media of different 
composition 
(32) 
[(VPGVG)2-
VPGGG-VPGAG-
(VPGVG)3-
VPGGG-VPGAG-
VPGGG]9 (also 
called ELP-90) 
Supplementation of 
medium with amino acids 
highly repeated in ELRs to 
avoid depletion 
(34) 
(VPAVG)20 and 
(VPAVG)9 
SELR with high yield by 
using auto-induction 
medium 
(35) 
(VPAVG)9 ‘One-factor-at-a-time’ 
optimization of the 
bioproduction of a SELR in 
shake flask cultures (low 
scale) 
(36) 
(VPAVG)9 Optimization of the 
bioproduction of a SELR in 
fed-batch culture in a 
bioreactor obtaining the 
highest yield reported to 
date 
(37) 
Eukaryotic Aspergillus 
nidulans 
fungus 
(VPGVG)120 Unique example of ELR 
expression in fungal hosts (38) 
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Pichia 
pastoris 
yeast 
ELP-90 First reported expression 
of secreted ELRs in yeasts (39) 
[(VPGVG)2--
VPGEG-
(VPGVG)2]21 
Suggestion of avoidance 
of LPS removal (40) 
ELP-90 
ELP-40 
[(VPGVG)2-
VPGGG-VPGLG-
(VPGVG)3-
VPGGG-VPGLG-
VPGGG]4 
Higher yields for shorter 
and more hydrophilic 
ELRs 
(41) 
Nicotiana 
tabacum 
cells and 
plants 
(VPGVG)121 First work describing ELR 
production in plant cells (42) 
(VPGVG)121 First expression of an ELR 
in plants (43) 
ELP-100 ELR fused to a spider silk 
protein produced through 
a simple and scalable 
method 
(44) 
 
Table 1. Table describing the heterologous hosts used for the bioproduction of ELRs to date. 
2.3. Novel design of elastin-like recombinamers with 
different features 
Taking advantage of the genetic engineering, which may allow the inclusion of changes in 
the amino acid sequence of ELRs or even the fusion of different proteins, the features of 
ELRs can be tuned and/or improved, increasing the complexity of these protein polymers 
(44). 
2.3.1. Substitution of the guest amino acid 
One of the first choices regarding the modification of the ELR sequences is the amino acid 
in the fourth position (guest residue) of the elastin-derived pentapeptide, or the X in 
VPGXG, as described above. Since this choice may change completely the physicochemical 
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properties of the ELR, the Tt above all, it is a common way to differently design ELRs and 
has been extensively evaluated (45). Moreover, the molecular biology methods used in 
the synthesis of ELR genes permit the construction of elastin-like block corecombinamers 
(ELbcR) that arise as a result of the combination of elastin-like sequences with different 
substitutions in the guest residue. This approach may confer different properties to a 
single ELR molecule (46), and also leads to more complex self-assemblies above the Tt as 
evaluated in different works (47,48). In addition, Meyer et al. studied the effect of the 
length and concentration on the Tt for different ELRs, showing that there is a higher 
decrease of Tt for ELRs with lower molecular weight (MW) when the concentration is 
increased, while this effect is lower for ELRs with higher MW (49). Furthermore, they 
proposed equations that may allow the prediction of the Tt for other ELRs. Some years 
later, the same group further evaluated the changes of Tt depending on alanine content 
as the guest residue, and on MW of the ELR and concentration, developing a model to 
predict Tt by changing these conditions (50). Through the combination of two different 
factors affecting Tt, i.e. the arrangement of blocks with different guest residues and the 
length of these blocks, Ribeiro et al. showed that it is not only the mean polarity what 
influences variations in Tt and enthalpy (ΔH) of the transition, but also the distribution and 
length of the polar/apolar blocks within the ELbcR molecule (51). 
2.3.2. Fusion of other protein polymers 
Many studies have explored the possibility of using ELRs in combination to other protein 
polymers like silk, collagen or resilin to improve or change their properties in different 
applications, most of them within the field of tissue engineering (52). 
The first examples of this section have already been shown above in relation to SELRs. 
Silk-like domains derive from the repetition of the GAGAGS hexapeptide found in Bombyx 
mori silk fibroin, which is known to self-assemble into β-sheet secondary structures, 
conferring high strength, toughness and ductile elongation to materials (21). They have 
been widely fused to elastin-like blocks by different groups. For example, Nagarsekar et 
al. described the design and production of different silk-elastin-like block co-
recombinamers (SELbcRs) that showed sensitiveness to diverse stimuli like pH and 
temperature (53). In another study, Wang et al. developed a high-throughput for the 
screening of SELRs matching specific material functions (54). For this purpose, they 
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expressed a library of different SELRs in E. coli cultured in 96-well plates and purified the 
recombinamers in situ. Then, they performed a physicochemical and mechanical 
characterization on those SELRs without taking them out of the plates, suggesting that it 
could be a rapid and powerful tool to elucidate the properties of recombinant materials. 
In another work, Bracalello et al. designed and produced a chimeric resilin-elastin-
collagen-like recombinamer that showed a different self-assembling pattern than any of 
each protein polymer had shown separately, with great tendency to form higher order 
fibrillar structures (55). 
2.3.3. Fusion of bioactive domains 
In order to generate extracellular matrix-like materials, cell adhesion motifs have been 
fused to ELR sequences by genetic engineering as described by different groups. In a first 
example, Panitch et al. combined a VPGIG repeated sequence with the REDV peptide 
found in the CS5 region of fibronectin that promotes endothelial cell attachment and 
spreading, but not smooth muscle cells or platelets (56). In their work, they showed a 
successful attachment of cells on surfaces coated with the ELR, compared to the control 
surfaces. Similarly, Girotti et al. fused the REDV sequence to an ELR including lysine-
containing blocks that could be cross-linked to form artificial matrices, as demonstrated 
(57). 
Regarding other cell-adhesion sequences, Urry and co-workers used the RGD tripeptide 
(58) for the first time to successfully enhance cell attachment on ELR-based matrices 
cross-linked by γ-irradiation (59). However, this first case of RGD modification was 
performed with chemically synthetized polypeptides. On the other hand, the first example 
found in the literature of a recombinantly produced ELR including RGD sequences was 
reported by Liu et al. who compared the cell response between RGD and REDV sequences 
(60). In their study, they found that RGD promoted a faster attachment while being 
stronger than in the case of REDV. Most probably because of that finding, many other 
groups have included RGD domains within ELR molecules since then to improve cell 
adhesion. 
In addition to these works regarding cell-adhesion sequences, other motifs have been 
fused to ELRs to undergo dimerization, therefore modifying the structural properties of 
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their supramolecular assembling. This is described in the work by Fernández-Colino et al., 
where they showed the fusion of a leucine zipper domain, containing a cysteine residue, 
to an ELbcR (61). This domain was shown to be able to form dimers stabilized by a disulfide 
bond, hence allowing the cross-linking of hydrogels based on this zipper-containing ELbcR 
in a reversible manner, depending on the redox conditions of the system. On the other 
hand, Zhang et al. designed and bioproduced ELRs including either a SpyTag short 
polypeptide or a SpyCatcher protein (62). This protein is able to recognize the SpyTag 
polypeptide undergoing an autocatalytic bond formation between them. The 
combination of ELRs comprising these Spy sequences resulted in different supramolecular 
structures that were further characterized.  
As can be deduced from the above paragraphs, many different sequences can be 
recombinantly introduced within the backbone of the ELRs depending on the physical, 
chemical and biological requirements of the final protein and the subsequent application. 
2.3.4. Fusion of full-length proteins 
In order to anticipate the properties of ELRs when fused to different proteins, Chilkoti and 
co-workers studied the effect of the arrangement of four proteins in the final fusion 
product, i.e. C-terminus or N-terminus, on the expression levels and yields of purified 
protein (63). By their results, they could conclude that the yield was higher when the 
proteins were placed at the C-terminus, and that the specific activity of the fused proteins 
was higher in that case for three out of four proteins. However, as they comment 
themselves in the manuscript, these results are applicable only to an ELR with a specific 
sequence, and to four particular proteins. Additionally, the same group was able to 
develop a model to predict the effect of hydrophilic proteins on the thermal behavior of 
ELR fusion proteins, showing that the presence of charged residues is the most important 
parameter affecting the Tt of the ELR when compared to the ELR itself (64). 
Many other proteins have been fused to ELRs to date. Some of them used ELRs as tags, 
taking advantage of their facile purification by ITC (31) to produce recombinant proteins 
(65) that are finally excised from the ELRs by different methods, namely intein self-
cleavage (66), protease-mediated cleavage (67), or by including the self-processing 
module from Neisseria meningitides FrpC (68). There are many examples in which this 
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approach has been employed in the expression of recombinant proteins in Nicotiana 
tabacum plants (69), like an anti-human TNF antibody (70), and in tobacco cell 
suspensions to produce human IL-10 (71). Furthermore, this strategy has been also shown 
to be successful to produce antimicrobial peptides in E. coli efficiently (72,73). 
3. STRUCTURES AND PHYSICAL CHARACTERISTICS OF 
ELASTIN-LIKE RECOMBINAMERs 
Materials based on ELRs underlie a high potential, characterized by the extraordinary 
biocompatibility, tunable mechanical properties and the variety of structures that can be 
generated (i.e. micelles, nanoparticles, hydrogels, films, and nanofibers). Besides the 
introduction of bioactive sequences into the ELR-based structures, ELRs can be designed 
to self-assemble into either micelles, physical hydrogels, nanoparticles, or solvent casted 
films (Figure 3). Furthermore, reactive cues can be introduced in the sequence to allow 
chemical modification. 
 
 
Figure 3. The diversity of ELR structures and their sequential origin.  
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3.1. Micelles and nanoparticles 
The first self-assembling ELRs were achieved with polymers containing blocks of different 
polarity, inspired by block-copolymers and their related properties, like phase separation, 
micelle formation, etc. The difference between block-copolymers and amphiphilic ELRs, is 
that in amphiphilic ELRs the blocks of different polarity retain the ELR pentapeptide 
sequence (VPGXG), and the changes in polarity are introduced through the X amino acid. 
The influence of the X amino acid, has been methodically described by Urry (74). As well 
as block-copolymers, elastin-like block co-recombinamers (ELbcRs) showed the ability to 
form micelles in solution. The hydrophobic block tends to be embedded in the core, 
hidden from the water solution, while the hydrophilic block(s) forms the corona exposed 
to the outer part of the structure. It has been shown that the formation of stable 
nanoparticles requires a relatively high molecular weight of at least 48 pentapeptides. 
Furthermore, the particle size and the molecular weight of the ELR are directly related 
(75). The ITT of the ELRs, depending on the characteristics of the micelles, can either lead 
to coalescence of micelles into lyotropic gels (76), through polydisperse microparticles 
(77), or to a simple swelling and deswelling of the micelles, accompanied by size changes. 
Typical sizes of ELR nanoparticles reported are usually in the range of 10 to 100 nm (78-
83), but due to the temperature sensitivity and related agglomeration, also micro sized 
particles have been reported (77, 84). The ability to trigger the formation of nanoparticles 
by the swelling and shrinking kinetics, intensified the research on the tuning of the micelle 
sizes and the Tt related changes. Several methods have been explored to either stabilize 
ELR-based micelles. For instance, the concentration of the ELR solution, which has been 
found to have a clear effect in the particle size (76); another method is the addition of 
surfactants that can stabilize or destabilize the ELR particles (85); salt concentration is 
crucial, higher compensation of the charges of the hydrophilic blocks through counter ions 
can lead to stronger agglomeration of particles (80, 81, 83); and last but not least, the pH 
affects the stability and size, depending on the chemical properties of the guest amino 
acid in the fourth position of the basic pentamer (VPGXG) of the hydrophilic block. In the 
case of cationic amino acids the charge is reduced at high pH, on the other hand, anionic 
amino acids show the same behavior at low pH (80). Moreover, more specific sensors for 
changes in salt concentrations have been designed. For instance, the introduction of a 
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calcium selective sequence amplified the influence of calcium concentration, by reducing 
the transition temperature of the corresponding ELR from 70°C to 35°C (86). Even when 
the general shape of homogenous micelles is round, it can be tuned to more anisotropic 
cylindrical shapes by varying the architecture of the ELRs introducing amphiphilic blocks 
of different sizes in the protein sequence (87). In principle, each ELR has one clear 
transition temperature, but in the case of amphiphilic ELRs with different blocks, long 
enough to develop an own intrinsic transition, the effect of temperature on the particles 
shows two temperature-induced changes. First, the rearrangement of the hydrophobic 
core, driven by a change in the secondary structure from random coil and β-sheets to 
type-II β-turns. This change as well corresponds with the exhibition of a cylindrical shape 
of the particles. This effect is also known as critical micelle temperature (CMT). The second 
and more prominent change is due to the collapse of the hydrophilic part, which is 
responsible for the coalescence, agglomeration and precipitation of the micelles (75). 
Other reported rearrangements describe the change from micelles to vesicles by 
reorganizations of the hydrophobic blocks. Here, vesicles could be obtained either by an 
increase of the length of the hydrophilic block, or by addition of another hydrophilic block 
to a triblock copolymer of the structure hydrophilic-hydrophobic-hydrophilic (48). 
3.2. ELR-coatings and films 
The generation of ELR coatings has a great interest for the creation of either antimicrobial, 
anti-fibrotic coatings, or for the deposition of a bioinductive layer that allows cellular 
interaction driving to a good implant integration within the surrounding tissues. In theory, 
there are two ways to accomplish a coating: physisorption by intermolecular interactions 
(hydrophobic and/or electrostatic interactions), or a grafting approach by covalent 
binding (Figure 3). For completion, a third possibility could be possible, which is the 
creation of elastin-like brushes by a grafting approach, but due to the relatively high 
molecular weight of ELRs, and the related cost to generate such proteins in a synthetic 
way, this approach is still a hypothetical option. Additionally, these proteins would not be 
ELRs since they are not obtained by recombinant techniques so they should be classified 
as ELPs (8, 19, 88, 89). 
68 
 
Physisorption of ELRs has been deeply studied and applied in different works. It was 
described by Srokowski et al. that longer ELRs formed more stable coatings by 
physisorption than ELRs with lower MWs (90). Another approach targets on the 
endothelialization of CoCr alloys, that could be enhanced by physically adsorbed or 
covalently bond ELRs that bear a REDV sequence (91). ELR coatings also proved to reduce 
platelet activation and smoothening of surface topographies when coated PTFE 
substrates by a layer-by-layer approach (92). This was corroborated by other studies that 
showed that longer ELR sequences not only have a better deposition, but also decrease 
platelet activation more than short ELRs (90). In an earlier study, the patency time of non-
thrombogenic ELR coatings could be more than doubled (93), and thrombus formation 
reduced (94). 
Further micelle solutions have been used to adsorb ELRs to surfaces under retention of 
their nano- and microtopography. For the generation of surfaces that induce bone 
mineralization nanotopographies, it was performed a coating with an ELR containing a 
human salivary statherin sequence (95). The coating of previously generated orientated 
electrospun fibers with ELRs led to a conserved orientation in the scaffold, which guided 
human vocal fold fibroblasts (96). The transition temperature of the ELRs was also used 
to enhance the physisorption by thermally induced deposition. Here, surfaces with a low 
RGD concentration were formed, high enough to allow cell adhesion, but too little to form 
a cellular monolayer. Thus cells were forced to cluster and semi-functional pseudoislets 
could be formed (97). The good mechanical performance of SELR hybrids further led to 
the development of coatings for osteochondral applications (98). Besides the deposition 
of ELRs in order to induce or avoid attachment of cells or proteins, the ability of the ELRs 
themselves to influence the microenvironment by temperature changes is of great 
interest, for example for biosensors, or drug delivery systems. By changing the 
temperature, features like the wettening of the surface (77), the release kinetics of drugs 
embedded in the coating (84), or the accessibility of active groups inside the ELR sequence 
in swelling and deswelling ELR/RGD brushes (99), can be controlled. 
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3.3. ELR-based hydrogels 
In tissue engineering, hydrogels have been the predominant matrices for application in 
the human body in the last 40 years (100). A high water content leads to convenient 
mechanical properties and stimuli-responsiveness, which in many cases chimes with the 
properties of natural tissues (101,102). ELRs, inspired in a natural protein such as elastin, 
are excellent candidates for many researchers focused on the generation of artificial 
matrices that can be used as scaffolds for biomedical applications. The ECM is a very 
complex system in which the physical properties (elasticity, stiffness), the nano-
topography, the presence of signaling molecules, protease-sensitive sites and adhesion 
domains are of great importance, and gathering as many of these properties as possible 
is a major requirement that have to be demanded to any material that might be used in 
tissue engineering. The generation of hydrogels from linear ELRs requires paying special 
attention to the mechanism that will drive the cross-linking of different ELRs molecules. 
These cross-linking methods can be either of covalent or physical nature and the position 
of cross-linking points along the ELR backbone can be fully controlled through genetic 
engineering to get a precise tuning of the mechanical properties. Polypeptide-based 
block-copolypeptides, for example, manage to self-assemble into stable hydrogels (103), 
which can be further stabilized when flanked by protein segments with coiled-coil 
secondary structure (104, 105). Another approach is the use of recombinant segments of 
elastin, silk and collagen (106-108). In contrast to general methods for the formation of 
hydrogels by radically or photo-polymerized acrylate cross-links, ELR hydrogels can be 
thoroughly controlled (e.g. chain and segment length, number of cross-links per chain). 
This leads to more homogeneous matrices, and to the reduction of artifacts, which could 
impair the mechanical properties of the resulting hydrogels (109). 
Cross-linking mechanisms for ELRs can be as versatile as ELRs themselves: ionic or 
hydrophobic interactions, reaction of complementary groups, or enzymatically induced 
cross-links (Figure 4) (110, 111). All these strategies can provide a very tight control over 
the length and the molecular weight of the proteins by the selection of the cross-linking 
sites, which usually correspond to lysine groups (112, 113). Besides the control of the 
cross-linking, aforementioned bioactivities can be introduced into ELRs, so that the matrix 
is able to interact with the organism, improving the good integration of the generated 
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tissue. The basic ELR sequence (VPGXG) is biocompatible, but lacks cellular adhesion sites. 
Nevertheless, the possibility of a tailored genetic design permits changes in the transition 
temperature, integration of protease-sensitive sites (114, 115), cellular adhesion motifs 
(59, 116), or biological triggers (117-119). 
 
Figure 4. Common ELR crosslinking strategies: A) ionic interaction, B) chemical crosslinking, C) 
hydrophobic interactions, D) enzyme triggered crosslinking. 
Physical cross-linking of ELRs can be obtained by several strategies. One approach is a 
cross-linking based on ionic interactions by segments of opposite charge (e.g. cationic and 
anionic amino acids in the X position of the ELR). Even though ionic interactions are 
relatively weak, a specific design of complementary charged strands (120, 121) helps to a 
better strengthening of these interactions which leads to obtain stable ELR hydrogels at 
room temperature and physiological pH (122). Potentially, the presence of ions could 
trigger the formation of hydrogels, since some ELRs are sensible to salts concentration 
changes, especially to chelating ions like calcium (121). More advanced approaches 
including ELR/chitosan blends, could be stabilized by sodium ions (123), and modification 
with monosaccharide side chains allowed a complexation with potassium (124). A second 
way of physical cross-linking is obtained by the introduction of self-assembling motifs, i.e. 
amphiphilic blocks, or interaction of protein secondary structures (β-sheets, leucine 
zippers). The self-organization is basically driven by aggregation of different segments. In 
71 
 
the case of amphiphilic block ELRs this self-assembling is due to the aggregation process 
of the hydrophobic segments. On the other hand, the interaction of secondary structures 
is triggered by the aggregation of β-sheets or pairing of leucine zippers. 
Hydrophobic blocks are generated when the ELR sequence has several hydrophobic amino 
acids (like alanine (Ala), leucine (Leu), isoleucine (Ile), valine (Val), phenylalanine (Phe), 
tryptophan (Trp), tyrosine (Tyr) or methionine (Met)) on the X position. This results in 
segments of distinct polarity within the same protein chain and leads to mutual repulsion 
between the different blocks, that tend to segregate. The segregation is locally 
constrained by the “forced cohabitation” of the blocks within the same ELR chain, 
resulting in a separation into different domains, which as a consequence, self-assemble 
into periodic nanostructures (125). Amphiphilic blocks can be designed to form stable 
hydrogels that even persist in vivo. One way to enhance stability is to create longer 
sequences with several blocks of alternating polarity (108, 126, 127). 
The interaction of intermolecular secondary structures, on the other hand, follows the 
key-lock-principle with the assembly of matching structures of similar polarity. From the 
tailor perspective, almost any protein secondary structure that is able to form a stable link 
with itself or contrary groups could be implemented. It has to be considered that in one 
component systems gelation can occur easily, and solvation is limited. Furthermore, the 
effect on the ELRs Tt has to be considered. 
The recent approaches to include physical cross-linking cues into ELRs are inspired by 
natural silk sequences that enable crystalline-like β-sheets formation with unique 
mechanical properties (128-132). The repetitive sequence responsible for the β-sheet 
formation and for the intrinsic strength is the GAGAGS hexapeptide (Bombyx mori 
silkworm) (133). In this silkworm, the blocks are stabilized by hydrophilic compartments 
within the protein and a complex mixture of stabilizing agents (134). The integration into 
ELRs needs to consider the stability of the resulting bonds and the amount of silk domains 
govern the manipulation of the material. Silk-ELR (SELR) hybrid materials reveal a two-
step gelation process when heated above the Tt. The ELR transition occurs first, enabling 
the thermodynamically driven annealing of silk sequences, hence forming stable 
physically cross-linked hydrogels in situ (108). SELRs are biocompatible and performed 
well in in vivo studies (135-137). Moreover, they have been forged into a variety of 
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structures like hydrogels, films, 3D porous matrices and submicron to macroscale fibers 
(138). 
Lately, ELRs physically cross-linked by leucine zipper domains (139-145) gained interest. 
The leucine zippers are capable to dimerize with other leucine zipper domains driven by 
hydrophobic interactions (139,146-148), and ionic interactions (149-151). On account of 
its novelty, ELRs with leucine zipper motifs have been less explored than SELRs, and the 
complete potential remains to be discovered. Nevertheless, the human origin of the 
domain and the conserved nature of the structure alleviate concerns regarding the 
biocompatibility. First studies on ELR-Zippers support the biocompatibility and showed 
enhanced stability when compared to pure amphiphilic block ELRs (61). Furthermore, a 
recent in vivo study regarding zipper-based scaffolds revealed no foreign body reaction 
(152). 
The introduction of amino acids bearing functional groups in the X position can be used 
for subsequent reactions without losing the pH and temperature sensitivity of the ELRs. 
The majority of published works used the free ε-amine of lysine residues within the ELR 
chain for chemical modification due to its reactivity. (153, 154) Regarding the cross-linking 
process, the MW, concentration and the number of cross-links are important to form 
stable hydrogels (155). ELRs with high molecular weight have a higher entanglement and 
are more prone to establish a sufficient number of cross-links to stabilize the hydrogel 
network. Due to the tailored design of the ELR sequence, the number of cross-linking sites 
and the segment length between cross-links can be precisely controlled, enabling the 
tuning of relevant features such as pore size, gelation time, stiffness and degradability. 
Functionalization of ELRs aims to introduce bioactive sequences, adhesion sites, 
inhibitors, antibodies or anchor and signaling molecules (156). Degradation can be further 
controlled through the introduction of protease-sensitive sequences, or through the 
introduction of labile chemical linkages (157). 
One drawback of common chemical linkages is that they are reactive under conditions 
that require organic solvents or other chemical reagents to avoid hydrolysis. To elude 
removal of this undesired components, the typical cross-linking of hydrogels is based on 
the reaction of complementary groups (158), enzymatic cross-linking (159-161), 
condensation reactions (162), or high-energy irradiation (163). The classical cross-linking 
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reactions of ELRs are solvent dependent, in organic solvents, due to the absence of a lower 
critical solution temperature (LCST). The obtained hydrogels are very homogenous, 
whereas in water the diffusion of active sites is limited above the LCST (112). The fusion 
of several ELR strands by cross-linking results in stable hydrogels, which remain stable 
when cooled below the ELRs Tt. Using enzymatic cross-links, hybrid protein hydrogels of 
ELR and other functional proteins can be obtained. Mild covalent cross-linking strategies 
without organic solvents and cytotoxic reactants have some important advantages, such 
as that the gelation can be performed in the implantation site, without further purification 
in situ, without the diffusion out of the injection site. Ravi et al. showed that an 
ELR/fibronectin gel cross-linked by genipin performed well in vitro. (164) Moreover, the 
Huisgen reaction has been introduced in the past years to form ELR networks in water 
(165, 166). The reaction of complementary groups can be used further to fuse ELRs of 
different bioactivity together (167), and to generate hybrid materials. This method has 
been used for the creation of non-thrombogenic stents (165). 
4. ELASTIN-LIKE RECOMBINAMERS: APPLICATIONS 
4.1. ELRs for gene delivery applications 
Gene therapy provides a unique approach to deliver a therapeutic gene into specific 
human tissues or cells; the modification of patient’s altered gene expression can be 
performed by gene addition, gene correction, gene knockdown or their combination (168, 
169). The concept of gene therapy is based on nucleic acids being used as pharmaceutical 
products to obtain in vivo production or silencing of therapeutic proteins (170, 171); the 
therapeutic material can be integrated into the host chromosome or remained as an 
episomal plasmid with transient expression (168, 172). The successful expression of the 
deficient gene product at physiological levels (168, 173) is based on an appropriate 
delivery system (174). The most important properties that a delivery vector must have are 
the biocompatibility and the ability to release the cargo into a specific target. 
Gene delivery systems can be divided into two categories: viral and non-viral vectors. 
Despite approximately 65% of clinical trials use a viral vector for DNA delivery (175), non-
viral vectors have been widely studied over the past few years and constitute the most 
promising alternative for overcoming the immunogenicity problems inherent to viral 
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vectors; moreover, they are easier to produce on a large scale (176, 177). Cationic 
polymers can form a complex with DNA by electrostatic interactions with the negatively 
charged phosphates from nucleic acids. The formed polyplex is able to protect the genetic 
material from degradation by nucleases (178). PEI (polyethylenimine), PEG 
(polyethyleneglycol), PLL (poly-L-lysine), chitosan, PLGA (polylactic-coglycolic acid), and 
PDMAEMA (polydimethylaminoethyl methacrylate) are some of the most widely used 
non-viral gene delivery vehicles (169, 179-181). The cytocompatible nature of the 
biomaterial forming the polyplexes and their ability to be internalized into the cell 
determine the success of the system (177, 179, 182-184). Nevertheless, most of the 
cationic polymers mentioned above are not ideal for drug delivery application. For 
instance, the main problem of PEI is its cytotoxicity, causing cell apoptosis in a wide 
number of human cell lines (185). Regarding PEG, not only hypersensitivity reactions occur 
when it is injected intravenously, but also cutaneous application can cause allergic 
reactions, such as contact dermatitis (186). 
Thus, it is required a new design of gene delivery vectors able to address the individual 
rate-limiting steps along the gene delivery process (187). ELRs have grown in popularity 
in the field of protein-inspired biomimetic materials, and they are becoming increasingly 
important in different fields of biomedicine (165, 188-190). ELRs are non-immunogenic, 
and according to with their biodegradability and biocompatibility for human tissue, blood, 
and other fluids, they can play a key role as carriers in delivery systems (189, 191, 192). 
ELRs have been previously used as oligo-lysine carriers by Furgerson’s group to deliver an 
EGFP−plasmid inside cells in in vitro assays (193). The use of specifically designed ELRs 
joined to functional peptides as agents shows promising results for delivering genes in 
vitro (190). Moreover, cellular transfection can be improved through the formation of 
charged polyplexes and their further interaction with the negatively charged components 
on the cell membrane, such as proteoglycans and cell-surface receptors (194, 195). In this 
study, taking advantage of the recombinant DNA technology to design and produce ELRs, 
functional motifs were incorporated into a basic ELR sequence. Then, imidazole groups 
were covalently bound, obtaining stable polyplexes composed of plasmid DNA and ELRs 
(190). Several studies have demonstrated the use of ELRs fused to a cell penetrating 
peptide (CPP) as a drug delivery vector for solid tumors (182, 196, 197). In this sense, a 
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similar combination of ELRs fused to CPPs was utilized to deliver therapeutic peptides into 
target tumor cells (198). Finally, Piña et al., specifically designed a lysine-enriched ELR in 
order to complex and protect the therapeutic DNA, forming stable polyplexes. In this 
work, for the first time, cancer-specific aptamers were incorporated into ELR polyplexes 
with potential application in the treatment of breast cancer (199). 
4.2. ELRs as vaccine delivery systems 
In the past recent years, due to the increasing knowledge about the mechanisms of 
protective immune responses, and about new biotechnology techniques, newer vaccine 
designs have been considered. For instance, a novel approach based on genetic 
engineering in order to obtain non-pathogenic vaccine strains, naked plasmid DNA 
vaccines, or for the preparation of relevant recombinant proteins that may lead to 
adequate immunity (199). Certainly, the ability to isolate and produce pure proteins and 
peptide antigens that are safer than traditional vaccines has enhanced the vaccine efficacy 
(201-203). However, a limiting factor with antigens made by recombinant DNA technology 
is that they are often weakly immunogenic on their own, thus it is often required the 
inclusion of immune adjuvants to enhance the resultant immune responses (204, 205). 
Adjuvants have the ability to activate antigen-presenting cells (APCs), and despite their 
clear relevance and essential role, only adjuvants that induce minimal adverse effects are 
acceptable for standard prophylactic immunization in healthy individuals. 
Certainly, the relative lack of antigenic carriers approved for the usage in humans suggests 
that better materials and new strategies are needed to generate successful nanovaccines. 
As it has been already described, biomaterials play a key role in the therapeutic field 
regarding vaccine development. The engineering of materials that can modulate the 
immune system, known as immunobioengineering, is playing an increasingly important 
part for the development of new particulate vaccines and adjuvants carrying the desired 
epitopes for immunization (201, 206, 207). Therefore, because of one of the most 
powerful strategies to form very small particles is based on self-assembled di-block co-
polymers, many different materials displaying stimuli-responsiveness with different 
molecular architectures have been investigated (207). 
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Several factors such as particle size, surface properties, particle shape, and hydrophobicity 
(201, 208, 209), affect the nature of the immune response caused by biomaterial-based 
nano-objects. It has been shown that the particles themselves are intrinsically recognized 
as a sign of danger (210), and considering that the particle size is the primary control 
parameter, a particulate vaccine can target several pathways depending on its size. 
Biomaterial particles can include specific functional domains such as targeting ligands that 
are able to bind specific receptors for endocytosis, promoting an increase of specific 
cellular uptake (204, 211). In addition, another important parameter is the hydrophilicity 
in the nanoformulation, that can modulate the amount of proteins adsorbed onto the 
surface of nanoparticles after the administration, increasing their residence time in 
circulating blood (212). 
ELRs play a key role in several biomedical applications due to the ability to control and 
manipulate the interface between them and the biological components. In this sense, the 
American Society for Testing and Materials (ASTM) has demonstrated their extraordinary 
biocompatibility, while the feasibility of tuning and controlling the shape and topology of 
ELRs has been previously explored (213, 214). In addition, elastin-like block co-
recombinamers (ELbcRs) are able to form multimeric nanoparticles by self-assembling, 
and considering the ability to control their hydrophobicity, molecular weight and block 
rearrangement, ELRs are exceptional candidates as carriers in vaccine-delivery 
approaches (191, 215). The recombinant production of ELRs allows obtaining a highly 
monodisperse, multivalent and biocompatible properties of the resulting constructions 
by a simple, affordable, reproducible and easy to scale up the process of bioproduction 
(216, 217). Furthermore, ELbcRs can be subjected to secondary processes such as 
sterilization, drying, packaging, and reconstitution of the resulting dried powder (126, 
218). 
Another advantage of the ELRs about the vaccine formulation regards the possibility to 
develop a single-gene product that self-assembles into a nanoparticle with the desired 
antigenic sequence. Therefore, thanks to the fusion strategy to produce ELR-based 
constructions, it is not required the use of bioconjugate chemistry to fuse other proteins 
to the nanoparticles. It has been already described the potential use of this strategy for 
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many biomedical applications such as protein purification (219) or as drug and gene 
delivery systems (216). 
Previous works (48, 51, 216) describe the nanoparticle structure of an ELbcR obtained by 
recombinant process, having the antigenic sequence(s) at the hydrophilic terminus 
gene(s); the genetically encoded synthesis does not affect the assembly of the 
nanoparticles, in fact, the elastin contribution serves as hidden support, whereas the 
antigen molecule(s) is oriented towards the outside of the particle. García-Areválo et al., 
developed a new ELbcR-based vaccine carrier that self-assembles into highly 
monodisperse and stable nanovesicles that can be used to present low antigenic peptides, 
for example, from the bacterium M. tuberculosis (189). In another work, it was described 
the expression and immunogenicity of a construct produced by combining plant-based 
production and the ELR fusion strategy in order to produce a potential vaccine candidate 
containing two major antigens from M. tuberculosis (220). 
4.3. ELR-based hydrogels for tissue engineering 
applications 
Widely defined, tissue engineering is the process of restoring, maintaining, or enhancing 
living, physiological, three-dimensional tissues and organs utilizing specific combinations 
of cells, scaffolds, and/or signals, both chemical and physical. The process involves mainly 
four components: a material scaffold, functional cells, biomolecules (e.g. growth factors, 
extracellular matrix (ECM) molecules, and other biological), and dynamic forces (221). 
Thanks to the recombinant DNA technology, ELRs allow the tailoring at the genetic level 
of the mechanical and biological properties to satisfy end-user application, thus offering 
numerous choices for the development of cell culture matrices for a specific tissue (222). 
Several studies have shown how different types of ELRs can be addressed over the most 
challenging fields in tissue regeneration, such as cardiovascular, ocular prosthesis and 
osteochondral applications, among others. 
Biofunctional materials require advanced design and preparation with the purpose of 
matching the sophisticated recognition ability of biological systems. The biocompatibility 
of any biomaterial has a critical importance and must be assessed prior to any clinical trial. 
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As regards the purity of the biomaterial, any contamination with (globular) proteins 
entails one of the greater risks, namely the development of immunological responses that 
preclude their application in regenerative medicine and tissue engineering. Thus, the 
biomaterial is required to pass the toxicological test that takes into account the duration 
and the type of tissue in contact with the tested one. 
As it has previously mentioned, ELRs have been used for the development of novel protein 
peptide biomaterials obtained through recombinant DNA technology that are playing an 
increasingly important role in a diverse range of applications such as drug delivery, tissue 
engineering, biosensors and a wide variety of ‘smart’ systems. Sallach et al. have 
described the production of a recombinant elastin-mimetic triblock copolymer and the 
further application in vivo for more than 1 year. During this time, the ELR-based hydrogel 
showed a minimal inflammatory response, confirming its high and extraordinary 
biocompatibility (127). 
Considering the ability of the ELRs to self-assemble into different structures such as 
hydrogels, and taking into account that ELRs completely fulfill the prerequisites of 
biocompatibility and bioactivity, ELRs play a key role for the development of scaffolds and 
advanced systems for application in the fields of regenerative medicine and tissue 
engineering. In this sense, specific requirements of ELRs, such as topographic, chemical 
configuration and viscoelastic patterns, determine the hydrogel properties. Hence, they 
can be tuned specifically to match proteins at the nanometer scale and cells at the 
micrometer scale. In the light of this, numerous reports have largely demonstrated 
requests from in vitro experiments (192, 223, 224). 
In vascular tissue, elastin is an essential extracellular matrix protein that plays an 
important biomechanical and biological signaling role. Elastin-like recombinamers are 
able to mimic the structure and function of native elastin, representing a practical 
alternative to the native elastic fiber (which is difficult to extract from tissues) for vascular 
applications. Several studies have demonstrated that stent surface endothelialization is a 
well-known methodology to inhibit restenosis and thrombosis (91, 225-227). The use of 
active ELR coatings with endothelial cell adhesion sequences onto stents surfaces is a 
great strategy to recover a healthy endothelium. In vivo studies have demonstrated how 
ELR scaffolds support the neovascularization in the total absence of an immune response 
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(91). In this sense, González de Torre et al. have shown the applicability of recently 
developed ELRs as a coating for vascular stents with the ultimate goal of producing a new 
endovascular device (165). The ELR applied on the stent gain a full endothelialization in a 
short time (2 weeks), showing high biocompatibility and a reduced response of the 
immune system. Finally, another approach by Weber et al. was to generate tissue-
engineered heart valves (TEHVs) by multi-step injection molding using ELR as a hybrid 
system with fibrin (228). 
In 2015, Mata’s group demonstrated the supramolecular interaction between peptides 
and ELRs to generate complex 3D architectures through a dynamic self-assembly system, 
forming a stable multilayer membrane. This membrane can be spatiotemporally 
controlled and can be used to form bioactive tubular scaffolds which may support and 
lead the growth of different cell lines (229). This tubular morphogenesis could play an 
important role in tissue engineering applications that requires the formation of tubular 
structures that usually are complex to obtain in the milli- and micro scale. 
According to the elastin-like nature of the hydrogel and the high percentage of elastin 
present in the native chondral matrix, ELR-based hydrogels are likely to simulate the 
properties of hyaline cartilage (230, 231). The hyaline articular cartilage is a highly 
specialized tissue characterized by its unique mechanical features and it is formed by a 
matrix that embeds chondrocytes. Considering that the articular hyaline cartilage does 
not repair itself and that the generally regenerated fibrocartilage is unable to maintain 
the biomechanical characteristics of articular cartilage (232, 233), ELR hydrogels could be 
used as scaffolds for osteochondral tissue engineering. As it has been previously described 
above, ELRs show thermo-sensitivity, on that regard is possible to form hydrogels stable 
at body temperature, whenever the transition temperature (Tt) of the ELR is lower than 
the body temperature. Moreover, ELRs containing bioactive sequences, such as the well-
known RGD cell-adhesion sequence found in fibronectin, which promotes specific cell 
attachment via integrins (162), are able to form a bioactive scaffold that improves the 
regenerative potential of the implanted hydrogel. 
Vila et al. showed how ELR coatings are able to improve the well-known biocompatible 
and bone regeneration properties of calcium phosphate-based materials (234). 
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Due to the development of novel tissue-engineering methods (52, 235), it has been 
considered the use of mesenchymal stromal cell (MSC) therapy (236, 237) for the 
treatment of musculoskeletal lesions (238, 239). For articular defect applications, the use 
of a hydrogel serves as a vehicle for the MSCs to acquire a 3D structure that could mimic 
the properties of the ECM providing a cell-friendly environment in order to increase the 
persistence of the implanted cells at the site of injury. According to ELRs properties, a 
homogeneous embedding of MSCs in the ELR solution can be achieved at a temperature 
below Tt, and further applied as a cell-scaffold system for injectable therapies (Figure 5). 
 
Figure 5. ELR-based injectable hydrogel for osteochondral applications. 
Moreover, ELRs might also have beneficial applications in the field of ocular tissue 
engineering. Cornea wound healing requires cell adhesion and proliferation on a substrate 
with ligands such as fibronectin, secreted by corneal epithelial cells and stromal 
fibroblasts during the first steps of corneal wound healing (240). Nevertheless, the ocular 
surface, unwounded cornea and conjunctiva do not express elastin. Therefore, several 
metalloproteinases (MMPs) have been described in pathological ocular processes such as 
dry eye (241) or conjunctivochalasis (242), while some other MMP present at the ocular 
surface are able to degrade elastin fibers (241). Thus, ELRs are a potential candidate for 
Bruch´s membrane prosthesis. Martínez-Osorio et al.  showed how a blend of ELRs was 
able to promote epithelial cell adhesion from human conjunctiva-derived primary cells 
(192). Finally, ELRs application as ocular implants was studied by Srivastasa et al., which 
confirmed ELRs as a suitable carrier for the transplantation of autologous RPE cells for the 
treatment of age-related macular degeneration (AMD) (243). 
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4.4. ELRs for surface bio-functionalization 
The ELRs properties of elasticity and self-assembling allow the formation of a wide range 
of biomaterial-based constructs such as aggregates (51), films (77), fibers (224), micelles 
(48, 244), nanoparticles (245), and hydrogels (246). Another advantage of this 
recombinant biomaterial is the capacity to form hybrid systems with materials having 
different origins, in order to obtain several morphologies and functional possibilities for a 
diverse range of applications such as functionalized surfaces, fibers, and drug delivery. 
Therefore, the recombinant technologies by which ELRs are obtained, allow a perfect 
control of their sequence, length and stereochemistry; moreover, for functionalized 
surfaces even a nanometric control of their position displayed by these systems is 
possible. 
Chilkoti’s group has created what they refer to as the "Thermodynamically Reversible 
Addressing of Proteins" (TRAP) (247), where an ELR is covalently micropatterned onto a 
glass surface obtaining a spatial-temporal system for protein binding that can be applied 
as a microsensor for detecting single biomolecules in bioanalytical applications. 
Additionally, different approaches based on controllable properties (stimuli-responsive) 
of the biofunctionalized surfaces have been studied in order to obtain a cell sheet 
harvesting system from a culture dish. In this sense Okano et al., have developed a smart 
surface with PIPAAm polymer (and its derivates) that can switch between a cell-adherent 
and non-adherent state as a result of a change in temperature (248). Despite this 
approach led a significant progress in this field (249-251), PIPAAm polymer lacks specific 
bioactivity, meaning that cellular membrane proteins, such as integrins, are not able to 
directly bind to the surface. To address this issue, Pierna et al. developed a smart surface 
system by covalent coupling of tailored ELRs onto glass surfaces by click chemistry 
methods. This cell sheet harvesting system leads to the exposition of the bioactive RGD 
motif to the water interface at physiological temperature, producing a cell adherent 
surface (252) (Figure 6). Na et al. also took advantage of the rapid response to external 
stimuli of a smart material surface created by adsorption of ELRs for use in cell-based 
biochips. The smart transition of ELR-based micropatterns between a hydrophilic and a 
hydrophobic surface glass at Tt allows to revert cell adhesion by way of the incubation 
temperature (253). 
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Figure 6. Schematic representation of a system based on ELRs for cell sheet harvesting. 
Layer-by-layer (LbL) techniques are one of the most versatile and easy-to-apply of the 
numerous surface-modification tools. They are based on the spontaneous adsorption of 
materials onto a substrate, generally a polymer, biomolecule, or inorganic particle, and 
allow the sequential formation of a nanostructured film, hence having a great interest in 
tissue-engineering applications (254-257). Layer-by-layer deposition of alternating ELR-
polyelectrolytes generated bioactive surfaces (258). In this work, it was developed a 
thermoresponsive thin coating by electrostatic self-assembly (ESA); the deposition of an 
ELR containing the bioactive RGD motif can be exploited for tunable cell adhesion and 
controlled protein adsorption by nanoscale surface tailoring (77). Another example of 
biomimetic surface-modification regards the chemical functionalization of ELRs in order 
to obtain metallic (Commercial pure titanium, Cp Ti) dental implants with 
osteostimulative capabilities by the covalent immobilization of biomolecules on the Cp Ti 
(259). Finally, Costa et al. demonstrated the feasibility of LbL synthesis using natural 
marine-based polysaccharides (chitosan and alginate) and ELRs (260) for possible 
application in wound dressings and drug-delivery systems (261, 262). Furthermore, ELR 
molecules can be used for the functionalization of surfaces in order to obtain stronger and 
faster cell responses on the tissue–biomaterial interface, thus promoting better implant 
integration than short peptides functionalization; for instance, ELRs have been used to 
enhance the properties of poly-methylmethacrylate (PMMA) surfaces. Although PMMA 
has a great usage in several biomedical applications (263-269), this study showed that 
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ELR-functionalized PMMA surfaces can enhance the cellular attachment efficiency and the 
cell anchorage strength (270). Finally, ELRs were thoroughly investigated as biocompatible 
vasculogenic surface coatings and smooth muscle cells (SMC) showed enhanced 
attachment under retention of their contractile phenotype on similar ELR-coated 
electrospun fibers (271). 
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1. INTRODUCTION 
1.1. Elastin-like recombinamers 
The prerequisites for the use of materials in tissue regeneration include biocompatibility 
and bioactivity. As such, elastin-like recombinamers (ELRs), which are novel biomaterials 
inspired by elastin, a component of the natural extracellular matrix (ECM), meet both 
these requirements (1). Elastin is a fibrous and insoluble protein that constitutes one of 
the most important structural and functional components of the ECM, allowing for high 
deformations without damage (2). It is abundant in the lungs (3-7%), skin (2-3%), blood 
vessels (28-32%) and elastic ligaments (50%) (3), where its elastic properties are essential. 
Elastin, the main function of which is to provide elasticity to organs and tissues, is an 
excellent example of how all the properties displayed by biological materials and systems 
are determined exclusively by the physicochemical properties of the monomers and their 
sequence (4, 5). Indeed, a single repeated pentapeptide sequence has been shown to be 
responsible for the elastic behavior in elastin and, as such, forms the basis of all ELRs (6, 
12).  
The most widely studied pentapeptide is (VPGXaaG), namely poly(Val-Pro-Gly-Val-Gly), 
where Xaa is any natural amino acid except proline. All functional ELRs present a reversible 
lower critical solution temperature (LCST) in aqueous solution with sharp responsiveness 
(13). According to Urry’s model, the polymer chains fold hydrophobically and undergo a 
conformational transition that leads to phase separation above this temperature (14, 15). 
It has been proven that the amino acid sequence has a significant influence on the LCST 
of ELRs (16). Thus, substitutions of the amino acid at the fourth position (Xaa) of the 
pentamer modify the LCST to an extent that depends on the polarity of the amino acid 
side-chain. The transition temperature of an ELR sequence based on (VPGXG)n can be 
controlled and adjusted to the desired applications by varying Xaa (hydrophobic AAs 
decrease Tt and hydrophilic AAs increase it) (16), the segment length n (longer ELR 
sequences have a lower Tt) (17, 18), concentration (higher ELR concentrations decrease 
Tt) (17), pH (19) and salt concentration in the selected solvent (20-22).  
Biotechnology provides us with a powerful set of tools, such as recombinant DNA design 
(23), that can be used to successfully control the physicochemical features of the amino 
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acid side-chains and their association (24, 25), or to include any protein-based 
functionality, such as protease active sites, which become important when degradation 
of the scaffold has to be adjusted to the growth rate of new tissue (26).  
1.2. Mechanisms to form ELR matrices for tissue-
engineering applications 
The predominant matrices for tissue regeneration, which were also the first to be applied 
in humans (27), are hydrogels. Indeed, due to their high water content, resemblance to 
natural tissue, biocompatibility and stimuli-responsiveness, these compounds have 
attracted increasing interest in the last 40 years (28, 29). However, as traditional methods 
of hydrogel synthesis lack an exact control over cross-linking points, chain length and 
sequence, the resulting three-dimensional structure may contain defects that can impair 
the mechanical properties of the material (30). These problems have been addressed by 
the development of novel polypeptide-based responsive hydrogels, including block-
copolypeptides (31), or recombinant co-polypeptides flanked by two coiled-coil blocks 
(32, 33) and recombinant segments of elastin, silk and collagen (34-36).  
The integration of crosslinking motifs that lead to a stable hydrogel is a prerequisite for 
the formation of ECM-like matrices from ELRs. This crosslinking can be of either a physical 
or a covalent nature, with the possible cross-linking mechanisms being as versatile as the 
ELRs themselves, ranging from ionic and hydrophobic interactions and the reaction of 
complementary groups to bioinspired protein crosslinks (37, 38).  
ELRs have the potential to form a material that is both biocompatible and has specific 
mechanical properties, and can also interact with the body to improve the natural 
regeneration of tissue. Although the repetitive ELR pentapeptide (VPGXG) itself does not 
facilitate adhesion, its extraordinary design means that adhesive (RGD) (39, 40) and 
degradation sequences (41, 42), as well as sequences that allow the inclusion of 
temperature-related or biological triggers, can readily be integrated (43-45). All these 
strategies can provide very close control over the length and molecular weight of the 
proteins by careful selection of the crosslinking sites, which usually correspond to the 
lysine groups (46, 47).   
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1.3. Physically Cross-linked ELR Hydrogels  
Several strategies can be applied to prepare physically crosslinked ELR hydrogels. Some of 
the most popular are described below. 
1.3.1. Crosslinking via ionic interactions  
Ionic crosslinking motifs are based on ELR segments of opposite charge, or the 
introduction of groups that can chelate multivalent cations into the ELR backbone, which 
can be further controlled by varying the salt concentration.  
Peptide sequences with alternating charges and with complementary ionic sites have 
been shown to perform well in physical crosslinking. Such sequences are classified into 
different moduli, depending on the size of the equally charged ionic blocks (1-4 amino 
acids): modulus I, – + – + – + –+; modulus II, – – + + – – + +; modulus III – – – + + +; and 
modulus IV – – – – + + + +. A modulus I sequence reported by Holmes et al. (48) exhibited 
salt-induced in situ gelation (49). Ion complexation is obtained by including glutamic and 
aspartic acid residues in the ELR sequence accompanied by the addition of Ca2+ ions. The 
resulting hydrogels can be stabilized at room temperature and at physiological pH (50) 
and are sensitive to chelating agents, which reduces the number of accessible Ca2+ ions. 
Another approach by Yeo et al. (51) involved the addition of monosaccharides to the side 
chains of the ELRs, thus allowing them to form stable complexes with potassium. 
Furthermore, ELR/chitosan blends have been shown to form stable films in the presence 
of sodium ions (52).  
1.3.2. Self-assembly of amphiphilic blocks and graft copolymers  
Hydrogels can be obtained by aggregation between the hydrophobic segments of multi-
block ELR copolymers. The hydrophobic functionalities are provided by alkyl-rich amino 
acids such as alanine (Ala), leucine (Leu), isoleucine (Ile), valine (Val), phenylalanine (Phe), 
tryptophan (Thp), tyrosine (Tyr) or methionine (Met). The resulting amphiphilic blocks 
have been shown to be stable in vivo (36, 53, 54). Furthermore, it is common to find 
protein polymers characterized by alternating blocks of essentially hydrophilic and 
essentially hydrophobic amino acids. The presence of chemically distinct segments within 
the same protein chain causes a mutual repulsion between the different blocks, which 
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tend to segregate. However, this segregation is constrained by the “forced cohabitation” 
of these blocks within the same molecule. As a result, they simply separate into different 
domains, thereby forming periodic nanostructures (55).  
1.3.3. Intermolecular interaction of secondary protein structures  
Structure design offers the possibility to include almost any sequence that is able to form 
intramolecular interactions via secondary structures into the ELR backbone using a 
recombinant approach. The limiting factors in this approach are the need to retain the 
ELR temperature transition and the fact that complex folding might not occur.  
One bioinspired approach involved the inclusion of natural silk sequences that are known 
to form intramolecular beta-sheets which self-assemble into crystalline regions and have 
unique mechanical properties (56-60). These silk-based materials can be used to form a 
variety of structures, such as hydrogels, films, 3D porous matrices and submicron to 
macroscale fibers (61). Furthermore, silk scaffolds have been proven to be biocompatible 
and to perform well in vivo (62-64). As regards the silkworm (Bombyx mori), the repetitive 
hydrophobic sequence GAGAGS has been shown to be responsible for the strength of silk 
fibers (65). These blocks are stabilized by hydrophilic compartments in the protein and a 
complex mixture of stabilizing proteins (66). Fernandéz-Colino et al. have shown that the 
GAGAGS sequence can be successfully integrated into an ELR, thereby facilitating in situ 
gelation of the material and its use as an injectable system (36).  
A more complex crosslinking has been achieved by using coiled-coil induced 
oligomerization via leucine zipper motifs, which include sequences that are known to form 
well-defined secondary structures (67-69). Leucine zippers are characterized by heptad 
repeating peptide units that form a distorted α-helix, designated as “abcdefg”, where the 
“a” and “d” positions are occupied by hydrophobic residues such as leucine and “b”, “c”, 
“e”, “f” and “g” are usually of a hydrophilic nature (see Figure 1) (70). The oligomerization 
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of different α-helices is primarily driven by hydrophobic interactions (71-74), and partly 
by electrostatic interactions (75-77) and the number of heptad repeats (72, 78, 79).  
 
Figure 1. Hydrophobic interaction of two leucine zipper heptad units. 
 
The potential extrapolation of these domains to the creation of bioinspired domains has 
been explored to a much lesser extent than in the case of their elastin or silk counterparts, 
thus meaning that fewer studies available concerning their biocompatibility are available. 
However, their human origin and the conserved nature of the sequence of these domains 
alleviate any concerns regarding their biocompatibility. To further support this notion, in 
vivo implantation of the leucine zipper based scaffolds in a mouse model was recently 
reported and no foreign body reaction to the scaffold was detected (80).  
Protein-based physical crosslinks are ubiquitous in nature, therefore it can be assumed 
that those reported to date are merely the tip of the iceberg.  
1.4. Functionalization of ELRs and covalent cross-linked 
ELR hydrogels  
Post-translational modification of ELRs is obtained by reaction of the functional groups in 
the protein backbone. In ELRs, this can be facilitated by including active amino acids into 
the X position of the (VPGXG) sequence, thus maintaining the pH- and temperature-
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sensitivity of the resulting ELRs (81, 82). These active amino acids facilitate both 
crosslinking reactions and chemical modifications. The concentration, molecular weight 
and lysine content of ELRs are key parameters in the hydrogel formation. Thus, below a 
critical concentration (83), the hydrogel network is not formed due to the lack of sufficient 
intermolecular contacts to allow a continuous entanglement of the ELR chains. Under 
these low concentration conditions, it is possible to form stable nanogels that already 
possess the thermal sensitivity found in the macroscopic ELR-based hydrogels (84). ELRs 
with a high number of potential crosslinking points are more prone to establishing a high 
number of intermolecular contacts that promote network formation. ELRs with a high 
lysine content are the most widely used in the preparation of hydrogel networks given the 
ability of the amino group on lysine to form covalent bonds between ELR chains. 
Furthermore, relevant features of the hydrogel, such as gelation time, network pore size, 
stiffness and degradability, can be closely controlled by varying the nature and 
concentration of the crosslinking agent. Labile chemical linkages that can be broken either 
enzymatically or chemically under physiological conditions can also be formed (85). 
Chemical crosslinking strategies have some important advantages. For instance, the 
covalent bonds avoid hydrogel network dilution and prevent components diffusing out 
from the site where the hydrogel is implanted. As a drawback, chemical crosslinking 
usually requires organic solvents and reagents that have to be exhaustively removed after 
synthesis of the network. To overcome this problem, click chemistry has been of growing 
interest for the formation of ELR-based networks in the past five years as this technique 
avoids the need for organic solvents (86, 87). In addition, it can be used to fuse ELRs with 
different bioactivities (88) or even to form hybrid ELR systems in an in situ gelation 
manner. This method has also been used to create non-thrombogenic stents (89).  
Chemical crosslinking can be achieved using the following techniques: 1) radical 
polymerization (acrylates), 2) coupling of complementary groups (click reaction, Michael 
addition (90), condensation (91)), 3) high-energy irradiation (92), or 4) enzymatic 
crosslinking (transglutaminase) (93-95). Typical functionalization motifs include bioactive 
sequences with adhesion sites (such as RGD (96)), inhibitors, antibodies and anchor or 
signalling molecules.  
107 
 
Permanent or chemical hydrogels are covalently cross-linked networks that may contain 
clusters dispersed within regions of low crosslinking density and high water swelling. Free 
chain ends also cause defects in the gel and do not contribute to the elasticity of the 
networks. Both aqueous and organic media can be used to form ELR networks, with 
crosslinking in an organic solvent resulting in hydrogels with a more uniform structure due 
to the absence of transitions. Conversely, the behavior of ELR molecules in water is 
governed by the LCST (47). Some organic solvents, such as tris-succinimidyl 
aminotriacetate, can react with the lysine residues of different ELR chains to form a 
network. Crosslinking confers structural stability on the hydrogel, which is insoluble in 
water even upon cooling. Intermolecular crosslinks between proteins can also be 
obtained using genipin, as shown for an ELR/fibronectin hybrid (97).  
2. IN VITRO CYTO- AND BIOCOMPATIBILITY OF ELRs 
Biofunctional materials require advanced design and preparation in order to match the 
sophisticated recognition capabilities of biological systems. Moreover, in order to ensure 
the safety and effectiveness of devices containing these materials, it is fundamental to 
clearly understand their effects on surrounding tissues. Thus, materials are required to 
pass a toxicological test, known as a biocompatibility test, that takes into account the 
duration and type of tissue that it may come into contact with, along with all the 
functional requirements of the corresponding host response (98).  
Any material proposed for use in biomedical applications must be biocompatible and 
highly pure as the contamination thereof with (globular) proteins that may provoke an 
immunological response is one of the most common factors precluding the use of 
biomaterials in such applications. However, it is also important to note that peptide-based 
materials are often touted as biocompatible in the absence of hard experimental 
evidence. Indeed, as noted by Chow et al. (5), there is no intrinsic reason for peptide-
based materials to be biocompatible other than the somewhat naive notion that they 
must be, simply because they are composed of building blocks that are native to all 
organisms. As an important counterexample, it should be noted that many peptides and 
protein drugs are immunogenic, so the potential immunogenicity of all peptide-based 
materials must be considered, especially peptides that are “non-self”. In contrast to 
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classical materials, biocompatibility studies, especially innate immunity induction, 
cytotoxicity and fibrosis, are often lacking for many novel biomaterials, including 
recombinant protein-based materials, as has been extensively explored in the scientific 
literature. 
ELRs have grown in popularity in the field of protein-inspired biomimetic materials and 
have found widespread uses in biomedical applications. These materials are playing an 
increasingly important role in a diverse range of applications such as drug delivery, tissue 
engineering, biosensors and a wide variety of “smart” systems. The great potential of ELRs 
in several biomedical applications is due to their ability to control and manipulate the 
interface between themselves and biological components, thus maintaining their 
biocompatibility. 
Given their recombinant production in Escherichia coli bacteria, ELRs could be affected by 
a potential source of risks in terms of biocompatibility. In this regard, the standard analysis 
recommended by the American Society for Analysis of Materials for materials in contact 
with tissues and fluids has demonstrated the extraordinary biocompatibility of ELRs (99). 
As has already been described, ELRs don’t provoke a. immunogenic response. In addition, 
given their biodegradability and biocompatibility for human tissue, tissue fluids, and 
blood, these polymers play a key role as carriers in delivery systems (99-101). ELRs used 
for tissue engineering have specific requirements in terms of biocompatibility that must 
be combined with topographic, chemical and viscoelastic patterns on materials to match 
proteins at the nanometer scale and cells at the micrometer scale. In this regard, 
numerous studies have clearly demonstrated both these requirements in in vitro 
experiments (102-104).  
Additional findings corroborating the in vivo biocompatibility of ELRs have come from 
studies published by Rincon et al., who evaluated the cytotoxic effects of microparticles 
prepared from poly(VPAVG) and showed that the particles did not induce any cytotoxicity 
or inflammatory response after subcutaneous injection in rats. These authors also 
demonstrated intraocular tolerance after intravitreal injection into pigmented rabbits 
(105). Herrero-Vanrell et al. also observed a poor inflammatory response when they used 
poly(VPAVG) as a vehicle for intraocular drug-delivery systems (1). Other studies by 
Sallach et al., who developed a recombinant elastin-mimetic triblock copolymer in the 
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absence of either chemical or ionic crosslinking, showed a minimal inflammatory response 
and robust in vivo stability for periods exceeding one year, thereby further highlighting 
the high and extraordinary biocompatibility of ELRs (53). Similarly, Gonzalez et al. have 
shown the applicability of recently developed ELRs as a coating for vascular stents with 
the ultimate goal of producing a new endovascular device (89). The ELRs used to cover 
the stent supported full endothelialization in less than two weeks in vitro and showed high 
biocompatibility, physiological hemo-compatibility and a reduced response of the 
immune system. Other medium- and long-term viability studies have revealed a good 
cyto-compatibility with respect to several human primary cell types in both surface and 
3D cultures (86). Furthermore, ELR molecules can be used to functionalize surfaces in 
order to obtain stronger and faster cell responses at the tissue–biomaterial interface, thus 
promoting better implant integration than functionalization with short peptides (106). For 
instance, functionalization of CoCr metallic surfaces with ELRs for cardiovascular 
applications may offer an efficient alternative to enhance rapid endothelialisation (107). 
As noted above, the biocompatibility of these materials is of vital importance given their 
wide-ranging potential applications in biomedical fields such as regenerative medicine 
and tissue engineering. The cyto- and biocompatibility of ELRs, along with their interesting 
possibilities in terms of functionalization via recombinant DNA technology, make them 
ideal candidates for the development of scaffolds and advanced systems for applications 
in the biomedical field. 
3. ELASTIN-LIKE RECOMBINAMERS FOR TISSUE-
ENGINEERING APPLICATIONS 
3.1. Osteochondral applications  
Musculoskeletal disorders include more than 150 different diseases and syndromes, the 
majority of which are progressive and painful. Such disorders can be classified as joint 
diseases, physical disabilities, vertebral disorders and trauma-related conditions. The 
most affected joint is the knee, followed by the hip, ankle and shoulder, all of which, but 
especially the knee, are liable to suffer cartilage degeneration. Chondral and 
osteochondral injuries, both traumatic and non-traumatic, produced in the articular 
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cartilage of the knee and in other joints progress with time to degenerative osteoarthritis, 
which is usually treated by total replacement of the joint by a prosthesis (110). These 
incurable injuries entail disability, and all treatments applied to date to restore the 
articular surface are unsatisfactory. 
The articular cartilage is formed by a matrix in which chondrocytes are embedded. This 
matrix is fundamentally made of various types of collagen (mainly type II) and 
proteoglycans (109). Articular hyaline cartilage, which covers the articular surfaces, is one 
of several types of cartilage (110). This cartilage is a highly specialized tissue characterized 
by its unique mechanical properties. It is a smooth layer, pearly bluish in colour, with a 
width of 2-4 mm, that is located between the bone and articular surface and has an 
extremely low friction coefficient due to its endurance to compression forces and 
elasticity. Articular hyaline cartilage has two main roles, namely to absorb the pressure 
overload at the articular surface and to allow the friction-less sliding of this surface (110-
114). Mature articular hyaline cartilage has no vascular or lymphatic vessels or nerves, 
therefore (115) renewal of this matrix is very slow and the chondrocytes are usually 
dormant, with few mitoses. Furthermore, articular hyaline cartilage does not repair itself 
and regenerated cartilage is generally rich in type I collagen (fibro cartilage) instead of the 
type II collagen essential for the articular hyaline functional properties. This fibro cartilage 
is therefore unable to maintain the biomechanical characteristics of normal articular 
cartilage (116, 117).  
Biomaterials play a fundamental role in the field of tissue engineering. There are several 
methods for obtaining biomaterials, the most common being by chemical reaction or 
purification from natural sources. In addition to these, recombinant DNA techniques have 
proven to be very powerful tools for the development of protein-based biomaterials, such 
as ELRs, over the last few decades (54). As mentioned previously, ELRs are able to self-
assemble into different structures, such as hydrogels, and may find uses in biomedical 
applications (23, 118).  
From another biological viewpoint, the development of novel tissue-engineering methods 
(119, 121) involving mesenchymal stromal cells (MSCs) (121, 122), which are pluripotent 
cells that can differentiate into diverse cell types (including chondrocytes and osteocytes) 
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and exert immunomodulatory properties, means that such methods are good candidates 
for the treatment of musculoskeletal lesions (123, 124). 
For articular defect applications, the suspension of MSCs needs a scaffold as a cell-carrier 
in order to acquire a 3D structure that could be re-populated by these cells and to increase 
the persistence of the implanted cells at the injury site. Moreover, the hydrogels used as 
vehicles for MSCs should closely mimic the properties of the ECM and provide a cell-
friendly environment that supports their regenerative potential. 
As described previously, elastin-like recombinamers are based on a repetition of the 
VPGXG pentapeptide found in natural elastin, in which X can be any amino acid except 
proline. Given the elastin-like nature of the hydrogel and the high percentage of elastin 
present in the native chondral matrix, ELR-based hydrogels are likely to be similar to 
hyaline cartilage (125, 126). Furthermore, ELRs show thermo-sensitivity, thus meaning 
that it should be possible to form hydrogels that are stable at body temperature provided 
the transition temperature (Tt) of the ELR is lower than body temperature. In addition, as 
they are soluble at low temperatures, ELRs can be injected at low temperature and rapidly 
form a gel at physiological temperature, thereby representing a good candidate for use in 
arthroscopy to reduce the invasiveness of the treatment (Figure 2). 
This remarkable property permits MSCs to be homogeneously embedded in the ELR 
solution at a temperature below Tt and to self-assemble into hydrogels above Tt, thus 
allowing the use of the cell-scaffold system in injectable therapies. Finally, in addition to 
the significant advantages of ELRs described in this chapter, they can also be designed to 
contain bioactive sequences, such as the well-known RGD cell-adhesion sequence from 
fibronectin, which promotes specific cell attachment via integrins (96), in order to achieve 
a bioactive scaffold that provides a cell-friendly environment, thereby improving the 
regenerative potential of hydrogel implantation. 
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Figure 2. ELR-based injectable hydrogel for osteochondral applications 
3.2. ELRs for (cardio-)vascular tissue regeneration 
Elastin is an essential extracellular matrix protein in vascular tissue that plays an important 
biomechanical and biological signaling role. However, as native elastin is insoluble and is 
difficult to extract from tissues, its use for the manufacture of vascular tissue engineering 
scaffolds remains relatively rare. ELRs that mimic the structure and function of native 
tropoelastin represent a practical alternative to the native elastic fiber for vascular 
applications, especially in cardiovascular implants, where metal-based stents are known 
to cause in-stent restenosis (ISR) and late thrombosis diseases (107). The most common 
surgeries in cardiovascular disease are coronary angioplasty and stent insertion (127,128), 
with stent thrombosis (ST) and ISR being the main reasons for the failure of bare metal 
stents after implantation. This effect is decreased to less than 10% with the use of drug-
eluting stents (DES), but remains critical (129), thus emphasizing the need for more 
efficient coatings. The coating of active ELRs containing adhesion sequences onto stent 
surfaces is one strategy for recovering a healthy endothelium. However, the bioactive 
sequences required to selectively promote endothelial growth remain unclear. 
ELRs have been thoroughly investigated as biocompatible vasculogenic surface coatings 
(53), with smooth muscle cells (SMC) showing enhanced attachment and retention of 
their contractile phenotype on similar ELR-coated electrospun fibers (130). It has also 
been shown that ELR coatings are able to reduce blood platelet activation on synthetic 
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scaffolds (131), which delays the formation of healthy endothelium due to the need for 
anti-proliferative drugs and leads to late ST, thereby increasing the time patients are 
required to take anti-platelet therapy (132), thus addressing a negative side-effect of DES. 
Several studies have also demonstrated that stent surface endothelialization is suitable 
for inhibiting restenosis and thrombosis (107, 132-134). In addition, ELRs including 
endothelial adhesion sequences (REDV) have been shown to facilitate endothelialization 
of CoCr alloys by an early HUVEC cell-adhesion response (107). These findings indicate an 
involvement of elastin-laminin in the initial SMC/ELR contact (130).  
de Torre et al. recently used catalyst-free click chemistry to cover stents by injection 
molding with an in situ gelating ELR system. Full endothelialization was obtained in a flow-
controlled bioreactor and enabled by REDV and RGD sequences in less than two weeks. 
Minimal platelet adhesion and fibrin adsorption were detected and the ELR-coated stents 
exhibited mechanical stability even under high flow conditions (89). A more 
heterogeneous approach by Weber et al. involved generating tissue-engineered heart 
valves (TEHVs) by multi-step injection molding using an ELR as a hybrid system with fibrin 
(135). Conditioning of TEHVs in bioreactor systems is necessary to achieve an adequate 
ECM to withstand the mechanical loads in bodily circulation, with 3D printing (136) and 
orientated electrospinning (137) also being used in TEHVs to address the stress 
differences. Since heart valves are elaborate and highly complex structures in the 
circulatory system, the spatial diversity of this hybrid system was considered to meet the 
challenges raised by the structural and mechanical anisotropy and optimal function of 
such valves. Thus, different materials were used for the wall (fibrin) and leaflets 
(fibrin/ELR) to maintain the functionality of the TEHVs and to address the problems of 
poor elastogenesis in tissue-engineered constructs (135, 138), which is of particular 
importance for their long term durability (139).  
In vivo studies of ELR-based scaffolds with leucine zipper motifs and RGD adhesion sites 
showed that they were able to support neovascularization without further growth factor 
treatment and an absence of immune responses, thereby underlining the potential of 
elastin-like materials for vascular tissue regeneration (80).  
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3.3. ELRs for ocular prostheses 
Corneal wound healing requires cell adhesion and proliferation, both of which are 
mediated by the binding of epithelial membrane-bound integrins to substrate ligands, 
such as fibronectin. The secretion of fibronectin by corneal epithelial cells and stromal 
fibroblasts increases exponentially in the first steps of corneal wound healing (140).  
However, the ocular surface, undamaged cornea and conjunctiva do not express elastin. 
Instead, a “diffusible factor” (141) secreted by the corneal epithelium has been implicated 
in maintaining the cellular and physiological homeostasis of the ocular surface. Several 
metalloproteinases (MMP) have been reported to be involved in pathological ocular 
processes such as dry eye (142) or conjunctivochalasis (143). As such, MMP-3 (Stromelysin 
1), MMP-7 (Matrilysin 1), and MMP-9 (Gelatinase B), which are present at the ocular 
surface and are able to degrade elastin fibers (142), are potential candidates for Bruch’s 
membrane prostheses. In this regard, Martínez-Osorio et al. (102) showed that an ELR 
blend containing four different types of building blocks was able to achieve an adequate 
balance of properties and to foster epithelial cell adhesion from human conjunctiva-
derived primary cells. This ELR consisted of VPGIG, which has outstanding biocompatibility 
(99) and appropriate mechanical behaviour (144), a lysine-containing block (VPGKG) for 
crosslinking purposes, a CS5 human fibronectin REDV domain for efficient cell attachment 
(145) and an elastase target domain to enhance bioprocessing by naturally occurring 
enzymes. The resulting biomaterial maintained the growth, phenotype and functional 
characteristics of the primary cell line and did not exhibit any cytotoxicity. The 
performance of ELRs as ocular implants was further confirmed by Srivastasa et al. (146), 
who retained the efficiency of retinal pigment epithelial (RPE) cells and demonstrated that 
ELRs could be suitable carriers for the transplantation of autologous RPE cells for the 
treatment of age-related macular degeneration (AMD). 
3.4. Other applications of ELRs 
Even though the excellent and tunable mechanical properties and very low 
thrombogenicity of these materials make them excellent candidates for applications 
related to traumatology or cardiovascular diseases, ELRs also have a wide range of 
possibilities in the wider field of tissue engineering. As noted above, elastin-like 
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recombinamers are a novel peptide-based biomaterial, therefore their full potential 
remains to be explored. For instance, very few studies have been performed concerning 
the application of ELRs in neural injuries such as spinal cord injuries, traumatic brain 
injuries, or nerve transection. As an example, two studies have shown how surface-
adsorbed recombinant protein can be used to modulate the behavior and differentiation 
of neuronal cells in vitro (147) and the biological activity of neurotrophin-ELR fusion 
proteins via in vitro culture models (148). As such, the potential applications of ELRs could 
be many and diverse. Indeed, they are currently being investigated for use in fields as 
disparate as diabetes treatment or in vitro fertilization. 
 
4. CONCLUSIONS 
This chapter has described elastin-like recombinamers, a family of novel protein peptide 
biomaterials obtained using recombinant DNA techniques. Moreover, ELRs meet all the 
prerequisites of biocompatibility and bioactivity for use in the field of tissue regeneration. 
Given that the predominant matrices for tissue regeneration are hydrogels, and that ELRs 
are able to self-assemble into different structures, including hydrogels, these biomaterials 
play a key role in the development of scaffolds and advanced systems for applications in 
the biomedical field. 
As noted previously in this chapter, numerous techniques can be used to form different 
ELR matrices via physical or covalent crosslinking or by functionalization. Furthermore, 
the range of tissue-engineering applications for ELRs is very extensive, with recent studies 
having shown how different types of ELRs can be applied in the most challenging areas of 
tissue regeneration, such as cardiovascular, ocular prosthesis and osteochondral 
applications or even in nerve regeneration, diabetes and in vitro fertilization.  
Finally, one of the greatest advantages of elastin-like recombinamers is that their 
biological and mechanical properties can be readily tailored at the genetic level to satisfy 
end-user applications, thus offering numerous choices for the development of cell-culture 
matrices for tissue engineering (149).  
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In order to address the objectives of this Thesis, several ELRs have been designed and 
produced. In Table 1 it is reported the amino acid sequence of each ELR, which has a 
specific composition comprising bioactive sequences. Moreover, in Figure 1 it is reported 
a scheme of all the ELRs, where the coloured blocks represent the disposition of the 
bioactive domains of each ELR.  
 
Code Name Sequence MW 
(Da) 
A (EIS)2-(I5R)6 MESLLP-{[(VPGVG)2-VPGEG-(VPGVG)2]10-(VGIPG)60-
[V(GAGAGSG)5]2G}-[(VPGIG)5-AVTGRGDSPASS]6V 
 
 
121012 
B VKVx24 MESLLP-VGVPGVG 
[VPGKG(VPGVG)5]23VPGKGVPGVGVPGVGVPGVGVPGV 
 
60451 
C HRGD6 MGSSHHHHHHSSGLVPRGSHMESLLP-{[(VPGIG)2-(VPGKG)-
(VPGIG)2]2-AVTGRGDSPASS-[(VPGIG)2-(VPGKG)-
(VPGIG)2]2}6V 
60660 
D REDV MESLLP-
[(VPGIG)2VPGKG(VPGIG)2EEIQIGHIPREDVDYHLYP(VPGIG)2VP
GKG(VPGIG)2(VGVAPG)3]10V 
 
80813 
E TI MESLLP-[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]10V 65075 
F TR MESLLP-
[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]10VETAAAKFERQHMD
SSTSAASSSNYCNQMMKSRNLTKDRCKPVNTFVHESLADVQAVC
SQKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCAYKTTQA
NKHIIVACEGNPYVPVHFDASV        
78618 
130 
 
G RT MESLLP-
VETAAAKFERQHMDSSTSAASSSNYCNQMMKSRNLTKDRCKPV
NTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDCRET
GSSKYPNCAYKTTQANKHIIVACEGNPYVPVHFDAS-
[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]10V 
78618 
H TRT MESLLP-
[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]5VETAAAKFERQHMDS
STSAASSSNYCNQMMKSRNLTKDRCKPVNTFVHESLADVQAVCS
QKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCAYKTTQAN
KHIIVACEGNPYVPVHFDAS-
[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]5V 
78618 
 
Table 1. ELRs used during the Thesis. Coloured sequences correspond to bioactive sequences as 
represented in Figure 1. 
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Figure 1. Scheme of all the ELRs used during the Thesis. 
ELR A has been used in Chapter 3; ELR B has been used in Chapter 4 and Chapter 5; ELRs 
C and D have been used in Chapter 4; ELRs E, F, G and H have been used in Chapter 6. All 
the ELRs have been produced and characterized according to the following methods. 
ELR biosynthesis and purification  
The gene construction was performed by molecular biology and recombinant DNA 
technique following standard methods previously described (1, 2). Briefly, the genes 
encoding the different polypeptides, both ELR and bioactive sequences are synthesized 
by an external service (NZYTech), and cloned in the pDriveAll plasmid. For the molecular 
cloning steps, they were used two restriction enzymes without interruptions ("seamless 
cloning"): EarI and SapI (Thermo Scientific). These two restriction enzymes are type IIS 
that have endonuclease activity on a sequence contiguous to the recognition, so they are 
optimal for this type of cloning. Once the final gene construct was obtained, it was 
extracted from the cloning plasmid and a subcloning was carried out in the expression 
plasmid pET7, resulting from different modifications on the commercial vector pET-25b 
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(+) (Novagen). Subsequently, this plasmid was used to transform expression strains of 
Escherichia coli, in particular BLR (DE3) (Novagen). BLR strain was cultured in a 15 L 
bioreactor (Applikon Biotechnology) under controlled conditions of pH, temperature, 
agitation and O2 concentration, in order to guarantee a correct bioproduction of the 
different ELRs. Subsequently, the bacterial cells were disrupted by a mechanical process 
(disruption model: TS 0.75KW, Constant Systems). Moreover, the ELRs were purified from 
the rest of cellular content taking advantage of their thermo-sensitivity; the purification 
process was carried out by several centrifugations preceded by inverse transition cycling 
(3). The pure ELRs were finally obtained, they were dialyzed and filtered through 0.22 μm 
filters (Nalgene) to achieve sterile ELR solutions which were then lyophilized (FreeZone 1, 
LABCONCO) for a better long term preservation.  
Physical - Chemical characterization of ELRs 
Analysis of the level of endotoxins 
The level of endotoxins was determined for all the ELRs used in vivo by the Limulus 
amebocyte lysate assay (LAL) with the Endosafe-PTS system (Charles River Laboratories). 
The Endosafe® cartridge technology is a fast and high sensitivity method to perform the 
analysis of the level of endotoxins (4). The cartridge technology eliminates a significant 
amount of the raw material and accessories required for traditional LAL methods. The 
cartridges are pre-loaded with all of the reagents required to perform a LAL test, 
eliminating the preparation of multiple reagents; thus only the ELRs solution was loaded 
for the endotoxins analysis. The endotoxin levels of the ELRs used for the in vivo 
experiments were measured, resulting in a maximum of 2 endotoxin units/mg ELR for the 
ELRs used at a lower concentration. ELRs used at higher concentrations (up to 300 mg / 
mL) contained less than 0.01 EU / mg ELR. Thus, even at the highest ELR concentrations, 
endotoxin levels remained below the limit set by the FDA (EU 20 / biomedical device). 
Polyacrylamide gel electrophoresis with SDS (in denaturing conditions, 
SDS-PAGE) 
SDS-PAGE (sodium dodecyl sulfate–polyacrylamide gel electrophoresis) is a variant of 
polyacrylamide gel electrophoresis, an analytical method for the separation of charged 
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molecules in mixtures by their molecular masses in an electric field. It uses sodium dodecyl 
sulfate (SDS) molecules to help identify and isolate protein molecules. SDS acts as a 
surfactant, covering the proteins' intrinsic charge and conferring them very similar charge-
to-mass ratios. The electrophoresis in polyacrylamide gels with SDS (5), entails the 
denaturation of the proteins (ELRs in our case) and the homogeneous distribution of 
negative charge for a migration dependent on their size. Considering that the migration is 
not dependent by the charge of the ELR or by the folding of the protein, this methodology 
allows to know the molecular weight (MW) of the ELRs, as well as the level of purity and 
degradation thereof. In this Thesis, it was used the vertical electrophoresis system 
"MiniVE" of Hoefer (Amersham Pharmacia Biotec). For the analysis by electrophoresis, 
around 1 mg/mL of ELR were loaded, according to the size of the well. After the 
electrophoresis, the polyacrylamide gels were stained with a 0.3 M solution of copper 
chloride. This staining works in a negative way; indeed, it does not stain the proteins, but 
copper interacts electrostatically with the SDS that contains the gel itself. Thus, the area 
containing the proteins are unstained, which appear as dark bands (6). The images of the 
gels were taken with the Gel Logic 100 Imaging System (Eastman Kodak) and analyzed 
with the Kodak 1D Image Analysis (Eastman Kodak) program. 
Mass Spectrometry (MALDI-TOF) 
In mass spectrometry, matrix-assisted laser desorption/ionization (MALDI) is an ionization 
technique that uses a laser energy absorbing matrix to create ions from large molecules 
with minimal fragmentation (7). MALDI methodology is a three-step process (Figure 2). 
First, the sample is mixed with a suitable matrix material and applied to a metal plate. 
Second, a pulsed laser irradiates the sample, triggering ablation and desorption of the 
sample and matrix material. Finally, the analyte molecules are ionized by being 
protonated or deprotonated in the hot plume of ablated gases, and then they are 
accelerated towards the detector (8). The type of a mass spectrometer most widely used 
with MALDI is the TOF (time-of-flight mass spectrometer), mainly due to its large mass 
range. The TOF measurement procedure is also ideally suited to the MALDI ionization 
process since the pulsed laser takes individual 'shots' rather than working in continuous 
operation. Mass spectrometry of the type "Matrix-assisted laser desorption / ionization - 
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Time-of-flight" (MALDI-TOF) allows to know exactly the MW. It is more accurate than the 
SDS-PAGE technique, hence it can be considered complementary to it. Mass Spectrometry 
has been carried out in the Laboratory of Instrumental Techniques (LTI) of the University 
of Valladolid (UVa) in the MALDI-TOF Voyager STR (Applied Biosystems). 
 
Figure 2. Schematic representation of the MALDI-TOF spectrometry. 
Amino acid analysis (HPLC) 
High-performance liquid chromatography (HPLC) is a technique used to separate, identify, 
and quantify each component in a mixture. It relies on pumps to pass a pressurized liquid 
solvent containing the sample mixture through a column filled with a solid adsorbent 
material. Each component in the sample interacts slightly differently with the adsorbent 
material, causing different flow rates for the different components and leading to the 
separation of the components as they flow out of the column. These interactions are 
physical in nature, such as hydrophobic (dispersive), dipole–dipole and ionic, most often 
a combination. HPLC is distinguished from traditional ("low pressure") liquid 
chromatography because operational pressures are significantly higher (50–350 bar), 
while ordinary liquid chromatography typically relies on the force of gravity to pass the 
mobile phase through the column. The analysis of ELR samples previously hydrolysed by 
"High-Performance Liquid Chromatography" (HPLC) allows to know the amino acid 
composition of the ELR molecules. First, ELR are hydrolyzed with 6M HCl, 1% phenol 
during 2.5 hours at 155˚C, and subsequently dried. Resulting powder is resuspended in 
20mM HCl and diluted 1/10 for separation by HPLC. Quantification is done by comparing 
to standard patrons. A schematic representation of the process can be seen in Figure 3. 
This method has been carried out in the LTI of the UVa with the Waters 600 gradient HPLC 
equipment coupled to a Waters 2487 UV detector (Waters). 
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Figure 3. Schematic representation of the experimental set for amino acid analysis. 
Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry, or DSC is a thermoanalytical technique in which the 
difference in the amount of heat required to increase the temperature of a sample and 
reference is measured as a function of temperature. Both the sample and reference are 
maintained at the same temperature throughout the experiment. In our case, the sample 
is the ELR solution dissolved in milliQ water or in saline solution, whereas the reference is 
the corresponding solution without the ELR. In this Thesis, DSC analysis has been used to 
measure the Tt of the ELRs. The basic principle underlying this technique is that when the 
sample undergoes a physical transformation such as phase transitions, more or less heat 
will need to flow to it than the reference to maintain both at the same temperature. 
Whether less or more heat must flow to the sample depends on whether the process is 
exothermic or endothermic. When a phase change or transition occurs, if the amount of 
heat necessary to be supplied to the ELR solution to increase the temperature is greater 
than the reference, then it is an endothermic process. This means that the process 
consumes part of the energy supplied to the system during the transition. The ELRs were 
dissolved at 50 mg/mL in milliQ water or in PBS, the Tt was measured at different pH 
values. The experimental procedure consisted of a first isothermal stage at 0 °C for 10 
minutes, followed by a heating step, from 0 to 60 °C, at a speed of 5 °C / min. 
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Fourier Transform Infrared Spectroscopy (FTIR) 
Fourier-transform infrared spectroscopy (FTIR) is a technique that can be used to obtain 
information about the functional groups of the sample analyzed. The theory behind the 
technique resides in measuring how much light a sample absorbs at each wavelength. The 
molecules absorb specific frequencies that are characteristic of their structure. Fourier-
transform spectroscopy shines a beam containing many frequencies of light at once and 
measures how much of that beam is absorbed by the sample. Next, the beam is modified 
to contain a different combination of frequencies, giving a second data point. This process 
is rapidly repeated many times over a short timespan. When the frequency of the IR is the 
same as the vibrational frequency of a bond, the absorption occurs. Afterwards, a 
computer takes all this data and the examination of the transmitted light reveals how 
much energy was absorbed at each frequency (or wavelength) revealing the presence of 
a certain chemical structure. In our case, the pure ELRs in the dry state were analyzed with 
a Bruker FTIR spectrophotometer (Bruker, USA). For each spectrum, a 512-scan 
interferogram was collected at single beam absorption mode with a 2 cm-1 resolution 
within the 4000 - 600 cm-1 region. For each sample, several FTIR absorption spectra were 
collected. Five measurements were averaged to obtain the final FTIR absorption spectrum 
of the sample. Residual water vapour absorption was interactively subtracted from the 
sample spectra. Finally, the spectral calculations were performed by the OPUS (version 
4.2) software (MATTSON INSTRUMENT, INC.). 
Proton nuclear magnetic resonance 1H-NMR Spectroscopy 
Proton nuclear magnetic resonance (1H-NMR) is the application of nuclear magnetic 
resonance in NMR spectroscopy with respect to hydrogen-1 nuclei within the molecules 
of a substance, in order to determine the structure of its molecules (9). Nuclear magnetic 
resonance spectroscopy (NMR) studies the behaviour of certain atomic nuclei in the 
presence of an external magnetic field. When an atomic nucleus with non-zero total 
angular momentum is placed in an external electromagnetic field, they interact via the 
nuclear magnetic dipole moment. The applied magnetic field produces a split of the 
degenerated energy levels of the nuclear spin, so that transitions between them can be 
induced as a result of absorption of the adequate electromagnetic radiation. This specific 
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orientation of spins depends on the molecular structure and, therefore, is different for 
each molecule; and the whole NMR spectrum of a molecule can be considered as a 
fingerprint of it. Moreover, the proton NMR spectrum (1H-NMR) of the bioproduced ELRs 
allows us to verify the absence of impurities for each one of them. The NMR analysis was 
performed with the NMR 500 (Agilent Technologies) equipment of the LTI. The 
measurements were carried out at 298 K with samples of 20–30 mg of the ELRs, purified 
and dissolved in DMSO-d6. The peak areas corresponding to three kind of hydrogen, 
namely -NH2, -CH3 and -CH- from the chain, were electronically integrated and compared 
to the calculated theoretical values. 
Following ELRs characterization 
Furthermore, according to the biomedical application for what the ELRs were designed, 
other analyses has been performed. For instance, in Chapter 3 it is reported the 
mechanical characterization of hydrogels by rheological measurements. In Chapter 4 the 
therapeutic capacity of the hydrogel-based on ELRs was evaluated with an in vivo study 
for osteochondral repair. Moreover, in Chapter 5 other types of characterization such as 
X-ray Photoelectron Spectroscopy and cell adhesion assay have been used to describe the 
new ELR-Peptide generated. Finally, in Chapter 6 an RNase A activity assay was assessed 
in order to monitor the allosteric control of the smart-ELRs generated. Many more 
methods of biomaterial characterization have been used along this Thesis, and they are 
all described in the following chapters. 
Statistical analysis 
All the values shown in this Thesis are expressed as mean ± standard deviation (n ≥ 3 
according to the specific experiment conditions). Depending on the group of data 
collected by each specific experiment, different statistical analyses has been used. Data 
were analyzed by performing the normality test Shapiro-Wilk. The parametric data were 
analyzed by one-way analysis of variance (ANOVA) followed by Tukey’s Honestly 
Significant Difference (HSD) post hoc test; if only two groups were being compared, an 
unpaired t-test was used instead of ANOVA to assess the statistical difference. The 
nonparametric data were analyzed performing the Kruskal-Wallis test followed by Dunn’s 
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multiple-comparison test. All statistical analyses were performed with GraphPad Prism. In 
all the cases, a P-value lower than 0.05 was considered statistically significant. 
 
 
  
139 
 
References 
1. Girotti A, Reguera J, Arias FJ et al. Influence of the Molecular Weight on the Inverse Temperature 
Transition of a Model Genetically Engineered Elastin-like pH-Responsive Polymer. 
Macromolecules 2004; 37:3396-3400. 
2. Rodríguez-Cabello JC, Girotti A, Ribeiro A et al. Synthesis of Genetically Engineered Protein 
Polymers (Recombinamers) as an Example of Advanced Self-Assembled Smart Materials. In: 
Navarro M, Planell JA (eds). Nanotechnology in Regenerative Medicine: Methods and Protocols. 
Totowa, NJ: Humana Press, 2012, 17-38. 
3. Meyer DE, Chilkoti A. Protein purification by inverse transition cycling. In: Protein Interactions. 
New York (USA): Cold Spring Harbor Laboratory Press, 2002, 329-343. 
4. Luis Jimenez, Narendra Rana, Kasey Travers, et al. Evaluation of the Endosafe® Portable Testing 
System™ for the Rapid Analysis of Biopharmaceutical Samples. PDA J Pharm Sci and Tech 2010; 
64:211-221. 
5. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage 
T4. Nature 1970; 227:680-5. 
6. Lee C, Levin A, Branton D. Copper staining: a five-minute protein stain for sodium dodecyl 
sulfate-polyacrylamide gels. Anal Biochem 1987; 166:308-12. 
7. Hillenkamp F, Karas M, Beavis R, Chait, Brian T. Matrix-assisted laser desorption/ionization mass 
spectrometry of biopolymers. Analytical Chemistry. 63 (24): 1193A–1203A. (1991) 
doi:10.1021/ac00024a002. 
 8. Karas M, Krüger R. Ion Formation in MALDI: The Cluster Ionization Mechanism. Chemical 
Reviews. 103 (2): 427–440. (2003) doi:10.1021/cr010376a. 
9. R. M. Silverstein, G. C. Bassler and T. C. Morrill. Spectrometric Identification of Organic 
Compounds, 5th Ed., Wiley, (1991).  
  
140 
 
  
141 
 
  
142 
 
RESULTS 
 
  
143 
 
 
  
144 
 
CHAPTER 3 
CARTILAGE REGENERATION IN PREANNEALED SILK ELASTIN-LIKE CO-
RECOMBINAMERS INJECTABLE HYDROGEL EMBEDDED WITH MATURE 
CHONDROCYTES IN AN EX VIVO CULTURE PLATFORM 
Filippo Cipriani,1 Melanie Krüger,2 Israel González de Torre,1,3 Luis Quintanilla Sierra,3 Matilde Alonso 
Rodrigo,1,3 Linda Kock,2 José Carlos Rodríguez-Cabello,1,3 
1 Technical Proteins NanoBioTechnology (TPNBT) S.L., Valladolid, Spain 
2 LifeTec Group B.V., Eindhoven, The Netherlands 
3 Bioforge, University of Valladolid CIBER-BNN, Paseo de Belén 19, 47001 Valladolid, Spain  
F. Cipriani, M. Krüger, I. González de Torre, L. Quintanilla Sierra, M. Alonso Rodrigo, L. Kock, J.C. Rodríguez-
Cabello. Cartilage Regeneration in Preannealed Silk Elastin-Like Co-Recombinamers Injectable Hydrogel 
Embedded with Mature Chondrocytes in an Ex Vivo Culture Platform. Biomacromolecules (2018). doi: 
10.1021/acs.biomac.8b01211. 
 
 
 
  
145 
 
Keywords   
Elastin-like Recombinamers; Polymers; Hydrogels; Cartilage repair; Ex vivo culture 
platform. 
Abstract 
Tissue engineering for cartilage repair requires biomaterials that show rapid gelation and 
adequate mechanical properties. Although the use of hydrogel is the most promising 
biomaterial, it often lacks in rigidity and anchorage of cells when they are surrounded by 
synovial fluid while they are subjected to heavy loads. We developed and produced the 
Silk Elastin co-Recombinamer (SELR), which contains both the physical interaction from 
elastin motifs and from silk motifs. In the first part of this work, we set up and optimized 
a pre-annealing treatment based on the evolution of silk motifs into β-sheet structures in 
order to fulfill the required mechanical properties of hydrogels for cartilage repair. The 
new pre-annealed SELRs (pA(EIS)2-(I5R)6) were characterized with the combination of 
several experimental techniques (CD, TEM, SEM, and rheology) to provide a deep insight 
into the material features. Finally, the regeneration properties of the pA(EIS)2-(I5R)6 
hydrogel embedded with chondrocytes were evaluated. After 4 weeks of culturing in a 
standardized and representative ex vivo model, the biochemical and histological analysis 
revealed the production of glycosaminglycans and collagen. Moreover, the 
immunohistochemistry showed the absence of fibro-cartilage and the presence of hyaline 
cartilage. Hence, we conclude that the pA(EIS)2-(I5R)6 hydrogel presents improved 
mechanical properties while conserving the injectability, which leads to successful 
regeneration of hyaline cartilage in an ex vivo model.  
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1. INTRODUCTION 
Articular cartilage is central to the proper functioning of synovial joints. It covers the 
opposing articulating bones and, through its properties of high resiliency and 
deformability, it protects them from compressive joint loads (1). Moreover, it provides a 
smooth and gliding surface with a very low coefficient of friction (2). Many people suffer 
from cartilage degeneration due to genetic abnormalities, trauma, or osteoarthritis (3). 
One of the main issues in this regard is that articular cartilage possesses limited 
regeneration ability due to its avascular character, and the fact that only one cell type 
(chondrocytes) is present (4,5).  
Because of the absence of self-repair abilities, various surgical interventions and 
biomaterials have been explored to facilitate regeneration of cells and cartilaginous 
matrix (5). The physical properties of the extra cellular matrix (ECM) often refer to its 
rigidity, porosity, insolubility, topography, and other characteristics that are essential for 
its scaffolding role in supporting tissue structure and integrity, and for its role in migration 
and anchorage of the cells (6). Moreover, another important parameter to take into 
account is the permeability of cartilage; it contributes to several tissue functions like the 
transport of nutrients to chondrocytes, the ability to carry heavy loads, and the 
maintenance of a lubricating fluid film between opposing articular surfaces (7). 
Permeability is a measure of the ability of fluid to flow through a porous-permeable 
material, such as an ECM, and is inversely proportional to the friction drag exerted by the 
fluid (8). The low permeability of articular cartilage prevents fluid from being quickly 
squeezed out of the matrix (9).  
The purpose of surgery is the regeneration of the chondral defects to ultrastructural and 
biomechanical competent hyaline cartilage. From a scientific point of view, the clinical 
treatments are limited in their ability to functionally regenerate cartilage defects, as they 
often result in the formation of fibrotic tissue, which consists mainly of collagen type I and 
is therefore mechanically inferior to native cartilage.  
Biomaterials with an elastic modulus in the range of 1-10 kPa are of widespread interest, 
as many native tissues also have moduli in this range (10,11). The hydrogels developed to 
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repair joint cartilage are more effective when their stress relaxation behavior matches 
with the native tissue, since such behavior affects load transfer and nutrient transport 
(12,13). Up to 80 % of articular cartilage wet weight consists of water (14). To replicate 
this environment, hydrogels have become a popular option for cartilage regeneration in 
situ and cartilage engineering in vitro (15-17). The purpose of these types of scaffold is 
not only to provide support for cell attachment and spreading, but also to have 
mechanical stability at the defect site; although it is important to take into account that, 
the aim of these scaffolds is not to substitute for the tissue, but to improve cartilage 
regeneration in order to obtain a mature tissue.  
Natural polymers such as collagen and hyaluronic acid have some limitations; for instance, 
the insufficient mechanical integrity and the short lifetime in inflamed defects due to 
degradation by matrix metalloproteinases (18). From a biological point of view, the major 
drawback of synthetic polymer hydrogels such as polyglycolic acid (PGA) and polylactide 
acid (PLA) is that they do not provide specific biological functions (19). Moreover, 
synthetic polymer hydrogels do not fully recapitulate the chemical and biological features 
of ECM, considering that they generally regenerated fibro cartilage instead of hyaline 
cartilage (20).  
Over the last few decades, recombinant DNA techniques have proven to be very powerful 
tools for the development of novel protein-based biomaterials that are able to self-
assemble into different structures, such as hydrogels (21). These biomaterials include 
elastin-like recombinamers (ELRs), which are protein based polypeptides that comprise 
repetitive units of the Val−Pro−Gly−X−Gly (VPGXG)n pentapeptide, in which X (guest 
residue) could be any amino acid except L-proline. Moreover, they show thermo-
responsiveness due to the change of the protein conformation above the so-called 
transition temperature (Tt), which itself depends on the amino acid composition of the 
polymer (22). Therefore, taking into account two ELRs with the same amino acid 
composition except for the guest amino acid, the Tt can be tuned depending on the 
polarity of the side chain for the guest residue in the X position of the pentapeptide (23, 
24). Furthermore, ELRs can be designed so the phase transition occurring above the Tt is 
translated into a hydrophobically driven self-assembly of the molecules toward 
supramolecular hydrogels (25).  
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In this work we have used previously described amphiphilic Silk-Elastin-like 
Recombinamers (SELR) (26, 27) including two types of elastin-like domains, one 
hydrophilic and the other one hydrophobic. SELR also contains the amino acid sequences 
derived from other structural proteins like the GAGAGS hexapeptide (G: Glycine, A: 
Alanine, S: Serine) found in Bombyx mori silk fibroin, hence giving rise to SELR (28). 
Furthermore, the final sequence also contains the well-known RGD cell-adhesion 
sequence, which promotes specific cell attachment via integrins that provide a cell-
friendly environment (29). This recombinamer contains a dual physical interaction that 
triggers gel formation, in order to obtain a rapid and stable gel that can be delivered into 
the area of interest via a simple injection. The elastin motifs have been reported to form 
elastomeric hydrogels, in which the hydrophilic blocks provide conformational elastic 
properties, and the hydrophobic blocks form cross-links by hydrophobic aggregation (30, 
31). The silk motifs have been reported to be responsible for the supramolecular 
rearrangement into β-sheets, which increases the moduli of the hydrogels (26). However, 
the rearrangement of silk motifs into β-sheets with the consequent formation of a 
fibrillary structure takes time; the long time needed represents a drawback in terms of 
surgical application for the cartilage environment, which is surrounded by synovial fluid.  
Furthermore, recent works have demonstrated that physical and structural features of 
the ECM, such as fibrils, are essential for its scaffolding role in supporting tissue structure 
and integrity (6, 32). The nanofiber environment plays an essential role in the migration 
and anchorage of the cells. Considering that one difficulty in nanofiber technology has 
been the placement of cells within a nanofibrillar structure (33), the purpose of this work 
is to design a system based on supramolecular self-assembly to form nanofibrillar 
matrices in situ, around the cells, without cellular damage.  
This study focuses on the correlation between the elastin motifs and silk motifs, in order 
to understand how to improve the gelation properties of the hydrogel to obtain a system 
capable of forming an ECM fibrillary structure directly after injection. We set up and 
optimized a thermal treatment (pre-annealing treatment), which accelerates the β-sheet 
formation without losing the injectability of the material. The new pA(EIS)2-(I5R)6 were 
characterized either with molecular analysis (Circular Dichroism and Transmission 
Electron Microscopy) or with rheological characterization, in order to investigate the 
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impact of the pre-annealing treatment on the arrangement of the silk motifs into β-sheet 
conformation. Moreover, the morphology of the hydrogel was checked using Scanning 
Electron Microscopy in order to verify the interconnected structure and an adequate 
porosity and permeability.  
The incorporation of cells into biomaterial scaffolds include multiple aspects in cartilage 
repair; thus, considering that cells are the driving force of cartilage formation, they can 
significantly help orchestrate regeneration and overcome some of the limitations of using 
cells or biomaterials alone (34). The use of mature chondrocytes is based on the premise 
that native mature cells are best suited to guide regeneration (34). Moreover, the 
remarkable property of ELRs permits a homogeneous embedding of cells in the ELR 
solution at a temperature below Tt, while molecules can self-assemble into hydrogels 
above the Tt, thus allowing the use of the cell-scaffold system in injectable therapies 
perfectly suitable to the shape of the injured area (35). Therefore, although other ELR-
based hydrogels have shown a minimal inflammatory response, confirming its high and 
extraordinary biocompatibility (36), we performed an in vitro study evaluating the 
metabolic activity of the chondrocytes embedded in the 3D hydrogel. 
The potential properties of pA(EIS)2-(I5R)6 hydrogel in cartilage repair were evaluated in 
an ex vivo osteochondral culture platform (37). The use of bioreactors has some 
advantages: first, bioreactors are devices in which biological or biochemical processes 
develop under a closely monitored and tightly controlled environment (38). Second, it 
must be taken into account that cartilage defect models in rodents and mature rabbits 
show spontaneous self-repair (39). In addition, there are some other disadvantages using 
an animal model: the limited control over physiological parameters, and the limited 
possibilities for monitoring and controlling the healing progress from a biological and 
biomechanical point of view, as well as the high costs of animal care and ethical issues 
(39, 40).  
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2. MATERIALS AND METHODS 
2.1.  (EIS)2-(I5R)6 Design 
Amino acid sequence: MESLLP-{[(VPGVG)2-VPGEG-(VPGVG)2]10-(VGIPG)60-
[V(GAGAGSG)5]2G}-[(VPGIG)5-AVTGRGDSPASS]6V 
The composition of this (EIS)2-(I5R)6 is based on previously synthetized block co-
recombinamers, which have silk-like motifs (SELR) (26, 41). The original block co-polymer 
was designed to comprise a hydrophobic block (containing isoleucine as the guest residue) 
with a low Tt, and a hydrophilic block (containing glutamic acid with a carboxylic group) 
with a high Tt (27). The final composition was further functionalized to include RGD cell-
adhesion sequences (Figure 1). Initial SELRs were kindly provided by Technical Proteins 
Nanobiotechnology. 
 
Figure 1. Graphical scheme of the composition of (EIS)2-(I5R)6. 
2.2. ELR biosynthesis and purification  
The cloning and molecular biology for gene construction of (EIS)2-(I5R)6 were performed 
using standard genetic-engineering methods. Production was carried out using 
recombinant techniques with Escherichia coli as the cell system, as described previously 
(42-45). Purification was performed using several cooling and heating purification cycles 
(Inverse Transition Cycling) following centrifugation.  
2.3. Pre-Annealing treatment  
The lyophilized recombinamer was dissolved in ultrapure water at a concentration of 50 
mg/ml, and incubated at 37 °C for different time points: 12, 24, 36 and 48 h. The 50 mg/ml 
concentration for the pre-annealing treatment was selected considering the inability to 
form a gel even when using a long incubation time (up to 48 h). Afterwards, the solution 
was frozen and the polymer lyophilized again to finally obtain the pre-annealed SELRs: 
pA(EIS)2-(I5R)6. The purity and molecular weight of the ELRs were verified by sodium 
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dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectroscopy using a Voyager STR 
apparatus from Applied Biosystems. Amino acid composition analysis was also performed. 
Additional characterization of ELRs was accomplished using infrared spectroscopy (FTIR), 
differential scanning calorimetry (DSC), and nuclear magnetic resonance (NMR) 
techniques (46) (Supporting Information Figures S1 - S5). 
2.4.  Circular Dichroism (CD)  
Circular dichroism is an excellent method for rapidly evaluating the secondary structure 
and folding of proteins (47). It is known that the ELR conformational state is temperature-
dependent as consequence of the ITT (Inverse Temperature Transition) behavior 
experienced by this class of molecules (41). For performing CD experiments, 
recombinamers (EIS)2-(I5R)6 and pA(EIS)2-(I5R)6 were dissolved at a final concentration of 
1 mg/mL and were kept overnight at 4 °C. Just before performing each measurement, a 
1:10 dilution was made. The CD spectrum was acquired using a Jasco J-815 150-S 
spectrometer (Servicios Centrales de Investigación, University of Almeria). A quartz 
cuvette with a path length of 0.1 cm was used. The scans were obtained over the 
wavelength range of 190−260 nm at the experimental temperatures of 4, 37 and 60 °C by 
acquiring points every 0.5 nm using a scan speed of 50 nm/min. Before each 
measurement, samples were equilibrated for 15 min. Spectra were corrected by 
subtraction of the corresponding blank solvent readings. The data was expressed as molar 
ellipticity [θ], which was calculated as follows:  
[𝜃𝜃] = 𝜃𝜃
𝑑𝑑 × 𝑀𝑀 × 10 
where θ is the ellipticity, d is the path length (cm) and M is the concentration (mol/L). 
2.5.  Transmission Electron Microscopy (TEM) 
Nanostructure formation was checked by TEM. Solutions of (EIS)2-(I5R)6 and pA(EIS)2-(I5R)6 
were prepared by dissolving pure, lyophilized products in Milli-Q water to a concentration 
of 25 μM. These solutions were kept at 4 °C overnight to allow complete dissolution of 
the proteins. The samples were incubated at 37 °C for 15 min and analyzed directly. TEM 
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measurements were performed using a JEOL JEM-1230 electron microscope operating at 
120 kV. The specimens were prepared by placing a drop of the solution on a plasma-
treated carbon-coated copper grid, followed by water evaporation at 37 °C. 
2.6. Visualization and characterization of the Sol-Gel 
behavior 
In order to check the capacity of pA(EIS)2-(I5R)6 to rapidly form hydrogel and to remain 
stable in an excess of water, the pure recombinamers were dissolved in PBS (Phosphate-
buffered saline) at 4 °C for 16 h at the concentrations of 100, 120, 150 and 180 mg/ml. 
Once the recombinamers were in a liquid state at 4 °C, they were placed inside an oven 
at 37 °C for 15 min and the Sol-Gel behavior was qualitatively observed tilting the 
Eppendorf containing the solution. Afterwards the hydrogels were removed and placed in 
an excess of water at 37 °C.  
2.7. Rheological characterization 
A strain-controlled AR-2000ex rheometer (TA Instruments) was employed to perform 
rheological experiments by using parallel plates of nonporous stainless steel (diameter = 
12 mm).  
Oscillatory measurements were carried out in shear deformation mode. The volume of 
the gel was 150 µl, a gap higher than 1000 μm was always reached after the sample 
relaxed until equilibrium. Measurements were performed at 37 °C, with the sample 
temperature being controlled and maintained using a Peltier device.  
Firstly, the solution of pA(EIS)2-(I5R)6 dissolved in PBS was placed over the plate at 37°C, 
and a time sweep experiment was performed up to 30 min with 1 % strain amplitudes and 
a frequency of 1 Hz; in this case, in situ gelation took place. Then, once the time sweep 
was over, two different measurements were carried out sequentially. First, the dynamic 
shear modulus was measured as a function of strain by a dynamic strain sweep with 
amplitudes ranging between 0.01% and 20% at a frequency of 1 Hz. This measurement 
was done to determine the range of strain amplitudes over which the gel exhibited a linear 
region of viscoelasticity. A second measurement consisted of the dynamic frequency 
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sweep between 0.1 and 50 Hz at a fixed strain (selected within the hydrogel linear region), 
with the aim of obtaining the dependence of the dynamic shear modulus and loss factor 
on the frequency. Rheological evaluation provided the storage modulus (G′), the loss 
modulus (G″), the complex modulus magnitude |G*|, (|G*|2 = (G′)2 + (G″)2), and the loss 
factor tan δ ≡ (G″)/(G′), where δ is the phase angle between the applied stimulus and the 
corresponding response as a function of strain amplitude or frequency. 
In order to obtain the evolution of the viscosity of the pA(EIS)2-(I5R)6 solutions with the 
shear rate, flow measurements were carried out at 4 °C. In this case, a parallel plate of 40 
mm of diameter was used to improve the measurement sensitivity; the corresponding 
volume of the gel was 1300 µl. Initially, a conditioning step was accomplished at a 
constant shear rate of 0.1 s-1 for 1 min. Next, the shear rate was swept from 0.1 to 500 s-
1 using a continuous ramp in a logarithmically ascending series of discrete steps. 
Specifically, 10 points were acquired for each order of magnitude and the complete 
measure took 5 min. 
2.8. Scanning electron microscopy (SEM) 
Scanning electron microscopy was employed to investigate the morphology of the 
hydrogel. Fully hydrated gels were dropped into liquid nitrogen, physically fractured, and 
immersed into liquid nitrogen again. Finally, they were freeze-dried. Images of lyophilized 
hydrogels were obtained by using a FEI Quanta 200 FEG with no prior coating procedures. 
Pictures were collected by SEM at Landing E of 7.00keV and Pressure of 0.7 Torr; 
afterwards they were analyzed with Image-J software. 
2.9. Chondrocytes isolation 
Pig chondrocytes were isolated from knee joints of Dutch Land Raise Hybrid pigs, male or 
female, 5-7 months of age, 100-110 kg live weight. Small cartilage pieces were removed 
from the cartilage of the knee joints and were digested in a solution of 0.5% (v/v) 
collagenase (PrepoTech) in high glucose DMEM (supplemented with 10% (v/v), fetal 
bovine serum (FBS; HyClone, (South America) Research Grade, GE Healthcare, Eindhoven, 
NL), 1% (v/v) penicillin/streptomycin (Lonza, Westburg, Leusden, NL), 1% (v/v) 
amphotericin B (Life Technologies, Bleiswijk, NL). Digestion in 8 ml collagenase solution 
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per gram of cartilage was executed for 16 h on a roller bank in the incubator. 
Subsequently, the cells were washed and filtered three times and stored in a cartilage 
medium until further use. The cartilage medium consisted of high glucose DMEM medium 
supplemented with 1% (v/v) penicillin/streptomycin, 1% (v/v) amphotericin B, 1 mM 
sodium pyruvate (LifeTechnologies, Bleiswijk, NL), 40 μg/ml L-proline (Sigma-Aldrich, 
Zwijndrecht, NL), 50 μg/ml L-ascorbic acid-2-phosphate (Sigma-Aldrich, Zwijndrecht, NL), 
1% (v/v) ITS+ Premix (Corning, Fisher Scientific, Landsmeer, NL) and 100 nM 
dexamethasone (Sigma-Aldrich, Zwijndrecht, NL). 
2.10. Hydrogel formation and embedding with chondrocytes 
Freeze dried pA(EIS)2-(I5R)6 was dissolved in plain DMEM (Dulbecco´s modified Eagle 
medium; Life Technologies, Bleiswijk, NL) for 16 h at 4 °C at 120 mg/ml. Afterwards, the 
solution was placed at 37 °C for 15 min and the gel was formed. For the hydrogel 
embedded with chondrocytes (20 million cells/ml), the cells were mixed with the solution 
of pA(EIS)2-(I5R)6 dissolved in plain DMEM at 4 °C. The mixture was placed at 37 °C for 15 
min, and the cell embedding gel was formed.  
2.11. Cell viability assay 
The viability of isolated chondrocytes embedded in pA(EIS)2-(I5R)6 hydrogels at 120 mg/ml 
was assessed by measuring the metabolic activity with PrestoBlue® assay (A-13261, 
Invitrogen). Chondrocytes were isolated and mixed into the hydrogel according to the 
protocol described above. Of each hydrogel condition, 100 μl were pipetted into a 24 well 
Transwell® tissue culture plate (Costar, Kennebunk, USA) in quadruplicate and topped 
with 2 ml of cartilage medium. Culture time was 4 weeks at 37°C and 5% CO2. After letting 
the cells adapt overnight, metabolic activity measurements were conducted on day 0, 14 
and 28. For this purpose, 2 ml of a solution of cartilage medium containing 10 % 
PrestoBlue® Viability Reagent (Life Technologies, Eugene, USA) replaced the culture 
medium and was incubated in darkness for 2 h. Afterwards, 100 μl of medium from within 
the Transwell® insert, directly above the gel, was pipetted into a black 96 well plate in 
triplicate and fluorescence was read out at an excitation wavelength of 560 nm and an 
emission wavelength of 590 nm with a plate reader (CLARIOstar microplate reader, BMG 
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LABTECH GmbH, Ortenberg, D). The cell viability assay is not an end point measurement 
analysis, thereby, after each measurement the solution was removed and replaced with 
2 ml of fresh cartilage medium. 
2.12. In vitro Study  
In order to evaluate the performance of the pA(EIS)2-(I5R)6 hydrogel embedded with 
chondrocytes, a 4-week in vitro study was conducted. Firstly, silicone cylinders were 
produced with an inner diameter of 4 mm and a height of 2 mm, in correspondence to 
the simulated cartilage defect in the ex vivo study. After autoclaving, these silicone 
cylinders were attached to the bottom of a 24 well plate. 150 μl of the pre-annealed (EIS)2-
(I5R)6 hydrogel embedded with chondrocytes (20 million chondrocytes/ml), and the 
pA(EIS)2-(I5R)6 hydrogel itself (as a control) were pipetted into the cylinders. After a 
gelation period of 15 min in the incubator at 37 °C, the cartilage compartment was topped 
with 3 ml of cartilage medium. The culture time was 28 days with medium changes every 
3-4 days.  
2.13. Ex vivo Study  
2.13.1. Osteochondral explant isolation 
Osteochondral explants (n=12) were isolated from knee joints of Dutch Land Raise Hybrid 
pigs, male or female, 5-7 months of age, 100-110 kg live weight. The knees were opened 
in a sterile manner and three explants were drilled from each medial femoral condyle with 
a dental drill bit of 8 cm diameter (MF Dental, Mantel, D). The site was cooled with cold, 
sterile phosphate-buffered saline (PBS; Sigma-Aldrich, Zwijndrecht, NL) with 2% (v/v) 
penicillin/streptomycin and 2% (v/v) amphotericin B and the explants were broken off 
from the bone with a custom-made tool. Successively, they were sewn to a bone length 
of 4 mm and incubated overnight in cartilage medium. 
2.13.2      Cartilage defect creation, hydrogel incorporation and 
culture 
To test the regenerative potential of the pA(EIS)2-(I5R)6 hydrogel for cartilage repair, full 
depth cartilage defects of 4 mm diameter were created with a biopsy punch (PFM Medical 
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AG, Cologne, D) and the defect site was cleaned of remaining cartilage with a sharp spoon 
(MF Dental, Mantel, D) (Figure 2A). These osteochondral explants with defects were then 
mounted in an osteochondral culture platform developed by LifeTec Group BV as 
previously described (37). Briefly, the explants were mounted in an insert with an O-ring 
situated at the exact interface between the bone and the cartilage (Figure 2C). This insert 
was then suspended in a custom made six well plate, thereby resulting in two separate 
compartments for the bone and the cartilage. By using respective tissue-specific media, 
complete preservation of native extra cellular matrix composition was achieved over 56 
days, thereby allowing regeneration studies in this ex vivo model. Once the explants were 
mounted in the described way into the insert, the pA(EIS)2-(I5R)6 hydrogel itself (control), 
and the pA(EIS)2-(I5R)6 hydrogel embedded with chondrocytes (20 million 
chondrocytes/ml) were pipetted into the defects (Figure 2B). In this manner, 30 μl of 
hydrogel itself, and 30 μl of hydrogel loading 600,000 chondrocytes filled each defect. 
After a gelation period of 15 min in the incubator at 37 °C, the cartilage compartment was 
topped with 3 ml of cartilage medium. The bone compartment was filled with 3 ml of bone 
medium consisting of high glucose DMEM medium supplemented with 10% (v/v) FBS, 1% 
(v/v) penicillin/streptomycin, 1% (v/v) amphotericin B, 50 μg/ml L-ascorbic acid-2-
phosphate, 10 nM β-glycerophosphate (Sigma-Aldrich, Zwijndrecht, NL), and 100 nM 
dexamethasone. The medium was changed every 3-4 days and explants were cultured for 
28 days at 37°C and 5% CO2. 
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Figure 2. Ex vivo osteochondral culture platform mounting scheme. A: Creation of the full 
cartilage defects of 4 mm diameter with a biopsy punch. B: Filling of the defects with 30 μl of 
pA(EIS)2-(I5R)6 hydrogel loaded with 600,00 chondrocytes and 30 μl of pA(EIS)2-(I5R)6 hydrogel 
itself (control). C: Mounting of the explant in the insert with the O-ring situated at the exact 
interface between the bone and the cartilage. 
2.14. Biochemical analysis  
2.14.1. DNA quantification 
The hydrogel samples were carefully and fully removed from the silicone cylinders (for the 
in vitro study), and from the osteochondral defect (for the ex vivo study) after the 
respective culturing period. They were then digested by a homogenizer (T 10 basic Ultra-
Turrax® IKA) until the gel was completely disrupted. The DNA content was determined by 
Pico Green® assay. Briefly, Pico Green® analysis for DNA content was performed in 96-well 
plates with standard fluorescein wavelengths (excitation: 480 nm and emission: 520 nm) 
according to the manufacturer’s instructions (Invitrogen) using an automated plate reader 
(Bionova Cientifica, Molecular Devices).  
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2.14.2. GAG quantification 
GAG content was determined with a modified DMMB (Dimethylmethylene Blue) assay 
according to Farndale et al. (48). After the respective culturing period, the gels were 
removed, digested and centrifuged in the same manner as for the DNA analysis. In brief, 
40 μl of centrifuged samples were pipetted into 96-well plates; the same volume was 
pipetted for standards, which are a shark cartilage chondroitin sulfate reference (Sigma, 
Zwijndrecht, NL). Afterwards, 150 μl of DMMB solution (containing 1-9-
dimethylmethylene blue (Sigma-Aldrich, Zwijndrecht, NL)) was added in each well. 
Immediately afterwards, absorbance at 540 and 595 nm was measured with a plate reader 
(CLARIOstar microplate reader, BMG LABTECH GmbH, Ortenberg, D) and the GAG 
concentrations were calculated.  
2.15. Histological analysis 
For the histological analysis, all the samples were fixed in 4% formaldehyde in PBS 0.05M 
(pH 7.3) at 4°C for about 18 h. Afterwards the samples were dehydrated and infiltrated by 
paraffin following the automatic procedure performed by the MICROM Tissue Processor. 
The resulting blocks were cut using a rotary microtome (Leica RM 2125 RTS, Leica 
Biosystems, Germany) into slices with a thickness of 4 µm. For general histo-
morphological evaluation, the sections were stained with Hematoxylin and Eosin (H/E) 
according to standard protocols. In order to evaluate the collagen and glycosaminoglycan 
content produced by chondrocytes, the sections were stained with Picro-Sirius Red Stain 
and Safranin-O/Fast Green, respectively, according to common methods. 
Immunohistochemistry for collagen type I and II was performed on 4 μm paraffin sections 
following the manufacturer’s instructions and well-established protocols. The samples 
were immunostained with primary antibody Mouse monoclonal anti-collagen type I 
(dilution 1:100, Sigma), and with primary antibody Mouse monoclonal anti-collagen type 
II (dilution 1:00, Merck), then incubated with the secondary antibody Goat anti Mouse IgG 
conjugated with HRP (dilution 1:100, abcam). Immunostaining was developed using DAB 
(Thermo Scientific) followed by Hematoxylin counterstaining (Sigma, St. Louis, MO).  
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2.16. Statistical analysis  
Values are expressed as mean ± standard deviation (SD). The data was examined with a 
one-way analysis of variance (ANOVA) followed by Tukey’s Honestly Significant Difference 
(HSD) post hoc test. If only two groups were being compared, an unpaired t-test was used 
instead of ANOVA to assess the statistical difference. All statistical analyses were 
performed with GraphPad Prism. A P-value lower than 0.05 was considered statistically 
significant. 
3. RESULTS 
3.1. Circular dichroism  
Circular dichroism (CD) was performed in order to investigate the impact of the pre-
annealing treatment on the (EIS)2-(I5R)6 on the consequent arrangement of the silk motifs 
into β-sheets. The silk motifs represented around 16% of the complete sequence of the 
(EIS)2-(I5R)6. The conformational state of ELRs is temperature-dependent as a 
consequence of the Tt behavior experienced by this class of molecules (49); thus, the CD 
spectra were recorded at different temperatures (4, 37 and 60 °C) in order to verify if such 
temperature dependence remained operational for pA(EIS)2-(I5R)6 with 12, 24, 36 and 48 
h of pre-annealing time. A sample of (EIS)2-(I5R)6 without pre-annealing was used as a 
control sample.  
At 4 °C, (Figure 3A) an intensely negative band at 197 nm is displayed for all the curves, 
which indicates a predominant disordered structure; however, it is possible to see clearly 
the differences along the curves. The signal of the (EIS)2-(I5R)6 (control) reaches lower 
values compare to the pA(EIS)2-(I5R)6 values with different pre-annealing times. At this 
temperature, in the band at 197 nm, a trend is appreciable (corresponding to the pre-
annealing samples) between the 4 curves regarding the different pre-annealing times. The 
12 h curve values are lower than the 24, 36 and 48 h; moreover, the 24 h and 36 h curves 
show the same behavior, whereas the 48 h curve values are higher, showing a more 
ordered structure. Such a reduced negative band at 197 nm suggests the presence of a 
mixture of β-turns and β-sheet structures, and agrees with the contribution of elastin and 
silk moieties to the final conformation (50). A shoulder is also present at 4 °C at 210 nm 
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for all the curves where the signal of the control reaches lower values compare to the 
pA(EIS)2-(I5R)6 values with a different pre-annealing time; all the curves maintain the same 
trend seen at 197 nm. 
At 37 °C (Figure 3B), the CD spectra for all the curves clearly displays a less negative signal 
at 197 nm compared to 4 °C. Yet, at 37 °C, a clear difference is still present between the 
control curve and the pA(EIS)2-(I5R)6 curves with different pre-annealing times. 
Furthermore, almost no difference is appreciable between the pre-annealed curves, apart 
from the 12 h curve which shows lower values compare to the 24, 36 and 48 h curves. 
Moreover, for all the curves, the magnitude of the signal at 210 nm increased, and such 
trend is also maintained when increasing the temperature to higher values (60 °C) (Figure 
3C) which suggests the induction of a type II β-turn conformation with an increase in 
temperature, as it has previously been observed for EL macromolecules (47,49).  
Finally, also at 60 °C, the 197 nm values recorded for the control curve are lower compared 
to the pA(EIS)2-(I5R)6 curves with different pre-annealing times, which all show similar 
values.  
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Figure 3. Circular dichroism spectra for (EIS)2-(I5R)6 (control) and pA(EIS)2-(I5R)6 with 12, 24, 36 
and 48 h of pre-annealing time. CD spectra were recorded for the samples at 0.1 mg/mL in 
deionized water. For each sample, CD spectra was recorded at different temperatures. A: 4 °C; B: 
37 °C: C: 60 °C. 
3.2. Transmission Electron Microscopy (TEM) 
Transmission electron microscopy (TEM) was used to visualize the supramolecular 
structures comparing (EIS)2-(I5R)6 and pA(EIS)2-(I5R)6 with 12, 24, 36 and 48 h of pre-
annealing time. The TEM image for the (EIS)2-(I5R)6 indicated the ability of this SELR to 
form spherical nanoparticles (Figure 4A). The TEM images for pA(EIS)2-(I5R)6 with 12, 24, 
36 and 48 h of pre-annealing time revealed the emergence of additional and different 
fibrillary structures (Figure 4B-4E). Moreover, a difference is appreciable in the density of 
the network of fibers between the 12 h treatment (Figure 4B) and the group of 24, 36 and 
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48 h (Figure 4C,4E), where a more dense network of fibers is evident for this group. Thus, 
the pre-annealing treatment enhanced the ability of the recombinamer to form a fibrillary 
structure. 
 
Figure 4. TEM images of the self-assembled nanoparticles formed by (EIS)2-(I5R)6 at the 
concentration of 25 µM in Milli-Q water (A) and pA(EIS)2-(I5R)6 with 12 h (B), 24 h (C), 36 h (D) 
and 48 h (E) of pre-annealing time. 
3.3. Visualization of the Sol-Gel behavior 
The pure recombinamers pA(EIS)2-(I5R)6 at each pre-annealing time (12, 24, 36, 48 h) were 
dissolved in PBS at 4°C for 16 h at a concentration of 100, 120, 150 and 180 mg/ml. 
Afterwards the solutions were placed in an oven at 37 °C for 15 min. For all the pre-
annealed (EIS)2-(I5R)6 at different annealing times, the lowest concentration possible to 
form a hydrogel within 15 min was 120 mg/ml (Figure 5). Moreover, the solution of the 
(EIS)2-(I5R)6 (without pre-annealing) subjected to the same procedure showed the 
incapacity to form a stable hydrogel. As it was already demonstrated by Fonseca et al., 
where the minimum concentration to form a gel was 145mg/ml (27). In order to verify the 
stability of the hydrogel, identical parameters to our application were selected (see 
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hydrogel formation in Materials and Methods). The hydrogel at 120 mg/ml was placed in 
an excess of water and showed the ability to remain stable after 1 week at 37 °C (Figure 
5E,F). 
 
Figure 5. Pictures showing the visualization of the Sol-Gel behavior. 24 h pA(EIS)2-(I5R)6 hydrogel 
at 100 mg/ml before (A) and after the incubation at 37 °C for 15 min (B). 24 h pre-annealed 
pA(EIS)2-(I5R)6 hydrogel at 120 mg/ml before (C) and after the incubation at 37 °C for 15 min (D); 
finally, the hydrogel was placed in an excess of water (E) showing the ability to remain stable 
after 1 week at 37 °C (F). 
3.4. Characterization of the Sol-Gel behavior 
In order to understand the driving force of the gelation of the pA(EIS)2-(I5R)6, a rheology 
study was performed. First of all, an in-situ gelation experiment was carried out for a 
solution of 120 mg/ml. The solutions dissolved in PBS at 4 °C for 16 h were placed in the 
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rheometer plate at 37 °C, where a time sweep experiment was carried out for 30 min 
(Figure 6A). The complex modulus increased with time in agreement with the study 
performed by Colino et al. (26). As can be seen, a clear difference is present between the 
(EIS)2-(I5R)6 curve (control) and the pA(EIS)2-(I5R)6 curves with different pre-annealing 
times. Along the pre-annealing conditions, no noticeable differences were observed in the 
complex modulus for the pre-annealing times of 24, 36 and 48 h at the end of the 
measuring time (around 1 kPa). Yet, a final complex modulus around 200 Pa was found 
for a pre-annealing time of 12 h.  
Therefore, the pre-annealing time of 24 h was selected and several concentrations were 
considered (100, 120, 150 and 180 mg/ml) (Figure 6B). A clear difference was observed 
between the concentration of 100 mg/ml and the rest of the concentrations, in agreement 
with the Sol-Gel behavior qualitatively observed in Figure 5.  
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Figure 6. Time Sweep measurement at 37°C for A: (EIS)2-(I5R)6 & pA(EIS)2-(I5R)6 hydrogels at 120 
mg/ml with 12, 24, 36 and 48 h of pre-annealing; B: pA(EIS)2-(I5R)6 hydrogels with 24 h of pre-
annealing at 100, 120, 150 and 180 mg/ml, and pA(EIS)2-(I5R)6 hydrogel with 48 h of pre-
annealing at 100 mg/ml. 
Finally, the effect of the pre-annealing time for different concentrations can be found in 
Figure 6B, where the concentration of 100 mg/ml was pre-annealed for 48 h. It could be 
expected to find similar modulus for samples pre-annealed for 48 h at a concentration of 
100 mg/ml and for samples pre-annealed for 24 h at a concentration of 120 mg/ml, 
considering that the lower concentration could be compensated by longer times of pre-
annealing. Instead, as can be seen, the curves of 100 mg/ml for 24 and 48 h in Figure 6B 
are similar, and a lower complex modulus was obtained with respect to the concentration 
of 120 mg/ml pre-annealed for 24 h. 
Therefore, the concentration of 120 mg/ml pre-annealed for 24 h presents a threshold for 
gelation, and these conditions were selected as the most suitable candidate for an 
injectable hydrogel for cartilage repair.  
3.5. Viscosity measurements of the solutions 
Rheological flow measurements were carried out in order to find the evolution of the 
viscosity of the pre-annealed (EIS)2-(I5R)6 dissolutions with the shear rate. Since viscosity 
is the resistance of a fluid to flow upon the application of stress, the viscosity value and 
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its dependence on shear rate provide some insight about the interactions between the 
micro/nanostructures in our dissolution. These measurements provide some insight into 
the injectability of the solutions of 120 mg/ml for different pre-annealing times. To 
guarantee injectability, the solution should be of sufficiently low viscosity to allow the use 
of a small gauge needle (51).  
In Figure 7, the dependence of the viscosity on the shear rate has been plotted in a lin-log 
scale for the control sample (without annealing), and for four pre-annealed samples at 
several annealing times (12, 24, 36 and 48 h). As can be seen, when the shear rate is higher 
than 200-300 s-1 all the curves overlap on a viscosity value around 70-80 mPa∙s. Yet, a 
significantly different evolution of the viscosity is observed in the shear rate range of 0.1 
- 50 s-1. Whereas no evolution of the viscosity with the shear rate is observed for the 
control sample (Newtonian fluid), the annealed samples show a decrease of the viscosity 
(shear thinning) with an evident linear dependence of the viscosity in the lin-log scale. 
Specifically, two slopes are detected in the experimental data. 
On the contrary, as can be seen in Figure S6 in Supporting Information (SI) obtained for 
an identical recombinamer lacking the silk motifs, no dependence of the viscosity with the 
shear rate for any annealing time was detected. 
A noticeable difference was observed in the viscosity of samples for 24, 36 and 48 h with 
respect to the sample for 12 h (Figure 7). The viscosity for the sample at 48 h was slightly 
higher than that of the samples at 24 h and 36 h. This trend for pA(EIS)2-(I5R)6 with 
different annealing time corroborates the behavior recorded with CD for at 4 °C (Figure 
3A).  
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Figure 7. Dependence of the viscosity on the shear rate in a scale lin-log for (EIS)2-(I5R)6 & 
pA(EIS)2-(I5R)6 hydrogels with 12, 24, 36 and 48 h of pre-annealing. These parameters were 
calculated by numerical fitting of the experimental data to Equation (1). In each fitting R2 > 0.990 
was found. 
Thus, from the viewpoint of injectability, the pre-annealing time of 24 h seems to be the 
most appropriate, considering enough maturation of the β-sheet structures and an 
adequate viscosity to make the injection process easier. 
3.6. Rheological characterization of the hydrogels  
Immediately after the 30 min of the in situ gelation of the hydrogels was finished, 
oscillatory rheological measurements were done, with special attention paid to the 
concentration of 120 mg/ml pre-annealed for 24 h. First, a sweep in the amplitude of the 
test signal was carried out in a strain sweep test, which provided the linear range where 
the rheological characterization should take place. According to Figure S7 (SI), a wide 
linear range was obtained. As a trade-off between linearity and noise, a strain of 1% was 
chosen for every subsequent rheological measurement. Moreover, this Figure also 
includes the results for the concentrations of 100, 150, and 180 mg/ml, showing a clear 
trend: the higher the concentration, the higher the complex modulus. 
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Dynamic frequency sweep measurements were performed in the frequency range of 0.1 
and 50 Hz. The evolution of the storage modulus (G´), and the loss modulus (G´´) as a 
function of the frequency were represented in Figure 8A. Whereas a dependence of G’ on 
frequency is observed, no significant dependence of G’’ is found up to 10 Hz. It should be 
pointed out that the value of G´ is significantly higher than G´´, which is calculated by the 
loss factor tan δ ≡ G´´/G´ (Data not shown). Specifically, δ is around 12 - 13° for the 
frequency of 1 Hz, indicating a visco-elastic hydrogel behavior. 
 
Figure 8. (A): Frequency dependence of the storage (G’) and loss (G’’) moduli for the pA(EIS)2-
(I5R)6 hydrogels at 120 mg/ml with 24 h of pre-annealing. (B): Dependence of the magnitude of 
the complex modulus on f½ for the concentration of 120 mg/ml. The dashed lines correspond to 
the least-squares linear regressions of each linear region. In every case, R2 is better than 0.990. 
Each curve corresponds to the average of three different samples measured. 
In order to obtain some information about the physical mechanisms that determine the 
frequency dependence of |G*|, the dependence of |G*| on f1/2 for the hydrogel of 120 
mg/mL has been drawn in Figure 8B. A linear dependence based on two different slopes 
was found in the frequency range considered.  
3.7. Scanning electron microscopy 
pA(EIS)2-(I5R)6 hydrogel at 120 mg/ml shows a pore size of 10.23 ± 2.87 µm and wall 
thickness of 0.71 ± 0.12 µm (Figure 9). pA(EIS)2-(I5R)6 hydrogels at 150 & 175 mg/ml show, 
respectively, a pore size of 6.97 ± 2.30 µm & 5.22 ± 1.87 µm; and wall thickness of 1.85 ± 
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1.40 µm & 2.85 ± 1.11 µm (SI Figure S8). The pA(EIS)2-(I5R)6 hydrogels at all of the 
concentrations showed a 3D porous environment with an interconnected structure. 
 
Figure 9. Representative SEM pictures for pA(EIS)2-(I5R)6 hydrogel at 120 mg/ml at different 
magnifications. 
3.8. Cell viability assay 
The chondrocytes (20 million cells/ml) were mixed with the hydrogel as described in 
Material and Methods. The mixture was further stained with DAPI (nuclear counterstain) 
according to the standard protocol. As it can be seen in Figure S9 (SI) the cells were 
uniformly distributed. A metabolic activity assay was performed for the in vitro study at 
time 0, 2, and 4 weeks of culture. The cell viability analysis revealed an increase of 
metabolic activity, especially within the first 2 weeks, most likely due to the increase in 
number of cells; moreover, the viability of the cells remained high throughout the 4 weeks 
of culture, proving a suitable concentration of pA(EIS)2-(I5R)6 hydrogel (Figure 10). 
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Figure 10. Cell viability test of pA(EIS)2-(I5R)6 with 24h of pre-annealing at 120 mg/ml 3D gel 
embedded with pig chondrocytes (20 million/ml) at different time points (**P<0.01). 
3.9. Biochemical analysis  
In order to quantify the GAG and the DNA content of the hydrogel embedded with 
chondrocytes for the in vitro and ex vivo study at day 0 and 28, a biochemical analysis was 
performed. In both studies, an increase in DNA content was recorded with more 
significance in the ex vivo study (Figure 11). Moreover, at day 28 the DNA content of the 
ex vivo study was higher compare to the in vitro study with a significant difference 
(P<0.001). 
The GAG content at day 0 has revealed the complete absence of polysaccharides, whereas 
at day 28 we recorded a large presence of glycosaminoglycan in both studies (Figure 11). 
Comparing the GAG content at day 28, the content was significantly higher in the ex vivo 
study than the content in the in vitro study (P<0.05) (Figure 11). Biochemical analysis of 
the hydrogel itself was performed for the in vitro and ex vivo study at day 0 and 28. As it 
can be seen in Figure S10 (SI), in both studies the values remained approximately zero, 
meaning the absence of contribution in GAG and DNA content from the surrounding tissue 
(in the case of ex vivo study).  
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Figure 11. DNA and GAG content of the hydrogels embedded with chondrocytes for the in vitro 
and ex vivo study at day 0 and 28. All the values have been normalized for 30 µl volume of 
hydrogel (*P<0.05; **P<0.01; ***P<0.001; ****P<0.0001). 
3.10. Histological analysis 
Histological analyses were performed for the hydrogels embedded with chondrocytes at 
day 28 for the in vitro (Figure 12) and ex vivo study (Figure 13). For general 
histomorphological evaluation, the sections were stained with H/E; moreover, in order to 
evaluate the general collagen and GAG content produced by chondrocytes, the sections 
of hydrogels were stained with Picro-Sirius Red Stain and Safranin-O/Fast Green, 
respectively. For both studies, the H/E staining reveled a very homogenous distribution of 
chondrocytes embedded in the hydrogel. The Picro-Sirius Red Stain and Safranin-O/Fast 
Green demonstrated how the cells started to produce and secrete collagen and GAG, and 
thus began forming their own ECM, in Figure 12 (B & C) for the in vitro study and in Figure 
13 (B & C) for the ex vivo study. 
172 
 
 
Figure 12. Histology of in vitro study with different staining, pictures collected at different 
magnifications (A&B): 1: H/E; 2: Collagen staining; 3: GAG staining. 
 
Figure 13. Histology of the ex vivo study with different staining, pictures collected at different 
magnifications (A&B): 1: H/E; 2: Collagen staining; 3: GAG staining. 
3.11. Immunohistochemistry (IHC) 
The sections of the samples from in vitro study and ex vivo study at day 28 were 
immunostained with primary antibody anti-collagen type I, and anti-collagen type II, in 
order identify the types of collagen stained by the general Picro-Sirius. The 
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immunohistochemistry revealed the absence of collagen type I produced by chondrocytes 
in both studies (Figure 14, B). The positive control for collagen type I was obtained 
embedding the hydrogel with HFF1 (Human foreskin fibroblasts 1). It’s well known that 
HFF1 are responsible for the production of collagen type I, which is a sign of fibro-cartilage 
formation (52). Diversely, in both studies the IHC showed a clear signal for the antibody 
against collagen type II (hyaline cartilage), which is a sign of adequate cartilage 
regeneration (Figure 14, A).  
 
Figure 14. Immunohistochemistry of the in vitro and ex vivo study with Ab anti-collagen type II 
and Hematoxylin (respectively 1A & 2A). Immunohistochemistry of the in vitro study and of the 
ex vivo study with Ab anti-collagen type I and Hematoxylin (respectively 1B & 2B). 3A: Ctrl-: 
absence of Ab anti collagen type II; 3B: Ctrl+: IHC with Ab anti collagen type I and hematoxylin of 
hydrogel embedded with HFF1 cultured 21 days. 
4. DISCUSSION 
Tissue engineering for cartilage repair lacks biomaterials that have adequate mechanical 
properties capable of rapidly forming a gel that can be delivered into the area of interest 
via sample injection. Considering the unique properties of ELRs and silk, we have focused 
our attention on SELR obtained by recombinant techniques. The composition of this SELR 
is based on synthetized block co-recombinamers, which have silk motifs, elastin motifs 
and bioactive sequence (RGD). This SELR sequence contains the optimal content of silk 
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motifs for adequate thermosensitive properties and for the expression in bacteria (28). 
Moreover, a repetition of six RGD sequences was included in order to have a good cellular 
adhesion response (53). The elastin motifs were designed to comprise a hydrophobic and 
hydrophilic block. The copolymer structures have been reported to form elastomeric 
hydrogels, in which the hydrophilic blocks provide conformational elastic properties and 
the hydrophobic blocks form cross-links by hydrophobic aggregation (30, 31). Thus, SELR 
hydrogels are formed by the physical interactions from elastin motifs and silk motifs. In 
the first part of this study, we set up and optimized a pre-annealing treatment based on 
the evolution of silk motifs into β-sheet structures, in order to fulfill the required 
mechanical properties of hydrogels for cartilage repair. We finally obtained the proposed 
pA(EIS)2-(I5R)6. Afterwards, we have carried out the characterization of our material with 
the combination of several experimental techniques (CD, TEM, SEM, and rheology), 
providing a deeper insight into the material features. 
The CD spectra recorded at all the temperatures indicates a predominantly disordered 
structure, where a proportional trend towards a more ordered structure can be 
appreciated for increasing pre-annealing times. This trend is based on the increase of the 
magnitude of the signal at 210 nm and at 197 nm, associated with the presence of β-turns 
and β-sheet structures, respectively. Thus, CD has shown that the pre-annealing 
treatment speeds up the arrangement of silk motifs into β-sheet conformation. 
It has already been investigated that a closely related ELR containing silk motifs is able to 
self-assemble into nanofibers through an evolution which is not immediate (26). The 
nanostructure formation of the pA(EIS)2-(I5R)6 checked by TEM (Figure 4), shows how 
these gels are able to form a dense network of fibers immediately after injection. This is 
due to the phenomenon of thermal memory, by which the supramolecular rearrangement 
of the silk motifs into β-sheets has been enhanced by the pre-annealing treatment (and 
conserved by the freeze-drying step). The density of the network of fibers for the 12 h 
pre-annealing time appears lower than for the group of 24, 36 and 48 h. 
The TEM results corroborate the CD analysis, where a similar trend has been observed. 
The visualization of sol-gel behavior (Figure 5) has shown that the rearrangement of silk 
motifs into β-sheet conformation has a direct influence on the gelation process, allowing 
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the gel formation at a lower concentration. Thereby, the gelation process for all the 
pA(EIS)2-(I5R)6 processes was investigated by rheological characterization. 
At the end of the measuring time (30 min) the corresponding complex modulus are: 100 
mg/ml: 512 Pa; 120 mg/ml: 1537 Pa; 150 mg/ml: 2040 Pa; 180 mg/ml: 3190 Pa (Figure 
6B). This modulus increase with the concentration is possibly attributed to the increase of 
the hydrophobic interactions between the elastin motifs.  
When the concentration is fixed (120 mg/ml), the dependence of moduli with the pre-
annealing time shows a lower stiffness for the pre-annealing time of 12 h, compared to 
longer annealing times. At the end of the measuring time (30 min), a similar modulus 
(around 1 kPa) is observed for the annealing time of 24, 36 and 48 h (Figure 6A). Since in 
this case the percentage of elastin is constant, these moduli are related to the presence 
of β-sheets. Thus, a similar maturation of β-sheets is suggested for annealing times from 
24 to 48 h. This result agrees with the results obtained by using CD and TEM.  
It has been reported that the concentration of 120 mg/ml represented a cut-off to obtain 
a significant effects of the pre-annealing treatment. Moreover, Figure 6B shows how for 
the pA(EIS)2-(I5R)6 at 100 mg/ml there are no changes for 24 and 48 h annealing times. 
The higher the concentration of pA(EIS)2-(I5R)6 in the hydrogel, the more difficult it is to 
dissolve the material, but also to mix in cells, while still achieving a homogeneous cell 
distribution, due to the high viscosity. It can also be expected that more gel is lost during 
handling by attachment to syringes or pipet tips. Thus, solution viscosity is a significant 
parameter during the injection process. 
The pre-annealing treatment affects the viscosity. It has been previously reported that the 
annealing time impacts the formation and maturation of the β-sheets existing in silk-
based ELRs (26). Thus, this increased viscosity may be related to the different β-sheet 
structures induced by the annealing process. The dependence of viscosity on the shear 
rate (Figure 7) suggests modeling according to the equation 
𝜂𝜂 (𝑠𝑠ℎ − 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) =  𝜂𝜂∞ +  ∑ 𝐺𝐺𝐺𝐺 ∙  𝑟𝑟𝑒𝑒𝑒𝑒−𝜏𝜏𝜏𝜏 ∙(𝑠𝑠ℎ−𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟)2𝜏𝜏=1   (1) 
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based on a series of two decreasing exponential functions (Maxwell dependence), where 
τi are the relaxation time constants, and Gi are the weight of the τi-type relaxation to the 
overall relaxation process that is mainly dominated by each time constant within the 
corresponding shear rate range. Finally, η∞ corresponds to the viscosity at an enormous 
(infinite) shear rate.  
The impact of the different annealing times on the viscosity corroborates the behavior 
recorded in the CD analysis at the same temperature (4 °C) (Figure 3A). Rheological flow 
measurements are in agreement with supramolecular analysis like CD and TEM. 
Moreover, considering that the temperature of the analysis for CD and rheological flow 
measurements is lower than the Tt of the SELRs, we can assume that the β-sheet 
structures formed by the pre-annealing treatment are conserved even after the freeze-
drying step. 
The experimental data of Figure 7 has been numerically fitted to Equation (1) and all the 
parameters have been obtained (Figure 15A and 15B). As can be seen, a threshold is again 
observed for the pre-annealing of 12 h both for the weights and the time constants of 
relaxation. For a fixed relaxation process, no noticeable changes are found for samples 
annealed for 24, 36 and 48 h, although for G1 the weight for the 48 h annealed sample is 
slightly higher. Relaxation process 1 shows a very short relaxation time (lower than 0.1 s), 
while the time constant of the second relaxation process is higher than 1 s. 
Thus, the annealing time of 24 h has been selected in our work as a trade-off between 
enough maturation of the β-sheet structures and to make the injection process easier. 
The rheological properties of the pA(EIS)2-(I5R)6 hydrogels with 24 h of pre-annealing at 
120 mg/ml are in agreement with the soft tissue engineering properties of hydrogel for 
biomedical application (54, 55). Dynamic frequency sweep measurements show at the 
frequency of 1 Hz a G’: 1489 Pa and a G’’: 334 Pa. As can be seen (where G’ >> G’’), the 
values of delta (specifically, δ is around 12 - 13° for the frequency of 1 Hz) for the pA(EIS)2-
(I5R)6 hydrogels at 120 mg/ml are in agreement with the viscoelastic behavior that has also 
been demonstrated in cartilage (56).  
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As for the physical mechanisms taking part in the rheological behavior of the hydrogel, 
the linear dependence of the complex modulus with f1/2 (Figure 8B) indicates that a 
poroelastic mechanism dominates the viscoelastic behavior in this frequency range. In the 
poroelastic mechanism, viscous drag of interstitial fluid (water) through the porous 
recombinamer network and fluid–solid frictional interactions due to fluid pressurization 
are predominant (57, 58).  
The slope is related to the hydrogel permeability that is a macroscopic measure of the 
ease with which a fluid can flow through the hydrogel matrix. In our case, two slopes are 
observed, whose values were numerically fitted: 282 ± 6 Pa/Hz1/2 for f1/2 < 2.5 Hz1/2, and 
753 ± 28 Pa/Hz1/2 for f1/2 > 2.5 Hz1/2. Thus, the slope increases when the frequency exceeds 
6.25 Hz. A slope increase was associated with a decrease in hydrogel permeability (54, 
59). A similar behavior was reported for elastin-like catalyst free click gels (54) and hybrid 
elastin-like recombinamer-fibrin gels (60). However, in both cases, a single slope was 
obtained throughout the frequency range analyzed.  
The pre-annealing treatment does have an effect on the gelation process. In fact, the 
observed increase in the storage modulus of pA(EIS)2-(I5R)6 hydrogels (Figure 6A) indicates 
the contribution of the pre-annealing treatment on the gelation process by the increase 
of the crosslinking network. Moreover, the pre-annealing treatment has an impact on the 
concentration of the hydrogel, allowing the formation of the hydrogel at a lower 
concentration than observed by Fonseca et al. (27).  
Fernandez-Colino et al. reported how the elastin contribution leads to the rapid and early 
formation of a hydrogel, whereas the silk domains can increase the modulus of the 
hydrogel over time (26). The same behavior has been recorded with the pA(EIS)2-(I5R)6 
hydrogels, with regards to the pre-annealing treatment that accelerate the β-sheet 
formation. CD and TEM confirms this phenomenon of thermal memory based on the 
growth-boosting of the β-sheet formation, which exerts an indirect influence on 
temperature trigger gelation.   
Therefore, taking into account the two slopes observed both in the evolution of the 
complex modulus with f ½ and in the viscosity dependence on the shear rate, we 
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tentatively suggest that these two slopes are related to the two interactions existing in 
our silk-based ELR: the hydrophobic interaction associated with elastin, and the β-sheet 
interaction due to the silk-block. Both of them contribute to the crosslinking network of 
the physical hydrogel. In the oscillatory measurements, the higher slope, corresponding 
to a higher hindrance of the fluid flow through the hydrogel structure, might be associated 
with the β-sheet structures, which are stiffer and more rigid than the elastin interaction.  
As for flow measurements, since more rigid blocks take more time to respond, the first 
process (characterized by G1 and τ1) might be related to the β-sheet structures. Following 
this idea, Figure 11 shows that both the β-sheets and the hydrophobic elastin interactions 
are affected by the pre-annealing time, although the former to a greater extent. Thus, it 
is suggested that both physical interactions are not independent, but that the maturation 
of the β-sheet structures the spatial location of the hydrophobic blocks modifies, altering 
this interaction, as it has been recently reported by Fonseca et al. (27).  
 
Figure 15. Fitted parameters according to Equation (1) obtained from the numerical fitting of the 
experimental curves of Figure 4. A: G1 and G2; B: τ1 and τ2. 
The morphology of the pA(EIS)2-(I5R)6 hydrogels at 120, 150 and 180 mg/ml was 
investigated by SEM (Figure 9 and Figure S8). The fibrillary structure, obtained by the pre-
annealing treatment, does not negatively influence the porosity of the hydrogel; in fact, 
pA(EIS)2-(I5R)6 hydrogels show a homogeneous porous environment with an 
interconnected structure. Porosity plays a critical role in the outcome of a tissue-
engineered scaffold; the cells seeded in there rely heavily on the void spaces within the 
construct for cellular in-growth, exchange of nutrients, and removal of waste products 
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(61). In addition, the extent of ECM secretion also increases by increasing pore size (62). 
Moreover, the chondrocytes are the exclusive cells in articular cartilage, with a size of 10–
13 µm diameters and are involved in the synthesis of the cellular matrix constituents (63). 
Considering the pore size of the pA(EIS)2-(I5R)6 hydrogels at 120 mg/ml: 10.23 ± 2.87 µm, 
pA(EIS)2-(I5R)6 hydrogel at 120 mg/ml presents a suitable pore size to create a 3D matrix 
embedded with chondrocytes. 
In summary, the first part of the study intended to characterize the material proposed, 
and to understand the physical contribution of the silk motifs in relation to the elastin 
motifs for the cross-linkage of the hydrogel. We have paid particular attention to the 
characterization of the pA(EIS)2-(I5R)6 hydrogels with different annealing times (12, 24, 36 
and 48 h) and different concentrations (100, 120, 150, 180 mg/ml). From the combination 
of the experimental results obtained by various techniques, the concentration of 120 
mg/ml pre-annealed for 24 h established a threshold for gelation, and these conditions 
were selected as the most suitable candidate as injectable hydrogel for cartilage repair. 
The second part of the study focused on the potential of the selected pA(EIS)2-(I5R)6 
hydrogels with 24 h of pre-annealing at 120 mg/ml, as a good candidate for cartilage 
repair. 
A well-accepted tissue-engineering paradigm is that, the most successful scaffold for 
tissue repair is a biomaterial that mimics the functional properties of native tissue extra 
cellular matrix (ECM), facilitates encapsulation of reparative cells and is supportive of cell 
repair activities, including proliferation and de novo production of ECM (64). Although, 
the biocompatibility of ELR-based hydrogels formed through physical cross-linking has 
been extensively studied (53), in this study we have performed for the first time a 4 week 
culturing metabolic activity assay of the pA(EIS)2-(I5R)6 hydrogel embedded with 
chondrocytes. The cell viability analysis has revealed that the selected concentration (120 
mg/ml) supports cell viability and metabolic activity. In order to evaluate the regenerative 
abilities of our newly developed hydrogel-scaffold systems, a well established ex vivo 
model as a culture platform was used (37, 65). The biggest advantage of using this ex vivo 
model is to test biomaterials in a native environment for relevant culture period, with the 
possibility to oversee the healing process monitoring the physiological and biochemical 
contents of the regenerated tissue. 
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In Figure 11 DNA and GAG content is shown. In both cases, the content is obtained for a 
given volume of hydrogel analyzed (66, 67). The increase in DNA and GAG content 
recorded through biochemical analysis shows how the pA(EIS)2-(I5R)6 hydrogel is an 
appropriate scaffold for chondrocytes embedding involved in cartilage repair. 
Furthermore, comparing the biochemical contents of the in vitro study with the ex vivo 
study, the DNA quantification shows how the osteochondral culture platform facilitates a 
better proliferation of chondrocytes. The same trend was observed with respect to GAG 
content, where the glycosaminoglycan content of the ex vivo study was higher compare 
to the in vitro study. According to the bibliography, the GAG density observed in our study 
was still not in the same range of mature cartilage (68). This was expected, considering 
that 28 days is a short time to obtain a mature regenerated cartilage. Anyway, comparing 
our scaffold with other hydrogel systems for cartilage repair, the media GAG content 
normalized to DNA obtained for our system (427 µg of GAG per µg of DNA), demonstrated 
a larger production of glycosaminoglycan (69).  
The biochemical analysis for GAGs and DNA confirms that the ex vivo osteochondral 
culture platform is a good and representative model to evaluate the healing progress in 
created cartilage defects.  
Histological analysis confirms the biochemical results, showing a higher amount of GAGs 
stained by Safranin-O/Fast Green in the ex vivo study. Moreover, the Picro-Sirius Red Stain 
staining revealed a larger production of collagen by the chondrocytes cultured in the ex 
vivo osteochondral culture platform. Finally, for both studies, the H/E staining 
demonstrated a very homogenous distribution of chondrocytes embedded in the 
hydrogel, showing efficient mixing of the matrix with the cells achieved by the adequate 
concentration of the hydrogel.  Some cells look like they underwent a mitosis step (Figure 
12: 1A, 2A and Figure 13: 1A, 2A), which results are in accordance with the values obtained 
by biochemical analysis for the DNA content.  
Immunohistochemistry for collagen type I and collagen type II revealed the absence of 
collagen type I (a sign of undesired fibro-cartilage formation) in both studies. Diversely 
the IHC in both studies showed a clear signal for the antibody against collagen type II 
(hyaline cartilage); furthermore, the IHC revealed a better production and secretion of 
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collagen type II in the ex vivo study compared to the in vitro study. The absence of collagen 
type I and the production of collagen type II, which gives tensile strength to cartilage (70), 
proves that pA(EIS)2-(I5R)6 hydrogel is an excellent candidate for osteochondral repair.  
As it is widely reported in literature, agarose and PEG hydrogels are considered ones of 
the best alternative for cartilage tissue engineering, due to the good biological and 
mechanical properties (66,71,72). However, they do not provide specific biological 
functions, which could be obtained by the recombinant protein technique used in our 
study for a bioactive hydrogel. Moreover, after 28 days of culturing in the ex vivo platform, 
our hydrogel demonstrated a GAG production per µg of DNA around 10 times more than 
in the case of PEG or agarose based scaffolds (69).  
Finally, the analysis recorded for the ex vivo study with the osteochondral culture platform 
confirms the importance of a native environment for the production of hyaline cartilage 
by mature chondrocytes. 
5. CONCLUSIONS 
We developed and produced the pre-annealed Silk Elastin co-Recombinamer (pA(EIS)2-
(I5R)6), which shows unique properties as a promising candidate for tissue engineering 
applications. We have focused on the need for biomaterials for cartilage repair, capable 
of being delivered into the area of interest, showing a rapid gelation and adequate 
mechanical properties when surrounded by synovial fluid. We have set up and optimized 
a pre-annealing treatment based on the evolution of silk motifs into β-sheet structures 
and on the phenomenon of thermal memory. In this study, we have carried out the 
physical characterization of our material in order to provide a deeper insight into the 
material features, analyzing the contribution of each component (Silk and Elastin) for the 
cross-linking formation. The pA(EIS)2-(I5R)6 has shown a fast gelation, improved 
mechanical properties, and the presence of a fibrillary structure directly after injection of 
the hydrogel. Moreover, culturing the hydrogel embedded with chondrocytes in the ex 
vivo culture platform for weeks has exhibited good biocompatibility and remarkable 
advantages; such as the de novo ECM formation, the absence of fibro-cartilage and the 
production of hyaline cartilage. The addition of the silk allows to make hydrogels with 
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lower concentration, leading to larger pores, which is most likely responsible for better 
cell spreading, and proliferation. In conclusion, the pA(EIS)2-(I5R)6 has shown to have new 
outstanding properties, which make the hydrogel a promising injectable scaffold in the 
field of cartilage regeneration. 
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SUPPORTING INFORMATION 
 
 
Figure S1. Molecular weight and purity assessment by SDS-PAGE and MALDI-TOF mass 
spectrometry for pA(EIS)2-(I5R)6. MALDI-TOF spectra represent non-quantitative intensity (a.u.) 
against m/z (mass divided by net charge of the molecule) of the ELR. 
 
 
Amino acid Theoretical Experimental 
ASP+ASN 6+0 5.78 
GLU+GLN 21 27.82 
SER 39 31.91 
HIS - - 
GLY 576 577.62 
THR 6 4.82 
ARG 6 4.58 
ALA 52 48.53 
TYR - - 
CYS - - 
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VAL 341 339.11 
MET 1 1.45 
TRP - - 
PHE - - 
ILE 150 154.44 
LEU 2 2.36 
LYS - - 
PRO 257 257.24 
 
Figure S2. Comparison between the theoretical number of each amino acid in pA(EIS)2-(I5R)6 and 
the experimental values. 
 
Figure S3. FTIR of pA(EIS)2-(I5R)6. 
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Figure S4. DSC graph of pA(EIS)2-(I5R)6 showing the experimental Tt in PBS at physiological pH. 
 
 
 
 
Figure S5. H-NMR spectrum of pA(EIS)2-(I5R)6 showing the integration of the peaks corresponding 
to the different types of hydrogens. 
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Figure S6: Dependence of the viscosity on the shear rate in a scale lin-log for an identical 
recombinamer hydrogels of (EIS)2-(I5R)6 lacking the Silk blocks with 12 h, 24 h, 36 h and 48 h of 
pre-annealing. 
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Figure S7. Strain dependence of |G*| for the 24 h pre-annealed pA(EIS)2-(I5R)6 hydrogels at 100, 
120, 150 and 180 mg/ml with a frequency of 1 Hz at 37°C. 
 
 
 
 
Figure S8. Representative SEM pictures for the pA(EIS)2-(I5R)6 hydrogels at 150 mg/ml (A, B,C) 
and 180 mg/ml (D, E, F) at different magnification. 
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Figure S9. Fluorescent microscope image of the hydrogel embedded with chondrocytes after 
DAPI staining. The cell nuclei are in blue. The bluish background is due to the fluorescence of the 
hydrogel. 
 
 
Figure S10. DNA and GAG content of the hydrogel itself for the in vitro and ex vivo study at day 0 
and 28. All the values have been normalized for 30 µl volume of hydrogel. 
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Abstract 
The aim of this study was to evaluate injectable, in situ cross-linkable elastin-like 
recombinamers (ELRs) for osteochondral repair. Both the ELR-based hydrogel alone and 
the ELR-based hydrogel embedded with rMSCs were tested for the regeneration of critical 
subchondral defects in 10 New Zealand rabbits. Thus, cylindrical osteochondral defects 
were filled with an aqueous solution of ELRs and the animals sacrificed at 4 months for 
histological and gross evaluation of features of biomaterial performance, including 
integration, cellular infiltration, surrounding matrix quality and the new matrix in the 
defects. Although both approches helped cartilage regeneration, the results suggest that 
the specific composition of the rMSC-containing hydrogel permitted adequate bone 
regeneration, whereas the ELR-based hydrogel alone led to an excellent regeneration of 
hyaline cartilage. In conclusion, the ELR cross-linker solution can be easily delivered and 
forms a stable, well-integrated hydrogel that supports infiltration and de novo matrix 
synthesis. 
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1. INTRODUCTION  
Chondral and osteochondral defects in the articular cartilage of the knee and in other 
joints caused by traumatic and non-traumatic injuries tend to progress to degenerative 
osteoarthritis over time. This scenario usually leads to total replacement of the joint with 
a prosthesis.(1) Several types of cartilage are known, including the articular hyaline 
cartilage, which is a smooth, pearly bluish layer with a width of 2 to 4 mm that covers the 
articular surfaces.(2) Articular hyaline cartilage is a highly specialized tissue characterized 
by its unique mechanical properties;(2) it has a structural role adsorbing the pressure 
overload the cartilage, and a functional role allowing the friction-less sliding of the 
articular surface.(3,4) When the cartilage layer is damaged, the structural components of 
hyaline cartilage (proteoglycans and glycosaminoglycans) tend to leak from it, reducing 
the ability to absorb the pressure overload.(5) Consequently, the functional capacity of 
friction-less sliding decreases, indeed, due to the remodeling of the layer, the water 
diffusion into the cartilage is reduced. Hyaline cartilage diseases bring synovitis, which 
progress to the inflammation of the articular layer.(6) In mammals, the ability of articular 
cartilage to durably repair decreases soon after birth and is almost completely lost by early 
adulthood.(7) Generally, the regenerated cartilage is rich in type I collagen (fibro cartilage) 
instead of containing type II collagen. Collagen type II provides tensile ability to the 
cartilaginous matrix and is essential for articular hyaline functional capacities,(8) whereas 
fibro cartilage is unable to maintain the biomechanical characteristics of articular 
cartilage.(2,4,5) All treatments currently used to restore the hyaline articular surface are 
unsatisfactory,(2) although several alternatives have been probed to promote the 
regeneration of damaged cartilage. In particular, the development of novel tissue-
engineering methods has started to play an important role.(9,10) Mesenchymal stromal 
cell (MSC) therapy(11-13) is a method that utilizes pluripotent cells, which can 
differentiate into various cell types, such as chondrocytes and osteocytes. As a result, 
these cells are good candidates for the treatment of musculoskeletal lesions.(14,15) MSCs 
are available from different auto-, allo- and xenogeneic sources.(16) The first two options 
offer an immunologically safer approach, whereas the latter hugely increases the 
availability of MSCs.(17) Although there are several studies with successful results using 
xenogeneic MSCs in different animal hosts,(18) only autologous(19) or allogenic cells(13) 
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have been successfully used in humans, with negligible immunological response.(20) 
Moreover, in the case of osteochondral application, it must be taken into account that 
articular cartilage is considered an immunoprivileged tissue, indeed, due to its 
avascularity, the immune system has some limitations for the detection of the implanted 
tissue.(21) The suspension of MSCs in a scaffold as a cell-carrier enhances the persistence 
of the implanted cells at the treatment site.(2) Taking into account that the majority of 
wet articular cartilage is formed by water,(22) hydrogels represent one of the most 
promising solutions for cartilage repair applications. Moreover, it is important to consider 
that, during surgery, it is crucial to minimize the severity of the intervention.(23) One 
advantage of the arthroscopic technique is that it can reduce infection risk and recovery 
time compared to open joint surgery. In the light of this, the use of injectable hydrogels is 
of special interest because they are compatible with arthroscopic methods.(23)  
The use of recombinant DNA techniques has brought new materials to the biomedical 
field, discovering new matrices for Tissue Engineering (TE) applications. An important role 
is played by elastin-like recombinamers (ELRs); they are based on the repetitive 
pentapeptide sequence Val−Pro−Gly−X−Gly (VPGXG)n, where the guest residue (X) is any 
amino acid except L-proline.(24) The thermo-sensitivity shown by ELRs is defined by the 
transition temperature (Tt). It depends on the charge of protein conformations and on the 
polarity of the amino acids that composed the ELRs.(25,26) Moreover, a great advantage 
of the ELRs is the ability to form different structures, among which a hydrogel is one of 
the most common for regenerative medicine application.(9) As pointed out above, ELRs 
show thermo-sensitivity, thus meaning that hydrogels, which are stable at body 
temperature, can be formed whenever the transition temperature (Tt) of the ELR is lower 
than this temperature.(27) Several studies have shown how different types of ELRs can be 
used in some of the most challenging fields of tissue regeneration, such as 
cardiovascular,(28) ocular prosthesis(29) and osteochondral applications,(30,31) among 
others.(27)  
The incorporation of cells into biomaterials can help to overcome some limitations of 
using cells or biomaterials alone. For instance, an ELR-based hydrogel can serve as a 
scaffold to allow MSCs to orchestrate tissue regeneration. Moreover, considering the 
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extraordinary compatibility of ELRs, the 3D hydrogel structure can mimic the properties 
of the ECM, thereby supporting the regeneration process.   
In this study, in order to promote cell attachment and stimulate matrix production, we 
developed an appropriate ELR-based bioactive hydrogel composition that provides an 
adequate balance of properties, such as mechanical support,(32) to foster cell adhesion 
and proliferation. Given their recombinant nature, ELRs were designed to contain 
bioactive sequences, such as the extensively studied RGD sequence, which supports cell-
adhesion via integrins,(33) CS5 human fibronectin REDV for efficient cell 
attachment(28,34) and VGVAPG as an elastase target domain (human leukocyte elastase 
I) to provide increased proteolytic sensitivity and increased functionality to the 
scaffold.(35,36) In this study, we obtained a homogeneous embedding of rMSCs (rabbit 
mesenchymal stromal cells) in the ELR solution at a temperature below body 
temperature, and injected this composition as a cell-scaffold system for osteochondral 
repair. This ELR-based bioactive hydrogel exhibited a cell-friendly environment, thus 
improving cartilage regeneration both with and without rMSCs embedded.  
2. MATERIALS AND METHODS 
2.1. Ethical approval 
All procedures regarding the collection of rabbit MSCs (rMSCs) specified below were 
approved by the Ethics Committee of the University Hospital of Valladolid (Spain) in 
accordance with the Declaration of Helsinki (1975), as revised in 2013. All animal 
experiments were conducted in accordance with the institutional guidelines for the care 
and use of experimental animals of the University of Valladolid (Spain) in accordance with 
Directive 2010/63/EU (Resolution Number 2010/2/23). 
2.2. Rabbit Mesenchymal Stem Cell collection 
Bone marrow was extracted from the tibias and fibulas of white New Zealand male rabbits 
and collected in sterile tubes (Falcon® A Corning Brand, Ref. 352070) previously damped 
with a heparinized saline solution of Phosphate Buffered Saline (PBS, Gibco Ref. 20012-
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068) and 5% Heparin Sodium (Chiesi Spain S.A.U) to avoid coagulation. Bone marrow 
samples were kept at 4 °C until they were processed within 24 hours. A fraction of 
mononuclear cells (MNCs) was selected using a density gradient method with Ficoll-Paque 
PREMIUM (GE Healthcare Ref. 17-5442-02). At the end of this process, counting and 
viability controls were performed using the Trypan Blue exclusion method with a 
Neubauer Chamber. After the selection process, MNCs were seeded at a density of 
190∙103 cells/cm2 and kept in culture at 37 °C and 10% CO2 with DMEM 4.5 g/L D-Glucose 
(Gibco, Ref: 31966-021 ) supplemented with 0.041 mg/mL of gentamicin (Gibco, Ref: 
15710-049) and 20% Fetal Bovine Serum (FBS, Gibco). Every 3 or 4 days, the appearance 
of the cell monolayer was observed with an inverted microscope and the percentage 
growth recorded. If confluence was less than 60-80%, a change of medium was performed 
until cells covered 80% surface of culture. Then, dissociation and cellular expansion 
(passage) were carried out and the subcultures developed in order to increase and purify 
the MSC cell line. The cells obtained during this first step were cryopreserved in FBS and 
10% DMSO (Dimethyl sulfoxide, Sigma Ref. D2650), and stored in liquid nitrogen at -196 
°C. Then, when the cells were needed for the assays, they were thawed at 37 °C, seeded 
at a density of 1000 cells/cm2 and kept in culture for approximately 7-10 days before use, 
changing the medium every 3 or 4 days.   
2.3. ELR biosynthesis and purification 
The gene construction was performed by molecular biology and recombinant DNA 
technique following standard methods previously described;(37,38) the purification 
process was carried out by several centrifugations preceded by inverse transition cycling. 
The ELRs obtained in this manner were dialyzed against MilliQ (MQ) water and lyophilized. 
Three ELRs extensively studied by Gonzalez et al., namely VKVx24, HRGD6 and REDV, were 
employed in this study(28) (Figure 1). HRGD6 was designed to contain the extensively 
studied RGD sequence, which supports cell-adhesion via integrins; REDV was designed to 
contain bioactive sequences such as the CS5 human fibronectin REDV for efficient cell 
attachment and VGVAPG as an elastase target domain (human leukocyte elastase I). The 
ELRs were further characterized by electrophoresis gel (SDS-PAGE), mass spectroscopy 
(MALDI-TOF), nuclear magnetic resonance (NMR), infrared spectroscopy (FTIR) and 
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differential scanning calorimetry (DSC).(39) The ELRs obtained were chemically modified 
and characterized by the transformation of the Ɛ-amine group in the lateral lysine chain 
to produce the cyclooctyne and azide groups necessary for subsequent “click chemistry” 
reactions, as reported previously.(28,40) The characterization results are provided in the 
Supporting Information (Figure S1- S9). 
 
Figure 1. Graphical scheme of the ELR compositions: A: VKVx24; B: HRGD6; C: REDV. 
2.4. Gel formation  
Freeze-dried ELRs were dissolved in plain DMEM (Dulbecco´s modified Eagle medium) for 
16 h at 4 °C at a concentration of 75 mg/mL.  The ELR-cyclooctyne solution comprised 
entirely VKVx24-cyclo, whereas the ELR-azide solution comprised REDV-N3 and HRGD6-N3 
(in equal amounts). To prepare the hydrogel embedded with rMSCs, the cells were mixed 
with the solution of VKVx24-cyclo and dissolved in neat DMEM at 4 °C. For gel formation, 
cold solutions of VKVx24-cyclo and REDV-N3 and HRGD6-N3 were mixed together and the 
gel formed using catalyst-free click reactions between an azide group and an activated 
cyclooctyne group.  
2.5. Rheological characterization 
Rheological experiments were performed using a strain-controlled AR-2000ex rheometer 
(TA Instruments) with the hydrogel submerged in water. Cylindrical swollen gel samples 
were placed between parallel, nonporous stainless steel plates (diameter = 12 mm). The 
gap between the plates was adjusted by applying the minimum normal force to prevent 
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slippage. Before the measurements started, all the samples were relaxed until 
equilibrium; the temperature was controlled and maintained at 37 °C using a Peltier 
device. Shear deformation measurements were carried out. The dynamic shear modulus 
was measured by performing a dynamic strain sweep with amplitudes having a range 
between 0.1% and 20% at a fixed frequency of 1 Hz. Thus, the linear region of 
viscoelasticity was determined. Afterwards, a dynamic frequency sweep was carried out 
between 0.05 and 70 Hz at a fixed strain amplitude (1%), thus the dependence of the 
dynamic shear modulus and the loss factor on the frequency was obtained. Finally, the 
rheological characterization presented the storage modulus and the loss modulus, G′ and 
G″ respectively. As a results of those, the magnitude of the complex modulus |G*| (|G*|2 
= (G′)2 + (G″)2), and the loss factor (tan δ ≡ (G″)/(G′), where δ is a function of frequency or 
strain amplitude) were calculated. 
2.6. Scanning electron microscopy (SEM) 
The morphology of the hydrogel was investigated by SEM using a FEI Quanta 200 FEG 
instrument. No coating procedures were used during the sample preparation; briefly, 
hydrated hydrogels were submerged into liquid nitrogen, mechanically fractured and 
freeze-dried. Afterwards, the pictures were collected using the microscope at Landing E 
of 7.00keV and a pressure of 0.7 Torr and finally the images were analyzed using image-J 
software. 
2.7. Cell viability assay 
The viability of isolated rMSCs embedded in ELRs at 75 mg/mL was evaluated using the 
Alamar Blue assay (Invitrogen) according to the manufacturer’s guidelines. Briefly, rMSCs 
were isolated according to the protocol described above and mixed with the hydrogels at 
a concentration of 8 million cells/mL. A 100 μL aliquot was then pipetted into a 24-well 
Transwell® tissue culture plate. After allowing the cells to adapt for four hours, the 
hydrogels were washed twice with PBS and metabolic activity measurements were 
conducted at 0, 3, 6, 9, 12 and 15 days of culture. For this purpose, 2 mL of a DMEM-
containing 10% Alamar Blue solution was used to replace the culture medium and the 
cells were incubated in darkness for 2 h at 37 °C and under a 5% CO2 atmosphere. 
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Subsequently, 70 µL of the reduced medium was transferred to a 96-well plate. The 
hydrogels were washed twice with PBS and the corresponding growth medium was added 
and incubated again in order to determine the metabolic activity at different times. 
Fluorescence (excitation: 560 nm; emission 590 nm) was measured using a SpectraMax 
M5e (Molecular Devices) microplate reader.(41) The fluorimetric reduction of 10% Alamar 
Blue reagent in the culture medium by the cells was measured at regular time intervals. 
Samples for the phase-contrast epifluorescence were fixed at 4% paraformaldehyde 
(Sigma-Aldrich) for 40 min. Staining was carried out after permeabilization of the sample 
with 0.2% Triton X-100 (Sigma-Aldrich) and stained with the fluorescent dyes Phalloidin–
Alexa Fluor488R and DAPI (Invitrogen). 
2.8. In vivo experimental model 
Ten female New Zealand white rabbits with an age of 6 months and an average weight of 
3 kg were used for the creation and treatment of the osteochondral defects. The number 
of animals was determined by power analysis and consideration of previous studies,(42-
44) following the 3Rs principles formulated by Russell and Burch for animal 
experimentation.(45) The animals were anesthetized intramuscularly with medetomidine 
(0.5 mg/kg) (Braun) and ketamine (25 mg/kg) (Ritcherpharma). Afterwards, both knees 
were shaved and cleaned. The surgical procedure involved a parapatellar incision of the 
skin, which was performed under sterile conditions in order to expose the distal femur. A 
critical-size (4 × 4 mm full-thickness) osteochondral lesion was created with a drill (Figure 
2A), following well-established surgical procedures.(46-49) The defect was deep enough 
to reach the osteochondral bone. The ELR-cyclooctyne and ELR-azide solutions were then 
mixed together and the cold solution (below Tt) was pipetted completely into the defect 
(Figure 2B). The gel was immediately formed by a catalyst-free click reaction between the 
azide group and activated cyclooctyne groups, filling the lesion created with the drill 
entirely (Figure 2C). Each animal was surgically operated at both knees and hydrogels with 
and without rMSCs embedded were pipetted into the right/left knee defects at random. 
Carprofen (50 mg/kg) (Norbrook) was administrated four hours after the surgical 
procedure. All animals were fed and watered ad libitum during the study period and 
maintained in individual cages. Animals were euthanized intravenously with pentobarbital 
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(200 mg/kg) at four months post-treatment and the distal femora extracted for further 
analysis.(17)  
 
Figure 2. A: Creation of the osteochondral defect with critical size; B: Pipetting of the ELR 
solutions with and without cells embedded inside the defect; C: Formation of the gel via a 
catalyst-free click reaction, thereby entirely filling the lesion created. 
2.9. Gross morphology 
The entire knees of each rabbit were dissected and the distal part of each femur was 
extirpated. Samples for each group were photographed and examined for evaluation as 
per the International Cartilage Repair Society (ICRS) gross morphology assessment scale 
for cartilage repair.(50,51)  
2.10. Histological analysis 
A blind macro- and microscopic analysis was performed by trained histologists for all the 
samples previously fixed in 4% formaldehyde in PBS 0.05 M (pH 7.3) at 4 °C. The sections 
were stained with several stains: Hematoxylin and Eosin (H&E), Picro-Sirius Red Stain and 
Safranin-O/Fast Green, for collagen and glycosaminoglycan (GAGs) stains, respectively. 
The staining procedures were performed according to common methods. Moreover, 
immunohistochemistry was performed with primary antibody Mouse monoclonal anti-
collagen type I and anti-collagen type II. Samples from each rabbit (n = 10 for each group) 
were graded by two observers using the ICRS visual histological assessment scale for 
cartilage repair.(52)  
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2.11. Statistical analysis 
Values are expressed as mean ± standard deviation. Statistical analysis was evaluated by 
one-way analysis of variance using the Tukey’s method. A P-value lower than 0.05 was 
considered statistically significant. 
3. RESULTS 
3.1. Rheological characterization 
The linear viscoelastic region of the ELR hydrogels comprising 50% VKVx24-cyclo, 25% 
REDV-N3 and 25% HRGD6-N3 at 75 mg/mL was determined by using strain sweep 
measurements from 0.01–20% strain at a frequency of 1 Hz (Figure 3A). The complex 
modulus (|G*|) at 75 mg/mL shows a constant value of 964 ± 156 Pa (at 1% strain) in this 
strain range. As such, a 1% strain was selected to carry out the dynamic frequency sweep 
measurements. Evolution of the storage (G’) and loss moduli (G’’) is represented in Figure 
3B. At a frequency of 1 Hz, the value of G’ is 960 ± 162 Pa, whereas the value of G’’ is 28 ± 
19 Pa. Moreover, the evolution of δ as a function of the frequency is represented in Figure 
3C (the value of δ at 1 Hz is 1.6 ± 0.9°).  
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Figure 3. Rheological measurement for the ELR hydrogel at 37 °C and 75 mg/mL. A: Strain 
dependence of the complex modulus (|G*|); B: Frequency dependence of the storage (G’) and 
loss (G’’) modulus; C: Frequency dependence of δ. Each curve corresponds to the average of 
three different sample measurements. 
3.2. Scanning electron microscopy (SEM) 
ELR hydrogels at 75 mg/mL show a porous environment, with pore sizes ranging from 
around 3 µm to 20 µm and a wall thickness of 1.11 ± 0.34 µm (Figure 4). This large variety 
of pore size is due to the internal interconnected structure of the ELR, where small pores 
are able to merge to form larger pore structures.  
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Figure 4. Representative SEM images for the ELR hydrogel at 75 mg/mL and different 
magnifications. 
3.3. Cell viability assay  
A cell viability assay was performed for two-week culturing of the ELR hydrogel at 75 
mg/mL when embedded with rMSCs (8 million/mL). Assay data were recorded at different 
time points (0, 3, 6, 9, 12 and 15 days) in order to gain a better understanding of the 
metabolic activity of the rMSCs. The cell viability analysis revealed an increment in 
metabolic activity, with a significant difference between 0 and 3 days and a constant 
increase from day 3 to day 15 during the culture process (Figure 5). The biocompatibility 
demonstrated by our ELR-based hydrogel is in agreement with similarly cross-linked 
hydrogels previously studied.(53) Moreover, the curve trend of this viability assay was in 
accordance with typical cell-growth behavior, whereby the number of cells increases 
exponentially in the first part of the culture, subsequently reaching a stable value.  
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Figure 5. Cell viability test of a 3D ELR gel (75 mg/mL) embedded with rMSCs at different time 
points (****P<0.0001). 
Furthermore, the Dapi/Phalloidin analysis (Figure 6) showed the morphology of the rMSCs 
embedded in the 3D structure after 15 days of culture. Mesenchymal stem cells are 
pluripotent cells that are able to differentiate into multiple cell-types widely used in both 
tissue engineering and regenerative medicine.(41) An extended and elongated cell shape, 
with long cytoplasmic processes, can be seen in all the different magnifications, thereby 
confirming colonization of the hydrogel over 15 days. The cells showed a well-spread 
morphology, with large extensions of their cytoskeleton actin filaments (green stained). 
The pictures collected at different magnifications (Figure 6A-C) help to visualize both the 
homogeneous distribution of the rMSCs and the colonization of the hydrogel at different 
focal points.  
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Figure 6. Optical microscope images of hydrogel colonization by rMSCs after culture for 15 days. 
Pictures collected at different magnifications (A,B,C). 
3.4. In vivo study results  
3.4.1. Macroscopic observation of repaired cartilage  
Rabbits were euthanized 4 months after the surgical procedure and the performance of 
cartilage repair initially evaluated by macroscopic observation. The surface of the defects 
(Figure 7) showed that the defects in the central area of the trochlea were completely 
filled at 4 months post-surgery in all animals from both groups (ELR hydrogels & ELR 
hydrogels embedded with rMSCs). In addition, the defects were covered by a white layer 
of fibrous tissue in both groups. The regenerated tissue had a greyish color and could be 
easily recognized in both cases. As such, the regenerated tissue showed a good integration 
with the surrounding tissue; indeed, there was no clear boundary between the injured 
region and the surrounding chondral tissue. The regeneration rate was further evaluated 
based on macroscopic observation of the regenerated knee cartilage.  
 
211 
 
Figure 7. Macroscopic appearance of defects in the trochlear groove (4 mm in diameter) at 4 
months post-surgery. A: ELR-based hydrogel embedded with rMSCs; B: ELR-based hydrogel 
alone. Defects are indicated with a black dashed line. 
As noted above, the samples were evaluated using the ICRS gross morphology assessment 
scale. Briefly, this gross evaluation takes into consideration three parameters, namely the 
degree of defect repair, integration with the border zone and macroscopic 
appearance.(54) Each of these parameters is evaluated on a scale of 0 to 4, with a total 
score ranging from 0 to a maximum of 12. The average score for the ELR hydrogel group 
was 9.7 ± 1.3, whereas the ELR hydrogel embedded with rMSCs scored 9.5 ± 1.9 (Figure 
8A). 
 
Figure 8. International Cartilage Repair Society (ICRS) macroscopic assessment scale. A: Gross 
morphology assessment; B: Histological and immunohistochemical assessment. Values are 
expressed as mean ± SD (n=10). 
3.4.2. Histological analysis of repaired cartilage  
Histological analyses were performed on the sections of the ELR-based hydrogel 
embedded with rMSCs (Figure 9) and on the ELR-based hydrogel alone (Figure 10). For 
histological analysis, all the sections were stained with H/E, Picro-Sirius Red Stain and 
Safranin-O/Fast Green, for morphological evaluation and detection of collagen and GAGs, 
respectively.  
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Histological analysis of the ELR-based hydrogel embedded with rMSCs (Figure 9) shows 
the absence of the hydrogel and that de novo bone tissue formation is present. It can also 
be seen that the new bone tissue exhibits the same porous and morphological structure 
as the native surrounding tissue. The upper bone region (underneath the cartilage layer) 
shows a less intense staining due to the degradation of the hydrogel combined to the 
uncompleted regeneration of the bone layer. Moreover, the collagen staining has the 
same intensity when comparing the regenerated cartilage with the native one. The 
regenerated cartilage layer also contained small egg-shaped cells, which is typical of the 
fibrocartilage-like tissue. Moreover, although GAG staining revealed glycosaminoglycan’s 
production and secretion in the cartilage layer, metachromatic Safranin-O staining 
appeared to be less intense for the regenerated cartilage than for the surrounding 
cartilage. Furthermore, although the regenerated tissue at the articular surface of the 
samples exhibited an adequate thickness in comparison with the adjacent non-injured 
articular cartilage, the tissue had a fibrotic appearance. Finally, the subchondral bone was 
mostly regenerated.  
 
Figure 9. Representative histological staining of repaired cartilage for ELR-based hydrogel with 
rMSCs. 
The first aspect that can be seen from the histological analysis of the ELR-based hydrogel 
alone (Figure 10) is the continued presence of the hydrogel within the created defect. 
Although the hydrogel remained intact in the inner part, it started to degrade from the 
periphery towards the center of the hydrogel. H/E staining clearly showed a difference 
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between native bone tissue and the hydrogel. In addition, in the boundary area of the 
hydrogel, a higher concentration of cells (revealed by the higher intensity of the staining) 
enrolled in the degradation of the hydrogel and in the de novo formation of bone tissue 
can be seen. Safranin-O staining revealed the presence of proteoglycan in the relatively 
thin repaired tissue. In addition, collagen staining indicated that the new tissue secretes 
an extracellular matrix. Histological staining revealed a columnar arrangement of the 
chondrocytes (typical of native cartilage) in the regenerated cartilage. The peripheral 
migration of these types of cells from the surrounding tissue towards the defect area 
displayed a smooth and regular surface of the regenerated cartilage, which, exhibited a 
complete integration with the adjacent non-injured cartilage. Moreover, the regenerated 
cartilage showed no structural differences with respect to healthy cartilage. 
 
Figure 10. Representative histological staining of repaired cartilage for the ELR-based hydrogel 
alone. 
The section of the ELR-based hydrogel embedded with rMSCs and the section of the ELR-
based hydrogel alone were further analyzed by immunohistochemistry with primary 
antibody anti-collagen type I (fibro cartilage) and anti-collagen type II (hyaline cartilage), 
for detection of different types of collagen previously revealed by the general Picro-Sirius 
stain. 
In the case of the ELR-based hydrogel embedded with rMSCs (Figure 11), no collagen type 
II was detected in the regenerated cartilage. This result is in accordance with the 
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histological analysis previously described, where a non-columnar arrangement of 
chondrocytes was revealed. The presence of collagen type II in the native cartilage 
ensures a correct staining performed for collagen type II. Moreover, the staining for 
collagen type I appears in a spot-like distribution throughout the section, possibly due to 
high exposure to this antibody, which is the signal for the non-appearance of collagen type 
I in the regenerated area. We can, therefore, conclude that the regenerative tissue in the 
ELR-based hydrogel embedded with rMSCs was mainly fibrous tissue with a small amount 
of hyaline-like tissue. 
 
Figure 11. Representative immunohistochemistry study with anti-collagen type I & II for the 
cartilage regenerated using ELR-based hydrogels with rMSCs. 
Notably, in the case of the ELR-based hydrogel alone (Figure 12), a marked production of 
collagen type II revealed the presence of hyaline cartilage in the regenerated layer. In 
addition, this result is in accordance with the histological analysis described previously, 
which exhibited a columnar disposition of the chondrocytes. Moreover, the 
immunohistochemistry study revealed how the chondrocytes involved in the 
regeneration process did not produce collagen type I, showing the absence of fibro 
cartilage. 
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Figure 12. Representative immunohistochemistry study with anti-collagen type I &II for the 
cartilage regenerated using the ELR-based hydrogel alone. 
As reported above, the samples were evaluated according to the ICRS visual histological 
assessment scale. The resulting score ranges from 0 to a maximum of 18, with the final 
score being the sum of six parameters, namely surface, matrix, cell distribution, cell 
population viability, subchondral bone and cartilage mineralization. Each of these 
parameters is given a value from 0 to 3. The average score in the ELR hydrogel group was 
11.4 ± 3.1, whereas the ELR hydrogel embedded with rMSCs scored 11.3 ± 3.3 (Figure 8B). 
4. DISCUSSION 
It is well known that articular cartilage has a limited regeneration capacity after disease 
or trauma and that fibro cartilage is produced where the cartilage regeneration takes 
place.(55,56) This type of cartilage can easily degenerate and develop into 
osteoarthritis.(57) Considering that the clinical treatment of defective cartilage remains 
problematic,(58) the purpose of surgery is to regenerate the chondral defects in order to 
obtain a structurally and biomechanically competent hyaline cartilage. From a functional 
point of view, clinical treatments are not able to promote the proper regeneration of 
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cartilage defects; TE represents a new approach for articular cartilage repair,(51) it 
consists in reconstructing living tissue by associating cells with biomaterials. The 3D 
structure of the biomaterial plays a supporting role for the cells, thus helping them to 
proliferate under physiological conditions.(59) The application of new materials in tissue-
engineered scaffolds has received particular interest,(60) and several studies have 
demonstrated how bioinspired materials can simulate the physiological characteristics, 
thereby enhancing the biological properties of the scaffold.(61-63) In this study, we have 
designed and developed an ELR-based hydrogel composed by VKVx24-cyclo, REDV-N3 and 
HRGD6-N3, as reported in Figure 1. The specific composition of the ELR-based construct 
has been previously investigated by Staubli et al., demonstrating a good composition of 
the hydrogel tailored for a TE study; indeed, whereas the ELR VKV counterpart gives 
stability to the hydrogel, the combination of ELRs containing RGD sequence and elastase 
target domain is crucial for cell infiltration and material colonization.(64) In the light of 
this previous study, we designed our ELR-hydrogel to contain 25% of an ELR bearing the 
elastase target domain, thus allowing a slower degradation of the scaffold. Moreover, it 
has to be taken into account that natural polymers showed some limitations in terms of 
mechanical integrity. Indeed, both collagen and hyaluronic acid have a short lifetime due 
to degradation by matrix metalloproteinases.(65)  
The composition of the hydrogel permits immediate gelation by click chemistry as it has 
been demonstrated by González et al.,(53) thus conferring the benefit of being an 
injectable scaffold on our system. The mechanical features of the scaffold are a crucial 
factor affecting cartilage repair. As it has been demonstrated, chemical cross-linkable ELR-
hydrogels having similar Molecular Weight to our hydrogel,(53,66) showed no 
dependence between the swelling ratio and the concentration for the range 50 mg/mL - 
150 mg/mL at 37 °C, maintaining a swelling ratio below 2. On the other hand, the 
hydrogel’s concentration directly influences the mechanical properties of the hydrogel. 
Considering the remarkable results obtained in the application of this material at a 
concentration of 75 mg/mL in TE,(28) we decided to use our hydrogel at the same 
concentration. The rheological characterization of the ELR-hydrogel at 75 mg/mL showed 
a complex modulus of around 1 kPa, which is in accordance with the elastic modulus of 
many native tissues(67) and with the mechanical features of efficient scaffolds for TE 
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applications.(53,64) Moreover, the low values of δ obtained for the ELR hydrogel agree 
with the viscoelastic behavior demonstrated in the cartilage layer.(68) As it has been 
reported above, the δ is the phase angle between the applied stimulus and the 
corresponding response as a function of strain amplitude or frequency; the constant 
values of δ calculated demonstrated a highly elastic energy storing hydrogel at different 
frequency values. It is important to take into account that articular cartilage has unique 
biological properties (such as permeability and viscoelasticity) when compared with other 
cartilage.(69) Indeed, the structure and physiochemical properties of articular cartilage 
are similar to those of hydrogels. SEM analysis revealed the morphology of the hydrogel 
at 75 mg/mL, which shows an interconnected structure with adequate porosity and 
permeability, along with an appropriate pore size for the creation of a 3D scaffold 
embedded with rMSCs. The pore size determines the exchange of nutrients and waste 
products as a result of the void spaces where the cells are seeded and influences the de 
novo secretion of ECM.(70) Moreover, the fluid movement in the hydrogel determined by 
the pore size plays a fundamental role in the regeneration process, and in order to 
guarantee a good regeneration, it should be similar to that for native tissue.(71)  
Cells play a critical role in the regeneration process; when incorporated into a biomaterial 
they can enhance tissue regeneration. Although it is well known that chondrocytes only 
form 1-5% volume of the mature articular cartilage,(72) it has been demonstrated that a 
higher MSCs seeding density results in better chondrogenesis.(73-76) We selected a 
seeding density of 8 x 106 cells/mL considering the outcomes of previous studies 
performed with a similar cell density.(77,78) The cell viability analysis revealed an 
increment in metabolic activity throughout the 15 days of culture, thus showing that the 
ELR-based hydrogel is a biocompatible scaffold for cell repopulation. Moreover, 
considering that the highest increase of metabolic activity was recorded within the first 
three days, the rMSCs appear to be more active when the hydrogel has a lower cell 
density, reaching a more quiescent state once the hydrogel starts to be repopulated. 
The Dapi/Phalloidin analysis showed the morphology of the rMSCs embedded in the 3D 
structure after 15 days of culture. The specific composition of the ELR hydrogel, which 
contains RGD and REDV bioactive domains, permitted efficient cell attachment. Indeed, 
the colonization process indicates that this specific composition of the scaffold is able to 
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support the culture of embedded cells. Assuming that a suitable scaffold for TE should 
mimic the ECM functional properties, the in vitro study showed an adequate composition 
of the ELR hydrogel, thereby facilitating the encapsulation of reparative cells into a 3D 
matrix.(79) Moreover, the elastase target domain (VGVAPG sequence) fosters cell-
mediated remodeling of the artificial scaffold. In addition, cell proliferation, and thus 
colonization of the scaffold, is guaranteed because of the action of proteases during the 
synthesis of new extracellular matrix. 
In this study, we tested the ELR-based hydrogel embedded with rMSCs and the ELR-based 
hydrogel alone to repair cartilage defects in vivo. Macroscopic examination of the surface 
of the defects (Figure 7) showed that the defects were completely covered 4 months after 
the surgery in all animals. The scores on the ICRS gross morphology assessment scale for 
the two hydrogels are practically the same, thus suggesting that both groups aid cartilage 
regeneration, allowing for the defects to be filled. However, histological analysis of the 
dissected knees was necessary to determine which type of cartilage was regenerated, and 
whether the gel was fully replaced by newly formed tissue. 
The H/E staining results for both groups showed no evident inflamed cells, such as 
neutrophilic granulocytes or lymphocytes, thus indicating that the ELR hydrogel has 
excellent biocompatibility. However, in contrast to the macroscopic evaluation, the 
histological analysis showed two different responses from the two groups as regards 
tissue, bone and cartilage. For the bone area, in the case of ELR-based hydrogel alone, a 
large quantity of intact hydrogel was present, whereas in the rMSCs group no intact 
hydrogel was present. In the boundary area of the ELR-based hydrogel alone, it was 
observed a higher concentration of cells enrolled in the degradation of the hydrogel and 
in the de novo formation of bone. This inflammatory cells infiltration in the hydrogel and 
the consequent degradation of the scaffold was mainly due to the presence of the elastase 
target domain. This behavior is in accordance with previous studies performed with ELR-
based hydrogel containing protease target domains.(64) Moreover, in this case, the 
degradation came only from the surrounding tissue and the tissue-replacement process 
was not complete at 4 months post-surgery. 
Finally, it is important to take into account that the rejection of engraftment depends 
essentially by the host immune response, whereby the proportion between inflammation 
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and pro-resolution is the key for successful implantation of the engineered tissue.(64,80) 
In contrast, the group treated with the ELR-based hydrogel containing rMSCs showed a 
much more marked degradation. Indeed, in that case, the degradation occurred both 
from the surrounding tissue and from the cells embedded in the hydrogel. For the 
cartilage layer, the histological and IHC staining showed how the group treated with the 
ELR-based hydrogel alone exhibited better cartilage regeneration compared to the group 
treated with the ELR-based hydrogel containing rMSCs. The group with no rMSCs 
exhibited all the typical features of hyaline cartilage, such as the columnar disposition of 
chondrocytes, excellent GAG staining, and the presence of collagen type II, that provides 
the tensile ability to the cartilage layer.(8) Moreover, the absence of fibro cartilage 
confirms that ELR-hydrogel is an attractive solution for cartilage regeneration. Although 
there is no significant difference in the scores for the ICRS visual histological assessment 
scale, we can conclude that the ELR-based hydrogel containing rMSCs leads to faster 
regeneration of the bone tissue and worse cartilage regeneration. In contrast, the ELR-
based hydrogel alone enhanced the quality of the regenerated cartilage but the 
degradation of the hydrogel in the bone area was not complete. During the repair process, 
the hydrogel was gradually replaced by de novo tissue formation. Starting with the 
assumption that the purpose of this scaffold is to promote the bone and cartilage 
formation instead than merely substitute the tissue, it is important to evaluate either the 
capacity to support the cell adhesion and proliferation and the mechanical stability at the 
defect site. A crucial aspect was played by the 25% of the ELR containing the elastase 
domain, which allows for degradation of the hydrogel. As such, it could be of interest to 
test other hydrogel candidates that have different percentages of protease sequences in 
order to synchronize bone regeneration and cartilage repair. Moreover, another 
important aspect to take into consideration is the proportion between the RGD sequence 
and the REDV domain; as discussed recently by Flora et al., the ratio between these two 
bioactive domains can tailor the selectivity of the biomaterial towards specific cell 
lines.(81) Generally speaking, the degradation time of materials should match the 
production speed of the new tissue. Rapid degradation of the scaffold affects both 
repopulation of the hydrogel by rMSCs and their differentiation or the colonization of 
chondrocytes from the surrounding native tissue. A slow degradation could hinder cell 
proliferation and matrix secretion,(82,83) although we found that a high density of rMSCs 
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in our scaffold increased the regeneration of fibro cartilage instead of hyaline cartilage. 
Another important aspect that has to be taken in consideration is the cell-cell contact in 
the hydrogel, which regulates not only the cell behavior and the MSCs differentiation, but 
it is also crucial for the development of the tissue architecture. This parameter is strongly 
correlated to the cells density of the hydrogel. One of the major challenges for 
osteochondral repair is to obtain regenerated cartilage with adequate mechanical 
properties. This outcome is not completely fulfilled by synthetic hydrogels, which do not 
show the biological features of ECM and tend to regenerate fibro cartilage.(84)  
Our ELR-hydrogel has been shown to have an adequate composition, with tunable 
degradation rate and adhesion behavior, exhibiting a good balance between the 
degradation rate and adhesion behavior, and allowing for the colonization of 
chondrocytes with an optimal secretion of extracellular matrix-collagen type II at the 
periphery of the hydrogel. Moreover, we observed excellent cartilage repair without the 
need for cellular implantation, which is a significant advantage in terms of eluding all the 
technical and ethical complications of cell implantation. Finally, these results are 
promising as regards the testing of other ELR-based hydrogels with higher degradation 
rates for bone regeneration, thus leading to an optimal system for osteochondral repair.  
5. CONCLUSIONS 
One of the biggest challenges in TE is to discover a new biomaterial that guarantees an 
adequate regeneration of either bone or cartilage tissue. In this study, we took advantage 
of the recombinant DNA technique to develop a bioactive ELR-based hydrogel with a 
specific composition as an injectable scaffold for osteochondral repair. The specific 
composition of this hydrogel allowed for faster bone regeneration when embedded with 
rMSCs compared to the injection of the hydrogel alone. Similarly, the specific composition 
of this bioactive hydrogel allowed for the infiltration and the recruiting of native cells 
(chondrocytes) to promote the repair and remodelling of articular cartilage. According to 
the outcomes revealed by this study, a promising therapy for osteochondral repair could 
be to develop a bilayer system based on ELR-hydrogels. This system would consist of a 
bottom layer composed by the hydrogel embedded with MSCs, which fill the sub-chondral 
bone cavity; whereas the upper layer would be composed by the hydrogel itself. In 
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conclusion, our bioactive ELR-based hydrogel alone was able to resemble native tissue in 
terms of hyaline cartilage content and the absence of fibro-cartilage, thus proving to be a 
promising scaffold for cartilage repair. 
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SUPPORTING INFORMATION 
Differential Scanning Calorimetry (DSC) measurements 
DSC experiments were performed using the Mettler Toledo 822e DSC with a liquid 
nitrogen cooler accessory and under a nitrogen atmosphere. All samples were 
equilibrated for 5 min at 0 °C inside the sample chamber before the experiment started, 
and then, heated from 0 to 60 °C with a speed of 5 °C/min.  
 
 
Figure S1. DSC graph of HRGD6-N3 showing the experimental Tt in PBS at physiological pH. 
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Figure S2. DSC graph of REDV-N3 showing the experimental Tt in PBS at physiological pH. 
 
Figure S3. DSC graph of VKV-Cyclo showing the experimental Tt in PBS at physiological pH. 
 
Fourier Transform Infrared Spectroscopy (FTIR).  
FTIR analysis was carried out using a Bruker FTIR spectrophotometer (Bruker, USA), 
whereas the spectral calculations were performed by the OPUS (version 4.2) software 
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(Mattson Instrument INC.). For each spectrum, a 512-scan interferogram was collected at 
single beam absorption mode with a 2 cm-1 resolution within the 4000- 600 cm-1 region. 
Measurements were performed in triplicates and averaged to obtain the final FTIR 
absorption spectrum of the sample. Residual water vapour absorption was interactively 
subtracted from the sample spectra. 
 
 
Figure S4. FTIR of HRGD6-N3. 
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Figure S5. FTIR of REDV-N3. 
 
Figure S6. FTIR of VKV-Cyclo. 
 
Proton nuclear magnetic resonance 1H-NMR Spectroscopy 
NMR analysis was carried out using a 400 MHz Agilent Technologies equip with an Agilent 
MR console 400 and a One NMR probe. The measurements were carried out at 298 K with 
samples of 20–30 mg of the modified elastin like recombinamers, purified, and dissolved 
in DMSO-d6. Chemical shifts (δ) are given in ppm. 
The no deuterated dimethyl sulfoxide peaks at d ¼ 2.5 ppm and d ¼ 39.51 ppm were used 
as internal reference for 1H and 13C NMR spectra, respectively. 
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Figure S7. H-NMR spectrum of HRGD6-N3 showing the integration of the peaks corresponding to 
the different types of hydrogens. 
 
 
Figure S8. H-NMR spectrum of REDV-N3 showing the integration of the peaks corresponding to 
the different types of hydrogens. 
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Figure S9. H-NMR spectrum of VKV-Cyclo showing the integration of the peaks corresponding to 
the different types of hydrogens. 
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Abstract 
Biomaterial design in tissue engineering aims to identify appropriate cellular 
microenvironments in which cells can grow and guide new tissue formation. Despite the 
large diversity of synthetic polymers available for regenerative medicine, most of them 
fail to fully match the functional properties of their native counterparts. In contrast, the 
few biological alternatives employed as biomaterials lack the versatility that chemical 
synthesis can offer. Herein, we studied the HUVEC adhesion and proliferation properties 
of elastin-like recombinamers (ELRs) that were covalently functionalized with each three 
high-affinity and selectivity αvβ3- and α5β1-binding bicyclic RGD peptides. Next to the 
bicycles, ELRs were also functionalized with various integrin-binding benchmark peptides, 
i.e. knottin-RGD, cyclo-[KRGDf] and GRGDS, allowing for better classification of the 
obtained results. Covalent functionalization with the RGD peptides, as validated by 
MALDI-TOF analysis, guarantees flexibility and minimal steric hindrance for interactions 
with cellular integrins. In addition to the covalently modified RGD-ELRs, we also 
synthesized another benchmark ELR comprising RGD as part of the backbone. HUVEC 
adhesion and proliferation analysis using the PicoGreen® assay revealed a higher short-
term adhesion and proliferative capacity of cells on ELR surfaces functionalized with high 
affinity, integrin-binding bicyclic RGD-peptides compared with the ELRs containing RGD in 
the backbone.  
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1. INTRODUCTION 
A central goal of research in tissue engineering and regenerative medicine is the design of 
biomaterials that can be used to control critical aspects of cellular behaviour. Such 
materials should guide cells toward the phenotypes and architectures that are needed to 
restore tissue function or induce cells from surrounding tissue to infiltrate implanted 
matrices (1), including vascular grafts (2), bone grafts (3), wound dressings (4), and 
injectable drug depots (5). One major problem that still remains is the inadequate 
interaction between polymer and cells, which leads to foreign body reactions such as 
inflammation, infections, and implant encapsulation, as well as thrombosis and 
embolization, in vivo. Research into the surface modification of polymeric materials to 
guide cellular activity in biomaterials (6-8) designed for tissue-engineering applications 
has mostly focused on the use of natural extracellular matrix (ECM) proteins and short 
peptides such as the integrin-binding tripeptide RGD (9,10). The use of small peptides 
offers several advantages, such as straightforward synthesis and a low immunogenic 
potential (11, 12). Moreover, they tend to exhibit high stability towards sterilization 
conditions, heat treatment, pH-variation and storage (13, 14). However, it is important to 
take into account that the peptide stability is strongly dependent on the sequence. In 
particular, peptides containing methionine, cysteine or tryptophan are prone to oxidation 
with resultant loss of bioactivity (15).  
While a large variety of modified synthetic polymers have been extensively explored in 
regenerative medicine, only a few biological materials, mostly purified proteins from 
animal tissues, have been studied in detail to date (16). In this regard, recombinant 
proteins have recently received interest as an attractive alternative for tissue-engineering 
applications and surface functionalization (17, 18). Elastin-like recombinamers (ELRs) are 
some of the most intensively studied groups of recombinant proteins over the past 
decade (19). ELRs comprise repetitive sequences comprising the pentapeptide “Val-Pro-
Gly-X-Gly”, where the guest residue “X” can be any amino acid except proline. These 
polypeptides are highly flexible due to weak hydrophobic interactions and hydrogen 
bonds that enable the chains to extend and retract similarly to a spring (20-22). ELRs can 
be codified in synthetic genes and expressed in Escherichia coli in large quantities, thus 
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allowing greater control of the amino acid sequence and molecular weight when 
compared with the chemical synthesis of large polypeptides (18). Furthermore, due to 
their inverse temperature transition property, they can easily be separated from the raw 
protein mixture (23), thereby resulting in a purified, biocompatible, biodegradable, and 
non-immunogenic engineered protein (24). ELRs have several advantages as regards 
tissue engineering applications, such as their defined macromolecular structure, 
controlled swelling behaviour and porosity, degradability, and controllable mechanical 
properties (25, 26).  
First described in 1992 by Nicol et al. (27), ELRs comprising integrin-binding motifs such 
as RGD (1, 28-30) or REDV (30, 31) have been investigated as possible materials for 
biomaterial applications. However, thus far, recombinant synthesis has limitations in the 
incorporation of non-canonical amino acids and does not allow the formation of cyclized 
peptides (32). Despite this, ELR hydrogels covalently functionalized with a peptide mimic 
of the receptor-binding region of VEGF (vascular endothelial growth factor) showed 
enhanced HUVEC proliferation over non-functionalized hydrogels (33).  
One drawback of the non-integrin-selective RGD sequence is the inability to elicit 
responses based on closely defined intracellular pathways (34). An elegant approach to 
circumvent this limitation, and an additional lever for the control of cell adhesion and 
proliferation, is orthogonal post-functionalization with peptides via modified lysine side-
chains, for example, via maleimide-thiol coupling (34). Functionalization via biorthogonal 
chemistry is a well-known strategy for the manufacturing of hydrogels and multifaceted 
cell culture scaffolds (35, 36). Another possibility to functionalize biomaterials with 
peptides is via copper-free click chemistry (37). For instance, Krause et al. applied a metal 
free click reaction to functionalize alginate with a cyclic RGD peptide (38).  
The integrin-binding RGD motif is generally applied in either linear or cyclic format, with 
the cell adhesion-promoting properties of these peptides depending on the material 
applied. Linear RGD derivatives, such as GRGDS, are still the most widely applied cell-
adhesion sequences despite the fact that cyclic RGD peptides or RGD peptidomimetics 
provide much higher integrin affinities and selectivities (39, 40). For example, ELRs 
functionalized with cyclo-[KRGDf] showed a 100% improved mouse osteoblast adhesion 
in comparison with ELRs functionalized with linear FGRGDS (16). However, this study 
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focused on the chemical functionalization of ELRs and did not include recombinant 
synthesized RGD-ELRs as a benchmark. In contrast, spider silk proteins genetically fused 
to GRGDSPG showed similar fibroblast adhesion and proliferation properties compared to 
spider silk proteins covalently modified with cyclo-[KRGDf] (41).  
Recently, Bernhagen and coworkers reported short bicyclic RGD-peptides that bind to 
either integrin αvβ3, or to both integrins α5β1 and αvβ3, with high affinity (42). For example, 
for integrin α5β1, the bicyclic peptide CT3RGDCT3AYJCT3 (J: D-Leucine, CT3 represents 
cysteines that were constrained using the trivalent scaffold 1,3,5-
tris(bromomethyl)benzene) exhibited much higher inhibition (IC50: 90 nM) compared with 
monocyclic RGD-peptide cyclo-KRGDf or linear GRGDS (each IC50: >10 μM) (43). Hence, 
bicyclic RGD-peptides potentially represent a new group of ligands that boost cellular 
adhesion and proliferation in biomaterials more than commonly applied linear RGD 
peptides. 
In this study, we have created RGD-functionalized ELRs by conjugating various high-
affinity integrin-binding bicyclic RGD-peptides to ELRs using copper-free click chemistry 
(44). We then evaluated the cell adhesion and proliferation properties of peptide-ELR 
conjugates for HUVECs. ELRs functionalized with high-affinity bicyclic peptides were 
compared with ELRs functionalized with benchmark RGD peptides and ELRs that 
comprised RGD as part of their backbone at the short, medium and long term.   
2. MATERIALS AND METHODS 
2.1. ELR biosynthesis, modification and characterization 
The ELRs used in this work were obtained using standard genetic engineering techniques 
(31). They were purified using several cycles of temperature-dependent reversible 
precipitations by centrifugation below and above their transition temperature (Tt), thus 
making use of the intrinsic thermal behavior of these compounds (31). The ELRs were 
subsequently dialyzed against purified water and freeze-dried. Two different ELRs, namely 
VKVx24, a structural recombinamer lacking a bioactive sequence, and HRGD6, a 
recombinamer containing the universal cell adhesion epitope (RGD) repeated six times 
per ELR molecule, were obtained. The purity and chemical characterization of these ELRs 
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were verified by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) 
and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF MS) amino acid composition analysis, differential scanning calorimetry (DSC) and 
nuclear magnetic resonance (NMR) spectroscopy (31, 45). ELRs were chemically modified 
by the transformation of the Ɛ-amine group in the lateral lysine chain to bear azide groups 
(46, 47). VKVx24-N3 and HRGD6-N3 were prepared and characterized by NMR, Fourier 
transform infrared spectroscopy (FTIR), and DSC (Supporting information).  
2.2. Reagents and chemicals 
Incubation and washing buffers were prepared using standard protocols. Amino acids 
were purchased from Iris Biotech (Marktredwitz, Germany) and Matrix Innovation 
(Quebec, Canada). Resins were purchased from Rapp Polymere (Tübingen, Germany) and 
Merck (Darmstadt, Germany). 1,3,5-Tris(bromomethyl) benzene (T3) and (1R,8S,9S)-
Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl carbonate (BCN-NHS) were purchased 
from Sigma-Aldrich (Steinheim, Germany). 2-Azidoethyl (2,5-dioxopyrrolidin-1-yl) 
carbonate was purchased from GalChimia (A Coruña, Spain).  
2.3. Peptide synthesis 
Linear peptide 3c and linear precursor peptides of 1a-1c, 2a-2c, 3a and 3b (Figure 1) were 
synthesized using a fully automated peptide synthesizer from Gyros Protein Technologies 
(Symphony) by Fmoc-based solid-phase peptide synthesis on Rink-amide resin using 
standard coupling protocols. Folding of knottin-RGD peptide 3a and backbone cyclization 
of cyclic RGD peptide 3b were performed according to previously published protocols 
(48). For the formation of bicyclic peptides (1a-c, 2a-c), purified linear peptides were 
dissolved at 0.5 mM in 1:3 MeCN/H2O, and 1.1 equiv. 1,3,5-tris(bromomethyl) benzene 
(T3) dissolved in MeCN (10 mM) and 1.4 equiv. ammonium carbonate (0.2 M in H2O) were 
added. After completion (30-60 min, monitored by UPLC/MS), the reaction was quenched 
with 10% TFA/H2O to pH < 4, followed by lyophilization. All peptides were purified by 
preparative HPLC on an RP-C18 column (Reprosil-Pur 120 C18-AQ 150x20 mm, Dr. Maisch 
GmbH, Ammerbuch, Germany) using a MeCN/milliQ gradient (5-65%) including 0.05% TFA 
followed by lyophilization (Christ Alpha 2-4 LDplus). An overview of all peptides can be 
found in Table 1.  
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2.4. Synthesis of peptide-cyclooctyne conjugates 
BCN-NHS ester (1.1 equiv.) and 10 equiv. N,N-diisopropylethylamine were added to the 
peptides dissolved in DMSO (5 mM, TEC218 10 mM). After completion of the reaction (15-
30 min, monitored by UPLC/MS), the reaction was quenched with 10% TFA/DMSO to pH 
< 4. The product was directly purified by preparative HPLC using a MeCN/milliQ gradient 
(5-65%) including 0.05% TFA, followed by lyophilization. Conjugation was verified by 
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectroscopy 
using a Voyager STR apparatus from Applied Biosystems.   
2.5. Formation of peptide-functionalized ELRs 
The ELRs comprising 5% or 10% peptide functionalization were modified based on the 
following calculations: azide-functionalized ELRs (62809 Da) comprised 24 lysine 
molecules, 80% of which were functionalized with azides (NMR), corresponding to 19.2 
azide groups per ELR molecule. The application of 1 equiv. BCN-functionalized peptide 
would result in the functionalization of 5.21% of the azide groups. Hence, application of 
0.96/1.92 equiv. BCN-functionalized peptide would result in 5%/10% functionalization. As 
such, the application of 3 equiv. and 4 equiv. BCN-functionalized peptide would result in 
15% and 20% functionalization. The conjugation of ELRs with BCN-functionalized peptides 
was performed as follows: azide-functionalized ELRs were dissolved in milliQ water (4 °C, 
20 mg/mL). BCN-functionalized peptides were dissolved at 5 mM in milliQ water (2a in 
50% MeCN/milliQ) and added to the ELR solutions. After shaking the copper-free click 
reactions for at least 24 h at 4 °C, the products were freeze-dried. Conjugation was 
subsequently verified by MALDI-TOF MS. 
2.6. Analysis of turbidity by UV/Vis-spectroscopy 
The ELRs comprising 5% or 10% peptide functionalization were dissolved in milliQ water 
(4°C, 1 mg/mL), and turbidity measurements were performed at a wavelength of 350 nm 
(Agilent Technologies Cary Series UV/Vis Spectrophotometer). The transition temperature 
(Tt) of each RGD peptide-functionalized ELR (ELR-Peptide) was detected by performing a 
temperature ramp analysis.  
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2.7. Adsorption of peptide-functionalized ELRs on TCPS 
The ELRs comprising 5% or 10% peptide functionalization were dissolved at 1 mg/mL in 
DPBS (Dulbecco’s Phosphate Buffered Saline) –Ca –Mg (O/N at 4 °C) then added to a 96-
well tissue culture polystyrene (TCPS) plate for incubation with ELR-Peptide solution O/N 
at 4 °C with gentle shaking. A positive control was obtained by incubating fibronectin at 
10 μg/mL in DPBS –Ca –Mg, whereas a negative control was obtained by incubating BSA 
at 5 mg/mL in DPBS –Ca –Mg. The plates were subsequently sterilized using an ultraviolet 
(UV) lamp for 20 min, the solutions removed and the wells washed twice with DPBS –Ca 
–Mg. Plates were then incubated with a 5 mg/mL BSA blocking solution at 37 °C for 2 h. 
Finally, the solution was removed and the plates washed twice with DPBS –Ca –Mg prior 
to cell seeding.  
2.8. Contact Angle measurements 
Contact angle (CA) measurements were performed using the sessile drop method on a 
Data Physics OCA20 System instrument. The drop profile images during micro-syringe 
dispensation were recorded using an adapted CCD video camera. Measurements were 
taken at ambient temperature 5 s after application of the drops to the surfaces. The 
contact angle values are the average of ten measurements, including standard deviation, 
for different locations on each surface in order to ensure a representative value of the 
contact angle. 
2.9. X-ray Photoelectron Spectroscopy (XPS) 
XPS experiments were carried out using a Physical Electronics (PHI) 5500 spectrometer 
equipped with a monochromatic X-ray source (Al Ka line, energy: 1486.6 eV and 350 W). 
The pressure inside the analysis chamber was 10-7 Pa. All measurements were performed 
at an angle of 45° with respect to both the X-ray source and analyzer. Survey scans were 
taken in the range 0–1100 eV, with a beam diameter of 200 µm, and high-resolution scans 
were obtained for C1s, N1s, O1s. The elemental surface composition was estimated from 
the area of the different photoemission peaks taken from the survey scans modified by 
their corresponding sensitivity factors.  
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2.10. Cell culture and cell adhesion assay  
Human umbilical vein endothelial cells (HUVECs) (Cat.# C-015-10C; Gibco) at passage 2 
were used in all experiments. HUVECs were cultured in Medium 200 (Gibco) 
supplemented with Low Serum Growth Supplement (LSGS) kit (Gibco), thus resulting in 
the following final concentrations: fetal bovine serum (FBS) 2% (v/v); hydrocortisone 1 
µg/mL; human epidermal growth factor 10 ng/mL; basic fibroblast growth factor 10 ng/mL 
and heparin 10 µg/mL. A separate vial of Gentamicin/Amphotericin solution (Gibco) was 
also incorporated at a final concentration of 10 and 0.25 μg/mL, respectively. HUVECs 
were incubated at 37 °C and 5% CO2 and harvested at 90% confluence by trypsin–EDTA 
treatment. 
HUVECs were seeded at a density of 5300 cells/cm2 in serum-free Medium 200 (Gibco) for 
30 min on different surfaces (n = 3), and allowed to adhere for 30 min, after which time 
Medium 200 was removed and the cells cultured in LSGS-supplemented Medium 200 for 
14 days. HUVEC adhesion and spreading were evaluated after incubation for 30 min, 4 h 
and 1, 3, 5, 7 and 14 days. Cultures were provided with fresh media daily, up to the time 
of the staining period or DNA quantification.  
2.11. DNA Analysis  
DNA content was determined using the PicoGreen® assay after incubation for 4 h and 1, 
3, 5, 7 and 14 days. Briefly, the cells were lysed with a solution of 0.1% Triton X-100 (Sigma 
Aldrich) in phosphate buffered saline (PBS) (v/v) (49), and the PicoGreen® analysis for DNA 
content was performed in 96-well plates at standard fluorescein wavelengths (excitation 
at 480 nm and emission at 520 nm) according to the manufacturer’s instructions 
(Invitrogen) using an automated plate reader (Bionova Cientifica, Molecular Devices). 
Fluorescence intensities were transformed into cell numbers using a calibration curve 
obtained by measuring the fluorescence of defined cell amounts (n = 0, 100, 1000, 10,000 
and 100,000): 
n = (y+4.4615)/0.0157 (n: number of cells, y: fluorescence emission) 
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2.12. 2D Immunofluorescent Staining  
Immunofluorescent staining of actin (red), vinculin (green), and nuclei (blue) were 
performed to visualize the HUVECs on different surfaces. After cell culture, cells were fixed 
with 4% (w/v) paraformaldehyde, permeabilized with 0.1% Triton-X 100 and blocked with 
1% bovine serum albumin (BSA) in PBS solution. Focal contact formation was evaluated 
by incubating overnight at 4 °C antivinculin rabbit monoclonal antibody (AlexaFluor® 488) 
(1:200) (Abcam). Cell actin cytoskeletons and nuclei were stained with Rhodamin 
phalloidin (1:80) (Invitrogen) and DAPI (1:10000) (Lonza), respectively. Cell adhesion and 
morphological changes were examined using an inverted fluorescence microscope (Nikon 
Eclipse Ti E) and its associated software. A scan of each surface at low magnification (10x) 
was analyzed for this study. The images are representative of the morphology found in 
the samples studied, with at least two to three captures per well being taken. Quantitative 
image analysis of cell spreading area has been performed at short time incubation (4h); 
the cell area was calculated by the software associated with the microscope Nikon Eclipse 
Ti E. 
2.13. Statistical analysis  
Values are expressed as mean ± standard deviation (SD). Data were analyzed by 
performing the normality test Shapiro-Wilk. The parametric data were analyzed by one-
way analysis of variance (ANOVA) followed by Tukey’s Honestly Significant Difference 
(HSD) post hoc test; if only two groups were being compared, an unpaired t-test was used 
instead of ANOVA to assess statistical difference. The nonparametric data were analyzed 
performing the Kruskal-Wallis test followed by Dunn’s multiple-comparison test. All 
statistical analyses were performed with GraphPad Prism. A P-value lower than 0.05 was 
considered to be statistically significant. 
3. RESULTS 
3.1. Selection and synthesis of RGD peptides  
For this work, we selected three high-affinity integrin αvβ3- and α5β1/αvβ3-binding bicyclic 
peptides for the synthesis of peptide-cyclooctyne conjugates (Figure 1). The αvβ3-binding 
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peptides are K(BCN)-linker-CT3HPQcT3RGDcT3 (1a), K(BCN)-linker-CT3HPQCT3RGDcT3 (1b), 
and K(BCN)-linker-CT3HSQCT3RGDcT3 (1c), whereas the α5β1/αvβ3-binding peptides are 
K(BCN)-linker-CT3RGDcT3AYJCT3 (2a), K(BCN)-linker-CT3RGDcT3AWGCT3 (2b), and K(BCN)-
linker-CT3RGDcT3AYaCT3 (2c). The linker sequence PPPSG-(Abz)-SG was designed based on 
the HexPPP spacer reported by Pallarola et al. (50) “T3” stands for the scaffold derived 
from 1,3,5-tris(bromomethyl) benzene, “Abz” represents 4-aminobenzoic acid, and “J” 
stands for D-Leucine. The selection of the linker will be explained below. In addition to 
these bicycles, we selected K(BCN)-linker-knottin-RGD (3a), cyclo-[K(K(BCN)-linker-)RGDf] 
(3b) and K(BCN)-linker-GRGDS (3c) as benchmark peptides. 
 
Figure 1. Overview of RGD-peptide–cyclooctyne conjugates for the functionalization of ELRs. 1a: 
K(BCN)-linker-CT3HPQcT3RGDcT3; 1b: K(BCN)-linker-CT3HPQCT3RGDcT3; 1c: K(BCN)-linker-
CT3HSQCT3RGDcT3; 2a: K(BCN)-linker-CT3RGDcT3AYJCT3 (J: D-Leu); 2b: K(BCN)-linker-
CT3RGDcT3AWGCT3; 2c: K(BCN)-linker-CT3RGDcT3AYaCT3; 3a: K(BCN)-linker-GCS-SRPRPRGDNPPLTCS-
SSQDSDCS-SLAGCS-SVCS-SGPNGFCS-SG (K(BCN)-linker-knottin-RGD); 3b: cyclo-[K[K(BCN)-
linker]RGDf]; 3c: K(BCN)-linker-GRGDS. Abz: 4-aminobenzoic acid. 
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For the synthesis of peptide-cyclooctyne conjugates, we chose an approach in which the 
integrin-binding sequence was coupled to a peptide linker in solid phase peptide 
synthesis. Pallarola et al. explored the role of the linker system attached to cyclic RGD 
peptides in the inhibition of binding of immobilized vitronectin to the soluble integrin αvβ3 
(50); in their study, linkers comprising a triple- (HexPPP), hexa- (HexPPPPPP) or 
nonaproline (HexPPPPPPPPP) motif did not significantly decrease the inhibition ability. 
Hence, we added a linker that is similar to the HexPPP linker, but with some variations, to 
all the RGD peptides. In order to improve solubility in water-based solvents, we included 
two additional serine residues, and for practical reasons, we used 4-aminobenzoic acid 
instead of a triazole group. Furthermore, we incorporated an N-terminal acetylated lysine 
comprising a free amine in the side chain that allows for conjugation with BCN. Linear 
peptides comprising RGD in one loop and a tripeptide motif providing integrin-selectivity 
and additional affinity in the other, both enclosed by cysteine residues, were transformed 
into bicyclic peptides via trivalent scaffold 1,3,5-tris(bromomethyl)benzene followed by 
reaction with BCN-NHS to form bicyclic RGD peptide-cyclooctyne conjugates. A table of 
calculated and theoretical molecular weights obtained via UPLC/MS analysis can be found 
in the Supporting Information (Table S1). 
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Table 1. Overview of ELRs investigated in this study, including degree of functionalization, RGD 
peptide, and integrin selectivity. ELR labels containing “P0” serve as controls that were not 
covalently modified via copper-free click reaction. * Data from competition ELISA (43). 
3.2. ELR functionalization and MALDI-TOF MS analysis  
We subsequently functionalized the ELR azides with the peptide-cyclooctyne conjugates 
via copper-free click chemistry. This orthogonal reaction does not require catalysts and 
can be performed at room temperature at short reaction time (below one hour). Due to 
the need to maintain the ELRs in solution (below the Tt), the functionalization of ELRs and 
ELR azides was performed at 5 °C overnight. Six bicyclic RGD-peptides (1a-c, 2a-c) and 
three non-selective RGD-peptides (3a-c) were used to functionalize either 5% or 10% of 
the ELR azide groups to receive a total of 18 ELR-peptide conjugates (Table 1). MALDI-
ELR 
reference
Azide functionalization 
degree [%] ELR modification or coating
Integrin 
selectivity
P1a 5
P1a-10 10
P1b 5
P1b-10 10
P1c 5
P1c-10 10
P2a 5
P2a-10 10
P2b 5
P2b-10 10
P2c 5
P2c-10 10
P3a 5 αvβ3,
P3a-10 10 α5β1, αvβ5*
P3b 5
P3b-10 10
P3c 5
P3c-10 10
P0-RGD ─ RGD as part of the ELR-backbone multiple
P0 ─ ─ ─
P0-FN ─ Fibronectin
P0-BSA ─ Bovine serum albumin (BSA) ─
J: D-Leu
αvβ3, α5β1
α5β1, (αvβ3)*
K(BCN)-linker-GRGDS
αvβ3, αvβ5*
multiple*
K(BCN)-linker-CT3HPQcT3RGDcT3
K(BCN)-linker-CT3HPQCT3RGDcT3
K(BCN)-linker-CT3HSQCT3RGDcT3
K(BCN)-linker-CT3RGDcT3AYJCT3
K(BCN)-linker-CT3RGDcT3AWGCT3
K(BCN)-linker-CT3RGDcT3AYaCT3
K(BCN)-linker-GCoxPRPRGDNPPLTCox
QDSDCoxLAGCoxVCoxGPNGFCoxG
cyclo -[DfK(K(BCN)-linker)RG]
αvβ3*
αvβ3*
αvβ3*
α5β1, (αvβ3)*
α5β1, (αvβ3)*
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TOF-MS analysis was performed to verify functionalization of the ELRs with the RGD 
peptides. Selected spectra (P0, P1a, P2a, and P3a–c) are shown in Figure 2. The peaks at 
around m/z 62,200 represent non-functionalized ELR, whereas additional peaks reveal 
ELRs that were mono-, di-, tri- or even tetra-functionalized with RGD peptides (Table 2).  
5% Mono-functionalization 
10% Di-functionalization 
15% Tri-functionalization 
20% Tetra-functionalization 
 
Table 2. Comparison between the different rates of functionalization and the peaks detected 
during MALDI-TOF MS analysis. 
All the spectra in Figure 2 reveal differences between 5% functionalization and 10% 
functionalization. In the spectra representing ELRs with 5% peptide functionalization, the 
peaks for monovalent functionalization have a higher intensity than those for bivalent 
functionalization. In contrast, the spectra representing ELRs with 10% peptide 
functionalization show different peak ratios, with the mono- and di-functionalization 
peaks showing higher intensity than the respective peaks for 5% functionalization. 
Moreover, additional peaks for tri- and tetravalent-functionalization of ELRs appear in the 
spectra for ELRs with 10% peptide functionalization. 
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Figure 2. MALDI-TOF MS spectra for non-functionalized ELR and ELRs functionalized with 
5%/10% of bicyclic RGD peptides 1a, 2a and control RGD peptides 3a–c. 
3.3. Analysis of turbidity by UV/Vis-spectroscopy   
A turbidity study was performed for all the functionalized ELRs. In all the cases, a slight 
shift in Tt to lower values was observed as compared to the non-functionalized ELR (VKV-
N3). The turbidity measurements are reported in the Supporting Information (Figures S9-
S11). 
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3.4. Contact Angle   
Static aqueous contact angle analysis was performed in order to verify the correct 
adsorption of ELRs and ELR-Peptides onto tissue culture polystyrene surfaces (TCPS). 
Measurements were taken using ultrapure water drops on four different surfaces: TCPS, 
VKV adsorbed on TCPS (VKV), VKV-N3 adsorbed on TCPS (VKV-N3), ELR bearing peptides 
adsorbed on TCPS (ELR-Peptide). The results (Figure 3) show that TCPS is moderately 
hydrophobic (Ɵ= 71.6° ± 0.5°), whereas VKV and VKV-N3 are markedly hydrophilic (Ɵ= 
24.2° ± 1.5° and Ɵ= 23.3° ± 3.3°, respectively). ELR-Peptides was the most hydrophilic (Ɵ= 
15.6° ± 1.6°), with the difference with respect to VKV-N3 being significant (p < 0.0001), 
thereby suggesting a hydrophilic contribution from the peptides. Measurements were 
repeated in different regions in order to confirm the homogeneous adsorption of ELRs 
and ELR-peptide onto TCPS.  
 
 
Figure 3. Contact angle analysis performed 5 s after application of the drops to the surfaces: 
TCPS; VKV adsorbed on TCPS (VKV); VKV-N3 adsorbed on TCPS (VKV-N3); ELR-bearing peptides 
adsorbed on TCPS (ELR-Peptide). (*P<0.05; **P<0.01; ***P<0.001; ****P<0.0001). 
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3.5. XPS   
XPS was used to characterize the TCPS surface adsorbed with ELRs and ELR-Peptides. The 
surface compositional results from XPS analysis, shown in Table 3, indicate a reduction in 
C1s upon comparing untreated TCPS with VKV-N3 adsorbed on TCPS (VKV-N3) and ELR-
bearing peptides adsorbed on TCPS (ELR-Peptide). XPS analysis also revealed a clear 
enrichment of nitrogen, passing from 0.8% for TCPS to 16.49% and 13.97%, respectively, 
for VKV-N3 and ELR-Peptide. Finally, oxygen also exhibited a slight increase compared with 
the TCPS surface.  
 C1s         N1s         O1s   
TCPS 85.64 ± 1.82       0.74 ± 0.09             13.63 ± 1.73               
VKV 68.69 ± 0.57       15.13 ± 0.28             16.18 ± 0.28               
VKV-N3 68.28 ± 1.29       15.71 ± 1.10             16.01 ± 0.20               
ELR-Peptide 69.79 ± 0.20       14.33 ± 0.51             15.89 ± 0.32               
 
Table 3. XPS analysis performed on different surfaces: TCPS; VKV adsorbed on TCPS (VKV); VKV-
N3 adsorbed on TCPS (VKV-N3); ELR-bearing peptides adsorbed on TCPS (ELR-Peptide). All the 
measurements were performed in triplicate. Values are expressed in % (average ± st. dev). 
 
3.6. Cell-adhesion assay   
3.6.1. Time-dependent cell quantification studies 
The capacity to promote cell adhesion and proliferation of HUVECs on the modified ELRs 
was evaluated at short, medium and long term. Figure 4 shows the time-dependent cell 
quantification for VKV-N3 (P0) and ELRs functionalized with 5% (P1a) and 10% 
modification (P1a-10). The cell count for all time points (except after 14 d) show a 
significant difference upon comparing P0 with P1a and P1a-10. However, no significant 
difference was observed between P1a and P1a-10 at any time point. Similar behavior was 
found for the remaining ELR-peptides (Supporting Information, Figure S7), and the various 
high-affinity integrin-binding peptides used in this study did not show any difference for 
the two concentrations used. As such, we decided to analyze the results for ELR-peptides 
functionalized at 5% (Figures 5–7).  
254 
 
 
Figure 4. Time-dependent cell quantification for VKV-N3 (P0), P1a 5% (P1a) and P1a 10% (P1a-
10) at different time points (30 min, 4 h, 1 d, 3 d, 5 d, 7 d, 14 d). All experiments were carried out 
in triplicate and error bars show standard deviations (*P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001). There was no statistically significant difference between P1a and P1a-10 at any 
time point. 
All the PicoGreen® data collected were subdivided into different groups based on the 
different time points: short-term (30 min, 4 h, 1 d; Figure 5), medium-term (3 d, 5 d; Figure 
6) and long-term (7 d, 14 d; Figure 7). In order to make the bar charts clearer, the ELR-
Peptides have been arranged and clustered into different groups: ELRs functionalized with 
αvβ3-binding bicycle peptides 1a–c (red bars); ELRs functionalized with αvβ3 and α5β1-
binding bicyclic peptides 2a–c (green bars); and benchmark RGD peptides 3a–c (blue 
bars). The grey scale bars represent other controls, namely the RGD in the ELR-backbone 
(P0-RGD), ELR with no RGD peptide (P0), fibronectin coating (P0-FN) and coating with BSA 
(P0-BSA). The positive (P0-FN) and negative controls (P0-BSA) remained between the 
highest and lowest, respectively, thus confirming the reliability of the study.  
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Figure 5. Short-term time-dependent cell quantification (30 min, 4 h, 1 d). Number of cells 
determined for ELRs containing bicyclic peptides 1a–c (red bars) and 2a–c (green bars), and 
control RGD peptides 3a–c (blue bars), RGD in the ELR-backbone (P0-RGD), ELR with no RGD 
peptide (P0), fibronectin coating (P0-FN) and coating with BSA (P0-BSA). The amount of cells was 
calculated from fluorescence intensities using a calibration curve. All experiments were carried 
out in triplicate and error bars show standard deviations. (*P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001). 
For the short-term study (30min, 4h, 1 d; Figure 5), the peptides included after click 
modification supported higher levels of cells than the recombinant ELR-RGD (P0-RGD). At 
30 min all the ELR-Peptides, except for P3c, showed the maximum statistical difference 
with P0-RGD. The differences in cell numbers remained high for almost all ELR-Peptides 
when compared with the P0-RGD for the whole short-term study. In contrast, no 
significant difference was observed between the recombinant ELR-RGD (P0-RGD) and the 
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ELRs lacking RGD (P0). The second comparison (indicated by a dashed line) shows the 
differences between the ELR-Peptide groups, in other words bicyclic peptides 1a–c (red 
bars), 2a–c (green bars), and control RGD peptides 3a–c (blue bars). Essentially no 
significant differences were found between the bicyclic peptide groups, with the only 
exception being for the group of non-selective RGD-peptides (3a-c), for which a greater 
variability and significance were evident. The ELR functionalized with 3a supported cell 
adhesion most efficiently within this group, with cell counts similar to those for ELRs 
functionalized with integrin-selective bicycles (1a-c and 2a-c), whereas 3c showed the 
lowest number of cells among the covalently functionalized ELRs at this time point, albeit 
still higher than for P0-RGD.  
The data collected at 4 h are similar to those obtained at 30 min, with all ELR-Peptides 
except P3c showing the same statistical difference with respect to P0-RGD. The inter-
group comparisons were in accordance with the trend observed at 30 min, with the 
bicyclic peptide groups 1a–c (red bars), 2a–c (green bars) showing no significant 
differences except for the group of non-selective RGD-Peptides (3a-c). 
After 1 day, the differences between groups tended to decrease further, although the 
previous trends were maintained. A slight increase in cell counts at this time point 
suggests an incipient proliferation, although this is not particularly pronounced at this cell 
stage.  
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Figure 6. Medium-term time-dependent cell quantification (3 d, 5 d). Number of cells 
determined for ELRs containing bicyclic peptides 1a–c (red bars) and 2a–c (green bars), and 
control RGD peptides 3a–c (blue bars), RGD in the ELR-backbone (P0-RGD), ELR with no RGD 
peptide (P0), fibronectin coating (P0-FN) and coating with BSA (P0-BSA). The number of cells was 
calculated from fluorescence intensities using a calibration curve. All experiments were carried 
out in triplicate and error bars show standard deviations. (*P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001). 
In the medium-term study (3 d, 5 d; Figure 6), the number of cells practically doubled for 
almost all conditions, with a similar trend as for the initial adhesion, although with some 
exceptions. However, the comparison between the ELR-Peptides and P0-RGD appears less 
clear than for the short-term culture. Thus, despite showing good initial adhesion, P2b 
proliferation on slowed down over longer time periods. In contrast, the difference 
between P0-RGD and P0 became more evident. A comparison within the same group 
revealed statistically significant differences only for P2a-c and P3b - P3c at day 3, and P2a 
- P2b and P3b - P3c at day 5. 
 
Figure 7. Long-term time-dependent cell quantification (7 d, 14 d). Number of cells determined 
for ELRs containing   bicyclic peptides 1a–c (red bars) and 2a–c (green bars), and control RGD 
peptides 3a–c (blue bars), RGD in the ELR-backbone (P0-RGD), ELR with no RGD peptide (P0), 
fibronectin coating (P0-FN) and coating with BSA (P0-BSA). The number of cells was calculated 
from fluorescence intensities using a calibration curve. All experiments were carried out in 
triplicate and error bars show standard deviations. (*P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001). 
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Long-term proliferation studies (7 d, 14 d) revealed that HUVEC growth tends to reduce 
the difference in the ability to promote cell adhesion by the various high-affinity integrin-
binding peptides (Figure 7). Thus, after 7 days almost all the bicyclic peptides, i.e. P1a-c, 
P2a and P2c, showed a significant difference compared with P0-RGD, whereas P3a-c and 
P2b exhibited no clear difference. No significant difference was found within ELR-Peptide 
groups. Finally, after 14 days all conditions except the negative control P0-BSA exhibited 
similar amounts of cells. Indeed, cell counts after 14 days were approximately threefold 
higher that after culture for 7 days under all conditions.  
3.6.2. Morphology studies 
The ELR-Peptides were also characterized by morphological in vitro studies to investigate 
cell attachment, cell spreading, cytoskeletal reorganization and formation of focal 
adhesions. In order to investigate the time-dependent morphology of the cells, they were 
stained with rhodamin/phalloidin (actin skeleton), DAPI (nuclei) and a fluorescent mAb 
(vinculin) and examined by fluorescence microscopy (Figures 8 and 9).  
 
Figure 8. Immunostaining of actin (red), vinculin (green), and nuclei with DAPI (blue) of HUVEC 
cells cultured for different time points (30 min, 4 h, 1 d, 3 d, 5 d, 7 d) on ELRs functionalized with 
bicycles 1a–c (P1a-c) and 2a–c (P2a-c). Scale bars: 100 μm. 
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Figure 9. Immunostaining of actin (red), vinculin (green), and nuclei with DAPI (blue) of HUVEC 
cells cultured for different time points (30 min, 4 h, 1 d, 3 d, 5 d, 7 d) on ELRs functionalized with 
controls 3a–c (P3a-c), and comprising RGD in the ELR-backbone (P0-RGD), no RGD peptide (P0), 
fibronectin coating (P0-FN) and coating with BSA (P0-BSA). Scale bars: 100 μm. 
Since non-adhered cells were discarded after seeding for 30 minutes, those that remained 
adhered, although small and spherically shaped, nevertheless showed small protrusions 
at the periphery or ring-shaped adhesions at the onset of cell culture (30 min) under 
practically all conditions tested (Supporting Information, Figure S8). At early time points, 
the focal contacts are circumscribed to the perinuclear zone, whereas at longer times a 
yellow coloration was found when overlapping actin and vinculin captures.  
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Figure 10. Quantitative image analysis of cell spreading area after 4 h. Cell area has been 
determined for ELRs containing bicyclic peptides 1a–c (red bars) and 2a–c (green bars), and 
control RGD peptides 3a–c (blue bars), RGD in the ELR-backbone (P0-RGD), ELR with no RGD 
peptide (P0) and fibronectin coating (P0-FN). A minimum of 25 images have been analyzed per 
sample, except for P1c, P2b, P3b-c and P0 where the number of images were less than 25 but in 
any case more than 10. The results correspond to a single independent experiment. The values 
are is expressed µm2; the error bars show standard deviations. (*P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001). 
 
The quantitative image analysis of cell spreading area has been performed after short time 
incubation (4 h) (Figure 10). P1a-b, P2c and P3a showed the highest statistical difference 
as compared with P0-RGD, whereas the difference between P3b and P2a was less 
significant. All the remaining ELR-Peptides (P1c, P2b and P3c) did not exhibit significantly 
different cell spreading as compared with P0-RGD. In any cases, no significant differences 
were found within the same peptide group. P2b showed the largest error bars, reflecting 
the vast population of cells having a different spreading area (Figure 10). In contrast, the 
negative control P0-BSA does not appear since no cells were present, (Figure 9). The data 
collected by quantitative image analysis after 4 h are similar to those obtained by cell 
quantification analysis reported in Figure 5. In both analyses, P2b and P3c showed less 
difference as compared with P0-RGD. With respect to the cell spreading area analysis, 
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also P3b and P2a showed a less significant difference compared to P0-RGD, whereas for 
P1c no significant differences were found. When comparing cell spreading areas on ELRs 
within the same group, the trends observed were in accordance with cell quantification 
analysis, where no significant differences were shown, except for the group of non-
selective RGD-Peptides (3a-c).  
4. DISCUSSION 
The focus of biomaterials research often lies with the biomaterial itself rather than the 
cell-adhesion sequence (51), especially given that the surface-protein interaction 
determines the nature of subsequent cell-surface behavior. Herein we have created 
peptide-functionalized ELRs by conjugating various high-affinity integrin-binding, bicyclic 
RGD-Peptides to ELRs via copper-free click chemistry in order to overcome the known 
limitations of recombinant synthesis; for instance, the inability to incorporate non-
canonical amino acids and to form cyclized peptides. Furthermore, this strategy allows 
the bioactive ligand to maintain the flexibility and minimal steric hindrance required for 
cellular interactions. The purpose of this study was to improve the cell-adhesion and 
proliferation abilities of the recombinant and biocompatible substrate ELRs by 
conjugating a very small number (one or two molecules per ELR) of high integrin affinity 
peptides. The choice of the different conditions and peptides was based on very recent 
studies by Bernhagen et al., who reported an exhaustive investigation of high-affinity 
integrin αvβ3- and α5β1-binding bicyclic RGD-Peptides (42, 43). Remarkably, in the same 
studies the researchers also found that linear GRGDS (non-functionalized version of 3c), 
which is probably the most common cell-adhesive ligand in hydrogels, showed relatively 
low integrin αvβ3 and α5β1 affinity, whereas the monocyclic peptide cyclo-KRGDf (non-
functionalized equivalent to 3b) showed a high affinity for integrins αvβ3 and α5β1. 
Similarly, the 32-mer knottin-RGD peptide (origin of 3a) published by Kimura et al. (52) 
non-selectively bound all integrins αvβ3, αvβ5 and α5β1 with high affinity. Finally, a battery 
of nine RGD-Peptides was successfully synthesized and conjugated with cyclooctyne using 
an approach in which the integrin-binding sequence was coupled to a peptide linker. 
Moreover, and discussed above, the solubility in water-based solvents was improved by 
the inclusion of additional serine residues. All the cyclooctyne-functionalized peptides 
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were conjugated to ELR azides via copper-free click chemistry. Functionalization was 
carried out as a mono-functionalization (5%) and di-functionalization (10%), and the ELR-
Peptides were further analyzed by MALDI-TOF MS. Although MALDI-TOF MS analysis does 
not allow the degree of functionalization to be determined quantitatively, a comparison 
of the spectra in Figure 2 reveals different degrees of functionalization depending on the 
type and amount of peptide applied, thus confirming the successful conjugation of two 
different quantities of peptides on the ELRs. Furthermore, a turbidity study was 
performed for all the functionalized ELRs, with a slight shift in Tt to lower values beings 
observed for all ELR-Peptides in comparison with the non-functionalized ELR. This 
essentially negligible Tt shift is likely due to the very small quantity of peptide molecules 
conjugated to the ELRs (one molecule for 5% functionalization and two molecules for 10% 
functionalization) and to the low molecular weight of the peptides. These data show how 
this functionalization strategy does not affect the physical properties of the ELR, 
represented by the Tt value (Supporting Information, Figures S9-S11). 
The ELRs comprising 5% or 10% peptide functionalization were adsorbed onto TCPS in 
order to further investigate the cell adhesion behavior and proliferation over these 
surfaces. XPS and CA analysis were used to confirm the correct adsorption. Thus, XPS 
analysis revealed a change in the surface composition, as can be seen from Table 3 for 
ELRs and ELR-Peptides, with a clear enrichment in nitrogen and a reduction in carbon, and 
oxygen increasing slightly compared with the TCPS surface. These changes in chemical 
composition confirm an adequate adsorption of ELRs and ELR-Peptides onto TCPS (53-55). 
CA measurements help to characterize the affinity of a solution or suspension towards a 
certain surface, with the CA value decreasing as the number and strength of these 
interactions increases. The adsorption of ELRs onto the surface increases the 
hydrophilicity with respect to TCPS and, given the XPS results, this is likely due to the 
enrichment in electronegative atoms like nitrogen and oxygen and to the reduction in 
carbon. This enrichment in electronegative atoms increases the number and strength of 
interactions, such as hydrogen bonds, with the aqueous solution. Surprisingly, the ELR 
containing peptides adsorbed on TCPS was the most hydrophilic surface, with the 
difference with respect to the other ELRs being significant. This suggests a hydrophilic 
contribution from the peptides, which likely expose their electronegative atoms 
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outwards, thereby increasing the number and strength of interactions with the aqueous 
solution. As reported previously, the hydrophilicity of a solid surface is an essential 
requirement for cell-surface interactions (56) and, in this case, combines with a correct 
exposure of RGD peptide sequences.  
HUVECs were chosen to investigate the cell adhesion behavior, proliferation and 
morphology by culture thereof on ELR and ELR-Peptide adsorbed surfaces. Endothelial 
cells form part of a highly specialized tissue for vessel formation that provides stable 
structural support for new vessels. Endothelial cells cover the blood vessels and are 
metabolically very active, being responsible for maintaining vascular homeostasis. In this 
study we have synthesized a battery of nine peptides, which can be sub-divided into 
groups of three with high affinity for αvβ3, α5β1/αvβ3, and multiple integrins (Table 1). 
According to the literature, the remodeling of blood vessels and concomitant 
reorganization of the cytoskeleton requires the involvement of integrins (57). In 
mammals, this family of integrins comprises at least 20 different αβ heterodimers, which 
are expressed on the surface of endothelial cells (57). Different combinations of integrin 
subunits on the cell surface allow cells to recognize and respond to a variety of 
extracellular matrix proteins under different physiological conditions; for example, the 
αvβ1 and α5β1 fibronectin receptors are highly expressed in quiescent endothelial cells, 
whereas the αvβ3 fibronectin and vitronectin receptor is expressed only during 
angiogenesis (57, 58). Herein we have evaluated either the functional avidity or 
proliferation of HUVECs on ELR and ELR-peptide adsorbed surfaces. Loosely adhered or 
unbound cells were removed from the surfaces after incubation for 30 min in order to 
determine the cell fate as a function of the extent of initial attachment to the different 
surfaces and, therefore, the avidity of the cells for the adhesion sequences exposed.  
The adhesion behavior was investigated in a short-term study (up to 1 day, Figure 5), 
which revealed that ELR-bearing peptides supported higher levels of cells than the 
recombinant ELR-RGD. This difference involves either the bicyclic peptides 1a–c or 2a–c, 
each of which exhibits high-affinity for αvβ3 and α5β1/αvβ3 integrins, or the control RGD 
peptides, which exhibit high affinity for multiple integrins 3a–c. It should be noted that 
the backbone-RGD functionalized ELR (P0-RGD) comprises six RGD motifs per molecule, 
while the covalently functionalized ELR-Peptides only comprise one RGD moiety per 
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molecule. This suggests either a higher adhesion capacity for the high-affinity integrin-
binding peptides to HUVECs or a better exposure of these peptides after protein 
adsorption. It is well known from the literature that cell attachment is influenced by 
several factors, one of the most important of which is the RGD concentration (59-61). By 
creating RGD-Peptides functionalized via copper-free click chemistry, we have improved 
the cell attachment capacity while reducing the RGD concentration on the surface, 
although the RGD-concentration function varies for each different bioactive surface and 
cell line (62, 63). 
Surprisingly, the adhesion and proliferation results for the different high-affinity integrin-
binding peptides used in this study showed no difference when compared with the same 
ELR-Peptide for the two concentrations selected. This identical behavior for ELRs having 
5% and 10% peptide functionalization is likely due to the similar and very low number of 
peptide molecules (one and two molecules for 5% and 10%, respectively) on the ELR 
substrate. In contrast, the presence of RGD in the backbone (P0-RGD) did not affect the 
adhesion behavior of cells in the short-term culture when compared with the ELR lacking 
RGD (P0). This could be related to the adsorption process of ELR-RGD molecules, which 
may have not allowed an optimal outwards exposure of the RGD sequence. Overall, the 
short-term results demonstrate a greater avidity of the cells for the bicycle-functionalized 
ELRs. According to the cell adhesion and proliferation results obtained for ELR-Peptides 
functionalized at 5%, the differences observed in the short-term cultures could be 
explained by considering that signal transduction after interaction with a specific integrin 
can trigger different or preferential cellular responses (proliferation, migration and/or 
organization into networks characteristic of early angiogenesis, for example). A 
comparison within the same groups of ELR-Peptides also revealed clear differences for 
various peptides at certain time points. However, these differences do not follow a trend 
as they arise due to the design and synthesis of the different peptides which, although 
they have the same composition, exhibit different affinities for the integrins expressed on 
the HUVEC membrane. The PicoGreen® study is in accordance with the morphological 
study, whereby the focal contacts, which are initially circumscribed to the perinuclear 
zone, give way to vinculin clustering of activated integrins, as can be inferred from the 
yellow coloration found when overlapping actin and vinculin captures. In addition, these 
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were numerous and not restricted to the nuclear periphery. The morphological study 
reveals that short-term capability to support cell adhesion is higher for the surface 
adsorbed with bicycle-functionalized ELRs than for all the other benchmarks. Moreover, 
the cell spreading area at a short time incubation (4 h) followed the same trend of cell 
adhesion, suggesting that bicyclic RGD peptides support cell adhesion and cell 
cytoskeleton. 
The differences in cell numbers were highest in the short-time study for almost all the 
peptide-bearing ELRs when compared with the recombinant ELR-RGD. However, a 
comparison between the ELR-Peptides and ELR-RGD showed much smaller differences in 
the long term, with HUVEC growth tending to minimize the initial difference in the ability 
to promote cell adhesion by the various high-affinity integrin-binding peptides. 
Differences within the same groups of ELR-Peptides were also relatively small. 
Intercellular contacts between HUVECs inhibit their proliferation and growth stops. A 
possible explanation for the similar cell numbers in long-term cultures (7 d, 14 d, Figure 
7) is that the rapid proliferation corresponds to the earlier confluence with respect to the 
cells that do not exhibit intercellular contacts. However, in contrast to the group of non-
selective RGD-Peptides, which exhibit high affinity for multiple integrins, almost all the 
bicyclic peptides exhibited the highest proliferation data at longer times, showing a 
significant difference with respect to ELR-RGD. The cell quantification data show that 
essentially similar proliferation rates were observed for the bicyclic peptides optimized 
for both αvβ3 and α5β1 affinity/selectivity, thus enabling either active or quiescent HUVECs 
to be targeted. The morphological study shows how the surfaces that have performed a 
better adhesion at short times, are those where the cells exhibit more expanded and less 
sharped morphology at longer times. Given that a similar situation is found for cells 
cultured on fibronectin (positive control), the peptide-bearing ELRs appear to be a better 
substrate for cell stretching compared with the recombinant-synthesized ELR-RGD (P0-
RGD) and ELR itself (P0). However, these differences became less apparent as cell cultures 
were maintained for longer periods, probably as a result of the analysis chosen for this 
cell type.  
In the light of these results, the various high-affinity integrin-binding peptides used in this 
study appear to play an important role, especially during short-term culture. RGD Peptide-
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functionalized ELRs enhance the ability to promote cell adhesion compared with 
recombinant-synthesized ELR-RGD, irrespective of the lower net RGD concentration of 
covalently functionalized ELRs. Moreover, taking into account the limitations of in vitro 
culture, an in vivo study would be required to determine whether active HUVECs involved 
in angiogenesis could be selectively targeted with bicycle-functionalized ELRs optimized 
for high αvβ3 integrin affinity (P1a-P1c). Similarly, bicycle-functionalized ELRs optimized 
for α5β1 affinity (P2a-P2c) could exhibit a specific interaction with endothelial cells in a 
quiescent state. Finally, we have opened up a new application for ELRs as a biocompatible 
substrate in studies to determine which integrins need to be targeted for optimal cell 
adhesion and proliferation. 
5. CONCLUSIONS 
The in vitro studies of ELRs functionalized with high-affinity integrin αvβ3- and α5β1-binding 
RGD bicycles suggest that these bicycles provide an interesting alternative to promote fast 
cell adhesion on 2D biomaterial surfaces compared with well-known linear or monocyclic 
RGD peptides. Our initial hypothesis that high-affinity integrin-binding RGD bicycles, as 
determined in solid-phase immunoassays (43), should improve integrin-mediated cell 
adhesion and proliferation to a significantly greater extent than monocyclic and linear 
RGD was partially verified. Furthermore, we have shown that covalent RGD-
functionalization of ELRs via copper-free click reaction is more efficient for inducing 
integrin-mediated cell adhesion and proliferation than the recombinant synthesis of ELRs 
comprising RGD as part of their backbone. This strategy could be used to ensure correct 
exposure of the bioactive sequence, thereby guaranteeing an optimal cell-material 
interaction. Finally, we believe that ELRs functionalized with integrin-selective RGD-
bicycles represent an attractive and efficient way to design integrin-selective polymer 
surfaces with the potential to evaluate cell-adhesion behavior and tailor high integrin 
peptides for specific biomedical applications.    
Notes 
Pepscan is the inventor of the CLIPS technology and holds a patent on the synthesis of 
bicyclic peptides using this technique. 
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SUPPORTING INFORMATION 
Differential Scanning Calorimetry (DSC) measurements 
DSC experiments were performed on a Mettler Toledo 822e DSC with a liquid nitrogen 
cooler accessory.  
Both temperature and enthalpy were calibrated with an indium standard at the same 
experimental conditions used for the studied materials. Water solutions of ELRs at 50 mg 
mL-1 were prepared at different values of pH. In a typical DSC run, 20 µL of the solution 
was placed inside a standard 40 µL aluminium pan hermetically sealed. The same volume 
of water was placed in the reference pan. As for ELR-hydrogel analysis, 20 mg of the 
hydrated hydrogel was placed in the sample pan. To account for the exact amount of 
polymer in the assayed hydrogel, the sample was lyophilized and weighted after DSC run.  
All samples were equilibrated for 10 min at 0ºC inside the sample chamber just before the 
beginning of each experiment, and then, heated from 0 to 60 ºC at a heating rate of 
5ºC/min. The scans were run under a nitrogen atmosphere.  
 
 
Figure S1. DSC graph of HRGD6-N3 showing the experimental Tt in PBS at physiological pH. 
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Figure S2. DSC graph of VKV-N3 showing the experimental Tt in PBS at physiological pH. 
 
Fourier Transform Infrared Spectroscopy (FTIR) 
FTIR analysis was conducted with a Bruker FTIR spectrophotometer (Bruker, USA). For 
each spectrum, a 512-scan interferogram was collected at single beam absorption mode 
with a 2 cm-1 resolution within the 4000- 600 cm-1 region. For each sample several FTIR 
absorption spectra were collected. Five measurements were averaged to obtain the final 
FTIR absorption spectrum of the sample. Residual water vapour absorption was 
interactively subtracted from the sample spectra. 
Spectral calculations were performed by the OPUS (version 4.2) software (MATTSON 
INSTRUMENT, INC.).  
 
 
 
274 
 
 
Figure S3. FTIR of HRGD6-N3. 
 
Figure S4. FTIR of VKV-N3. 
 
Proton nuclear magnetic resonance 1H-NMR Spectroscopy 
NMR analysis was carried out using a 400 MHz Agilent Technologies equip with an Agilent 
MR console 400 and a One NMR probe. The measurements were carried out at 298 K with 
samples of 20–30 mg of the modified elastin like recombinamers, purified and dissolved 
in DMSO-d6. Chemical shifts (δ) are given in ppm. 
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The no deuterated dimethyl sulfoxide peaks at d ¼ 2.5 ppm and d ¼ 39.51 ppm were used 
as internal reference for 1H and 13C NMR spectra, respectively. 
 
 
Figure S5. H-NMR spectrum of HRGD6-N3 showing the integration of the peaks corresponding to 
the different types of hydrogens. 
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Figure S6. H-NMR spectrum of VKV-N3 showing the integration of the peaks corresponding to the 
different types of hydrogens. 
 
 
Table S1. Molecular weights of all cyclooctyne (BCN)-functionlized RGD peptides as obtained 
from UPLC/MS analysis. Calculated masses were determined using ChemDraw software. 
Peptide Sequence Mfound [Da] Mcalc [Da]
1a K(BCN)PPPSG[Abz]SG-CT3HPQcT3RGDcT3 2176,78 2176,47
1b K(BCN)PPPSG[Abz]SG-CT3HPQCT3RGDcT3 2176,59 2176,47
1c K(BCN)PPPSG[Abz]SG-CT3HSQCT3RGDcT3 2166,43 2166,43
2a K(BCN)-PPPSG[Abz]SG-CT3RGDcT3AYJCT3 2162,34 2161,50
2b K(BCN)-PPPSG[Abz]SG-CT3RGDcT3AWGCT3 2129,34 2128,43
2c K(BCN)-PPPSG[Abz]SG-CT3RGDcT3AYaCT3 2119,40 2119,41
3a K(BCN)-PPPSG[Abz]SG-knottin-RGD 4337,85 4336,81
3b cyclo -[K(K(BCN)-PPPSG[Abz]SG)RGDf ] 1648,57 1648,84
3c K(BCN)-PPPSG[Abz]SG-GRGDS 1534,37 1534,65
J: D-Leu
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Figure S7. Time-dependent cell quantification for ELRs containing peptides at 5% and 10%; 1a–c 
(red bars) and 2a–c (green bars), and control RGD peptides 3a–c (blue bars), at different time 
points (30 min, 4 h, 1 d, 3 d, 5 d, 7 d, 14 d). All experiments were carried out in triplicate and 
error bars show standard deviations. There was no statistically significant difference between 5% 
and 10% at any time point. 
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Figure S8. Some examples of magnified captures of immunostained HUVEC cells seeded on P1a 
(A), P3a (B), P2c (C); P0-RGD (D), P0-FN (E) and P0-BSA (F) that remained adhered after 30 min of 
incubation and washing. Actin is stained in red, vinculin in green, and nuclei with DAPI in blue. 
Small protrusions are marked with white arrows. Scale bars are 50 µm. 
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Figure S9. Turbidity analysis of VKV-N3 and ELRs functionalized with bicycles 1a–c at 5% (P1a-c) 
and 10% (P1a-c-10). 
 
Figure S10. Turbidity analysis of VKV-N3 and ELRs functionalized with bicycles 2a–c at 5% (P2a-c) 
and 10% (P2a-c-10). 
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Figure S11. Turbidity analysis of VKV-N3 and ELRs functionalized with controls 3a–c at 5% (P3a-c) 
and 10% (P3a-c-10). 
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Abstract 
A new generation of smart biomaterials that show multiple modular behaviour is a real 
challenge for targeting complex biomedical system. Herein we developed a smart 
biomaterial based on Elastin-like Recombinamers with allosteric control of RNase A 
activity. Taking advantages by the recombinant DNA techniques, we obtained a smart-
ELRs containing bioactive sequences sensible to external stimuli. It was designed 
containing 10 consensus sequence phosphorylation sites regularly distributed along the 
ELR, and by the Ribonuclease A active sequence (RNase A). According to the position of 
RNase A relative to the ELR backbone, several variants of the smart-ELR have been 
produced. The smart-ELRs were further characterized by several experimental techniques 
(SDS-PAGE, FTIR and HPLC-HR-MS), showing the capacity to be fully phosphorylated and 
further de-phosphorylated. This reversible system was then investigated by turbidity 
analysis, demonstrating an evident shift in Temperature transition (Tt) value due to the 
(de-)phosphorylation. Finally, the allosteric control of the RNase A catalytic activity was 
evaluated for all the different variants of the smart-ELR. The allosteric control of RNase A 
activity by the selective phosphorylation was demonstrated. Moreover, the different 
designs of the smart-ELRs exhibited different catalytic activity, showing the importance of 
the RNase A position according to the ELR backbone. 
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1. INTRODUCTION 
Research is moving towards the development of new materials capable to combine 
modular features in order to tailor custom applications. Smart materials have gained 
widespread interest in material science, they have been used in a large variety of 
applications (1-4). In particular, this new class of material opened new frontiers in the 
biomedical fields, such as for tissue engineering, regenerative medicine application and 
for medical diagnostics (5, 6).  The concept of smart, intelligent or stimuli-responsive 
materials derived from the development of materials that show large conformational 
changes in response to small environmental stimuli such as temperature, ionic strength, 
solvent polarity, electric/magnetic field, or light (7). Above the variety of all the stimuli 
that can be employed, an increasingly important concept is about biomaterials with 
enzyme responsiveness due to the enzyme’s ability to perform in mild conditions, and to 
their high selectivity in reaction they catalyze (8). The escalation in the development of 
enzyme-responsive materials is driven by the motivation to mimic bio-molecular 
recognition processes (9). One of the most common application is therapeutic delivery; 
for instance, Fouladi et al. developed enzyme-responsive liposomes for delivery of 
anticancer drugs (10). Moreover, it is important to take into account the versatility of this 
new class of biomaterial, considering which type of biomaterial has been chosen to be 
engineered and for which purpose. For example, Overstreet at al. developed a novel 
thermoreversible copolymer of poly-NIPAAm with collagenase-sensitive solubility 
behaviour (11). Considering that for the most biomedical applications based on enzymes 
it is often essential to switch on or off the enzymatic reaction, Kim et al., performed a 
study where the use of conducting polymers was employed for building a “bio-switch 
chip” based on nanostructured polymers and entrapped enzyme; the authors 
demonstrated the switching of enzyme (glucose oxidation) in real time (12). Therefore, 
enzyme-responsive smart biomaterials can be applied not only in biomedical applications; 
Yang e al. created a controllable switching of enzyme activity by Poly(N-
isopropylacrylamide)-based microgels through mineralization of calcium carbonate in 
high-pressure CO2 (13). Allosteric regulated enzymes are very functional; in many cases, 
protein functionality is related to changes in the conformational state of certain parts of 
the molecule; whereby these changes render molecules active or inactive. The features 
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that have to be taken into account for the development of smart biomaterial with 
allosteric domains are the ability to be post-translationally and reversibly modified by 
enzymatic reaction, and the capacity to exhibit a movable solubility frontier close to the 
body temperature. The common strategy for the development of enzyme-responsive 
material is to covalently link enzymatic substrates to amphiphilic copolymers (14, 15). In 
addition to that strategy, there is also a supramolecular strategy for the preparation of 
enzyme-responsive biomaterials, which features the non-covalent integration of 
enzymatic substrates into assemblies (16, 17). A promising and powerful strategy 
extensively study for the design of bioactive biomaterials is the genetic engineering 
strategy based on recombinant DNA techniques (18). One of the most important 
biomaterials taking part in this category is Elastin-like Recombinamers (ELRs). ELRs are 
protein based polypeptides that comprise repetitive units of the Val−Pro−Gly−X−Gly 
(VPGXG)n pentapeptide, in which X (guest residue) could be any amino acid except L-
proline. ELRs shows several advantages of designing smart biomaterials. First, they exhibit 
thermo-responsiveness due to the change of the protein conformation above the so-
called transition temperature (Tt), which itself depends on the amino acid composition of 
the polymer (19). ELRs are soluble below their Tt and become insoluble and aggregate at 
a temperature above their Tt, thereby, ELRs are close to a frontier between solubility and 
insolubility (20-22). This feature is important considering that gives the possibility to begin 
the design of temperature triggered self-assembling polymers using a repeated motif that 
is intrinsically responsive to its environment (23). Second, the genetic engineering method 
enables biosynthesis of fusion constructs with precise control over chain length and 
protein position which, makes their sensitivity to the environment highly tuneable (24, 
25). Third, the design of the ELR can be engineered in order to be responsive to other 
triggers in the context of self-assembly (26, 27). Finally, taking advantage from the ability 
of ELRs to modify the activity of functional proteins, they can be used for the development 
of natural systems with added allosteric control of their function (28, 29). 
There are many examples of smart biomaterials based on ELR (smart-ELR); for biomedical 
and biomimetic applications (30-34), some of them are smart-ELR with enzyme-
responsiveness (23, 35-37). Du et al. fused an ELR to the D-amino acid oxidase, thereby 
increasing the solubility and stability of that enzyme (38). Later, in a paper from the same 
288 
 
group, Gao et al. (39) fused ELRs to two enzymes to form ELR-fusion R-ω-transaminase 
and ELR-fusion D-amino acid oxidase, which, at temperatures above the Tt of the ELR part, 
assembled to form two-enzyme complexes with significantly improved catalytic 
efficiency. Herein, we propose a new type of enzymatic responsive smart-ELR with 
allosteric control of enzymatic activity. The smart-ELR enzyme was designed containing 
the consensus sequence for the Kinase/Phosphorylase enzyme. Furthermore, it was 
engineered with the sequence of RNase A which is a type of digestive enzyme used to 
specifically cleave single-stranded RNA (40). RNase A was chosen as the modular enzyme, 
considering its relatively small protein structure consisting of only 124 amino acid (41), 
and its well-known optimal refolding properties (42, 43). Finally, taking into account that 
the folding of the smart-ELR into the 3D structure can alter the enzymatic activity it was 
carefully designed three different variants of the smart-ELR according to the position of 
the RNase A domain relative to the ELR backbone. Finally, the RNase A activity modulated 
by the enzymatic phosphorylation/de-phosphorylation was evaluated, and a comparison 
between the different variants has been made.    
2. MATERIALS AND METHODS 
2.1. ELR biosynthesis and purification 
The cloning and molecular biology for gene construction were performed using standard 
genetic-engineering methods (44). In this study, four different smart-ELRs were designed 
(Figure 1). The four smart-ELR designed differ among each other for the composition of 
bioactive sequences and for the disposition of those sequences. All of the smart-ELRs were 
designed containing ten consensus sequence for the Kinase/Phosphorylase enzyme (45); 
in order to provide a better exposition of the consensus sequence, the consensus 
sequence was flanked by hydrophilic sites. Moreover, all the smart-ELRs were composed 
by hydrophobic blocks having Isoleucine as the guest amino acid. Finally, the smart-ELRs 
was further engineered with the RNase A sequence. According to the position of the 
RNase A domain relative to the ELR backbone, four different types of smart-ELRs were 
generated: TI, TR, RT and TRT.  
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TI is composed of the hydrophilic sequence and the hydrophobic block. MESLLP-
[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]10V 
TR has the same composition of TI, plus the RNase A sequence at the N-terminal. 
MESLLP[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]10VETAAAKFERQHMDSSTSAASSSNYCNQM
MKSRNLTKDRCKPVNTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNC
AYKTTQANKHIIVACEGNPYVPVHFDASV  
RT has the same composition of TR, plus the RNase A sequence located at the C-terminal. 
MESLLPVETAAAKFERQHMDSSTSAASSSNYCNQMMKSRNLTKDRCKPVNTFVHESLADVQAVCS
QKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCAYKTTQANKHIIVACEGNPYVPVHFDAS-
[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]10V 
TRT has the identical composition of TR and RT, but in this case, the RNase A domain was 
located exactly in the middle of the ELR backbone sequence.  
MESLLP[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]5VETAAAKFERQHMDSSTSAASSSNYCNQMM
KSRNLTKDRCKPVNTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCA
YKTTQANKHIIVACEGNPYVPVHFDAS-[(VDLDVPIPGRFDRRVSVAAE(VGIPG)10]5 V 
 
Figure 1. Graphical scheme of the smart-ELRs. The hydrophilic sequence containing the 
consensus sequence is represented by the blue block; according to the key, the consensus 
sequence is marked in bold, and the Serine residue where occurs the phosphorylation/de-
phosphorylation is marked in red. The hydrophobic block is represented by the red block. RNase 
A sequence is represented by the green block. 
Production was carried out by recombinant techniques using Escherichia coli as the cell 
system, as described previously (44, 46-48). Purification was performed by several cooling 
and heating purification cycles (Inverse Transition Cycling) following centrifugation; the 
ELRs obtained in this manner were dialyzed against MilliQ (MQ) water and lyophilized. 
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The purity and molecular weight (MW) of the ELRs were verified by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Amino acid composition analysis 
and infrared spectroscopy (FTIR) was also performed (49). The characterization results are 
provided in the Supporting Information (Figure S1 – S7). 
2.2. Smart-ELRs phosphorylation and de-phosphorylation 
Phosphorylation and de-phosphorylation reactions were performed to modulate the 
smart-ELR state. The smart-ELRs were dissolved at a concentration of 5 mg/mL either for 
phosphorylation or de-phosphorylation reaction. Specific buffers were prepared for the 
two reactions. For the phosphorylation: the phosphorylation buffer was composed by 
NEBuffer for protein Kinases (PK) 1X (New England BioLabs), Adenosine 5’-Triphosphate 
(ATP) 200 µM (New England Biolabs), and milliQ water. The concentration of ATP was in 
excess according to the stoichiometry of the reaction (2,6 times more), in order to 
guarantee the presence of phosphates groups for complete phosphorylation of the ELRs. 
The cAMP-dependent Protein Kinase (PKA) catalytic Subunit (New England BioLabs) was 
added to the solution buffer with a ratio of 5000 Units of enzyme per mL of reaction 
buffer. The solution was further incubated 3 h at 20 °C (temperature on which the ELRs 
were at dissolved state) under shaking. For the de-phosphorylation: the de-
phosphorylation buffer was composed by CutSmart Buffer 1X (New England BioLabs), and 
milliQ water. The Alkaline Phosphatase, Calf Intestinal (CIP) (New England BioLabs) was 
added to the solution buffer with a ratio of 100 Units of enzyme per mL of reaction buffer.  
The solution was further incubated 3 h at 20 °C under shaking. According to the design of 
the biomaterial, ten phosphate groups can theoretically be transferred/removed to each 
smart-ELR. After both the reactions, the enzymes (PKA and CIP) were removed in the same 
way: the solution was heated up to 80 °C for 15 min in order to inactivate and unfold the 
enzyme. Afterwards, quick centrifugation was performed and the pellet was re-dissolved 
in MilliQ water at 1 mg/mL O/N at 4 °C under shaking. Then, quick centrifugation at 4 °C 
was performed to remove the unfolded enzyme from the solution. Finally, the solution 
went through dialysis and freeze-drying steps.  
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Figure 2. Graphical scheme of the phosphorylation and de-phosphorylation reaction of the 
smart-ELRs. Ten phosphate groups can theoretically be transferred/removed to each smart-ELR. 
2.3. Mass analysis (HPLC-HR-MS) 
The phosphorylation/de-phosphorylation rate of the four different smart-ELRs was 
analyzed by High-Performance Liquid Chromatography-High Resolution-Mass 
spectrometry (HPLC-HR-MS). Mass spectra were performed using an ultra-high-resolution 
QTOF instrument (MAXIS II, BRUKER, Bremen-Germany). Electrospray ionization source in 
positive mode was used for all the analyses and the parameters were adjusted as follows: 
Capillary voltage 3400 V, End plate offset 500 V, in-source Collision Induced Dissociation 
energy (isCID) 130 eV. Nitrogen was used as nebulizer gas (pressure of 3 Bar) and drying 
gas (heated to 250°C, flow 4 L/min). The scans of MS spectra were conducted in the m/z 
range of 1000 to 12000. For accurate high-resolution mass spectrometry (HRMS) external 
calibration was performed after each chromatographic run by means of a mixture of 
phosphazenes. Prior to mass detection samples were separated in a HPLC instrument 
(HP1100 Series, Agilent Technologies) using a Vydac-C4 Protein column (300 Å, 250 mm, 
4.6 mm id, 5 mm particle size), the flow rate was set to 0.5 mL/min, solutions of 0.2% 
trifluoroacetic acid in water (v/v) and 0.1% trifluoroacetic acid in acetonitrile (v/v) were 
used as mobile phases A and B respectively. For each sample, a 4 mg/mL solution was 
prepared in DMSO and 100 µL of it was loaded on the column. The separation was 
achieved by a 25 min linear gradient from 30% to 80% B, afterwards, isocratic conditions 
were kept for a 60 min total run time. Finally, the MaxEnt algorithm was applied to the 
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protein spectrum to de-convolute the multi-charged signals in order to obtain the neutral 
intact mass protein. 
2.4. Turbidity analysis 
The Tt of all the ELRs was verified by Turbidity using the Cary Series UV-Vis 
Spectrophotometer (Agilent Technologies). The analysis for the determination of the Tt 
shift before and after the phosphorylation and the de-phosphorylation was recorded for 
ELRs at 5 mg/mL. For all the turbidity analysis (including buffer and concentration 
dependence experiments), a thermal ramp was carried out at 1 °C/min and the turbidity 
was recorded at a wavelength of 350 nm.   
2.5. Dynamic Light Scattering (DLS) 
Light scattering measurements were performed using a BI-200SM multi-angle goniometer 
(Brookhaven Instrument, Holtsville, NY) with a 33mWHe−Ne vertically polarized laser at a 
wavelength of 632.8 nm and a digital correlator (BI-9000AT). All the ELRs solutions were 
prepared by dissolving the ELRs in RNase buffer, thus stored at 4 °C overnight to allow the 
complete dissolution of the smart-ELRs and filtered using 0,45 µm PVDF syringe filter. 
Afterwards, the samples were introduced into the polystyrene cuvette and stabilized for 
5 min at 37 °C to allow supramolecular assembly. DLS measurements were performed to 
calculate the size distribution (Volume mean (nm)) and polydispersity index (PDI). All the 
measurements were performed in triplicates. 
2.6. RNase A activity analysis 
The RNase A activity of each smart-ELRs was evaluated either for the phosphorylated or 
dephosphorylated state. The assay was performed following the general ribonuclease 
assay using methylene blue (50). The buffer of the assay was adjusted for the RNase A 
activity. Briefly, the RNase buffer was prepared (50 mM Tris HCl, 250 mM KCl, 3 mM 
MgCl2, 10 mM DTT); Methylene Blue buffer was obtained dissolving Methylene Blue 
(Sigma-Aldrich) in RNase buffer at 0,1 mg/mL, whereas RNA solution was obtained 
dissolving RNA from yeast (Roche) in RNase buffer at 10 mg/mL. RNA solution (100 µL) 
was mixed with the methylene blue buffer (400 µL) and pre-incubated at 37 °C for 10 min 
in the dark. Afterwards 500 µL of the ELRs solution (1 mg/mL) was added to reach a final 
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volume of 1 mL and an ELRs concentration of 0,5 mg/mL. Afterwards the solution was 
incubated at 37 °C for 15 min in the dark, and then the spectrophotometer analysis was 
performed at 688 nm. 
2.7. Statistical analysis 
Values are expressed as mean ± standard deviation (SD). The data were examined with a 
one-way analysis of variance (ANOVA) followed by Tukey’s Honestly Significant Difference 
(HSD) post hoc test. All statistical analyses were performed with GraphPad Prism. A P-
value lower than 0.05 was considered statistically significant. 
 
3. RESULTS 
3.1. Smart-ELRs phosphorylation and de-phosphorylation 
The design of our smart-ELR was composed by the inclusion of ten (de-)phosphorylation 
consensus sequence regularly distributed along the ELR, moreover, the consensus domain 
was flanked by a hydrophilic sequence for better accessibility to the Kinase (PKA) and 
Phosphatase (CIP). Finally, the Isoleucine was selected as a guest amino acid in order to 
have a counter hydrophobic-part tailoring our smart-ELR for mild conditions. 
Furthermore, according to the position of RNase A sequence in relation to the ELR 
backbone, three different versions of the smart-ELRs were obtained by DNA recombinant 
techniques (TR, RT, TRT) (Figure 1). 
The phosphorylation/de-phosphorylation rate of all the smart-ELRs was analyzed by HPLC-
HR-MS. Mass Spectrometry spectra are shown in Supporting Information (Figure S8-S11). 
In table 1 there are reported the values of all the smart-ELRs in different states, where 
Native means before phosphorylation, Phosphorylated means after phosphorylation, and 
De-Phosphorylated means after De-phosphorylation. 
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HPLC-HR-MS 
(Da) 
Native Phosphorylated Dephosphorylated Δ Native - 
Phosphorylated 
TI 65077 65873 65075 796 
TR 78611 79410 78612 799 
RT 78612 79412 78610 800 
TRT 78609 79411 78613 802 
 
Table 1. HPLC-HR-MS of all the smart-ELRs in different states. Native: before Phosphorylation; 
Phosphorylated: after Phosphorylation; De-Phosphorylated: after De-phosphorylation. Mass 
values are expressed in Dalton (Da). 
In the case of TI, the mass measured in the native state is 65077 Da; whereas the 
phosphorylated state showed a mass of 65873 Da; finally, the de-phosphorylated TI mass 
was 65075 Da. The difference between the Native and the Phosphorylated Mass of TI was 
796 Da, which coincides with the difference in MW recorded between the Phosphorylated 
and the De-phosphorylated state of TI (798 Da). On the other hand, the mass values 
recorded for TR, RT and TRT in their native state are higher than the mass of TI in the 
native state, due to the presence of RNase A sequence. These values were 78611 Da for 
TR, 78612 Da for RT and 78609 Da for TRT; whereas after the phosphorylation it was 
recorded 79410 Da, 79412 Da and 79411 Da, for TR, RT and TRT respectively. As it was 
recorded for TI, also for TR, RT and TRT the difference between the Native and the 
Phosphorylated Mass was in around 800 Da, which coincides, also for the last ones, with 
the difference recorded between the Phosphorylated and the de-Phosphorylated state.  
The thermally driven aggregation of the ELRs was investigated using the turbidity 
approach. The increment in temperature beyond the critical point results in a sharp 
increase in turbidity (51, 52). The Tt is defined as the temperature at 50% maximal 
turbidity (51). Turbidity was measured as a function of the temperature of ELR solutions 
to investigate the aggregation temperature. The turbidity analysis was performed for all 
smart-ELRs in order to verify the smart-ELR state modulation by the enzymatic 
phosphorylation and de-phosphorylation. As it has reported above, a thermal ramp was 
recorded before and after the phosphorylation (Figure 4, red lines), and before and after 
the de-phosphorylation (Figure 4, black lines). All the smart-ELRs showed a sharp peak in 
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turbidity when they turned to aggregate states; this subsequently stabilized over the 
entire temperature range analyzed, with a maximum optical density (OD) of around 2.5.  
In all the cases, a clear shift in temperature was recorded. The difference in Tt for TI 
between before and after phosphorylation was of 15 °C, passing from 26 °C to 41 °C. 
Whereas for TR, RT and TRT the Tt shift was around 12 °C in all the cases. The smart-ELRs 
dissolved in the phosphorylase buffer showed lower Tt compared to the kinase buffer due 
to the different saline composition (Figure 4, red dashed line compared to the black 
continuous line). The difference in Tt between the smart-ELRs before and after de-
phosphorylation was in all the cases less evident than after the phosphorylation. After the 
de-phosphorylation, TI showed a Tt shift of 13 °C; whereas for TR, RT and TRT the Tt shift 
was around 8 °C. Although the delta (Δ) in Tt shift recorded after the de-phosphorylation 
was lower than after the phosphorylation, the Tt of the de-phosphorylated smart-ELRs 
was similar to the Tt of the native smart-ELRs in all the cases. Indeed, for TR, RT and TRT 
the Tt before phosphorylation (Figure 4 B, C, D red continuous lines) coincides with the Tt 
after the de-phosphorylation (Figure 4 B, C, D black dashed lines). The turbidity analysis 
for TI before phosphorylation (Figure 4 A red continuous lines) showed a Tt slightly higher 
(26 °C) than the Tt after the de-phosphorylation (24 °C) (Figure 4 A black dashed lines).  
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Figure 4. Turbidity analysis of TI (A), TR (B), RT (C), TRT (D). All the samples were measured at 5 
mg/mL carrying out thermal ramp at 1 °C/min for the range between 5 and 65 °C. Red lines show 
the turbidity behavior of the smart-ELR before phosphorylation (continuous line) and after 
phosphorylation (dashed line). Black lines show the turbidity behavior of the smart-ELR before 
de-phosphorylation (continuous line) and after de-phosphorylation (dashed line). 
 
In order to see the effect of saline buffer on the Tt, a turbidity analysis was performed 
dissolving TI in milliQ (Figure 5A). The Tt shift recorded in MQ was much higher than the 
Tt shift in saline buffer. Indeed, the Tt shift caused by phosphorylation was of 41 °C, passing 
from 35 °C for the TI before phosphorylation to 76 °C for the TI after phosphorylation. 
Moreover, the Tt before phosphorylation (Figure 5A, black line) coincides with the Tt after 
the de-phosphorylation (Figure 5A, orange line). 
298 
 
 
 
 
Figure 5. (A): Turbidity analysis performed in milliQ at 5 mg/mL carrying out thermal ramp at 1 
°C/min for the range between 5 and 65 °C of TI before phosphorylation (black line), after 
phosphorylation (light blue line) and after de-phosphorylation (orange line). (B) Turbidity 
analysis of TR performed in RNase buffer at different concentration carrying out thermal ramp at 
1 °C/min for the range between 5 and 45 °C. For all the measurements a thermal ramp was 
carried out at 1 °C/min and the turbidity was recorded at a wavelength of 350 nm. 
In order to see the dependence of concentration on the Tt, a comparison between 
concentrations was also performed as it is reported in Figure 5B. A turbidity analysis was 
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performed dissolving TR in RNase buffer at several concentrations. The highest 
concentration analyzed was 2 mg/mL, showing a Tt of 24 °C; whereas the lowest 
concentration analyzed was 0,05 mg/mL, showing a Tt of 32 °C. The concentration of 0,5 
mg/mL showed a Tt of 27 °C, and it was selected for RNase A activity analysis.  
Once that the concentration was fixed at 0,5 mg/mL, a turbidity analysis of the smart-ELRs 
in RNase buffer was performed. As it is reported in Figure 6, the turbidity behavior of each 
smart-ELRs was evaluated in its three different forms: native-ELR (before the 
phosphorylation) represented with the black, phosphorylated smart-ELR (after the 
phosphorylated) represented with the blue line, and de-phosphorylated smart-ELR (after 
the de-phosphorylated) represented with the light green line. TI showed a Tt shift of 25 °C 
after the phosphorylation, passing from around 29 °C to 54 °C. Whereas for TR and RT the 
Tt shift was around 28 °C. On the other hand, TRT showed a Tt shift around 19 °C; in this 
case, the native and de-phosphorylated TRT showed a Tt of 36 °C, which was higher 
compared to the Tt of the other smart-ELRs in the same state. Moreover, all the smart-
ELRs containing RNase A sequence showed a less sharply curved, especially at the 
phosphorylated state compared to TI. Finally, the Tt shifts recorded for every smart-ELRs 
dissolved in RNase buffer at 0,5 mg/mL (Figure 6) are much higher than the ones recorded 
in Kinase or Phosphatase buffer at 5 mg/mL (Figure 4). 
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Figure 6. Turbidity analysis of TI (A), TR (B), RT (C), TRT (D) dissolved in RNase buffer at 0,5 
mg/mL carrying out thermal ramp at 1 °C/min for the range between 5 and 70 °C. Black lines 
show the turbidity behavior of the smart-ELRs before phosphorylation; blue lines show the 
turbidity behavior of the smart-ELRs after phosphorylation; light green lines show the turbidity 
behavior of the smart-ELRs after de-phosphorylation. For all the measurements the turbidity was 
recorded at a wavelength of 350 nm. 
In all the cases, the temperature of 37 °C has comprised in the Δ Tt occurred by the (de-
)phosphorylation. Indeed, the smart-ELRs in the native and de-phosphorylated state are 
aggregated, whereas the smart-ELRs in the phosphorylated state are dissolved. Finally, in 
all the curves obtained by turbidity measurements, it can be observed a small shoulder 
for the smart-ELRs around 15 °C, which, always showed values less than 0,5 OD.  
3.2. Dynamic Light Scattering  
The temperature-dependent self-assembly of smart-ELR into supramolecular structures 
was investigated by DLS to determine their size and polydispersity. As it has been reported 
in Material and Methods section, the DLS measurements for all the smart-ELRs was 
performed at 0,5 mg/mL in RNase buffer at 37 °C. The DLS analysis provided the size 
distributions for the different smart-ELRs (TI, TR, RT, TRT) at the native and de-
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phosphorylated state (Table 2). The DLS measurements showed that smart-ELRs native 
and dephosphorylated formed aggregate at 37 °C. The volumes of the smart-ELR 
aggregates in the native form were, TI: 3076 ± 299 nm; TR: 2812 ± 318 nm; RT: 2804 ± 551 
nm; TRT: 2782 ± 267 nm. The smart-ELRs in the phosphorylated state were dissolved at 
37 °C; indeed, no aggregates were recorded by DLS analysis. Moreover, the volume of the 
smart-ELR aggregates in the de-phosphorylated form were, TI: 2852 ± 538 nm; TR: 1553 ± 
417 nm; RT: 1457 ± 110 nm; TRT: 1837 ± 154 nm. In this case, only TI kept the same volume 
size than the smart-ELR in the native state. For TR, RT and TRT the volume size of the 
aggregates for the de-phosphorylated state was lower compared with the native ones. 
Finally, the DLS analysis showed a Polydispersity Index (PDI) less than 0,2 in all the cases. 
Volume (nm) (± SD) 
[PDI] 
Native De-phosphorylated 
TI 3076 ± 299 
[0,11] 
2852 ± 538 
[0,07] 
TR 2812 ± 318 
[0,16] 
1553 ± 417 
[0,15] 
RT 2804 ± 551 
[0,16] 
1457 ± 110 
[0,17] 
TRT 2782 ± 267 
[0,19] 
1837 ± 154 
[0,16] 
 
Table 2. Volume (± SD) and Polydispersity Index [PDI] from three different measurements of the 
different smart-ELRs at 0,5 mg/mL in RNase buffer at 37 °C. 
3.3. RNase A activity analysis 
As it has been described above, the RNA quantification was performed over the smart-
ELRs solutions at 0,5 mg/mL in RNase buffer by the spectrophotometer analysis at 688 nm 
after 15 min of incubation at 37 °C in the darkness. Figure 7 shows the outcomes of the 
set of the smart-ELRs (TI, TR, RT, TRT). The RNase A activity of each one was evaluated in 
different states: The native state of ELRs (N) is represented with the grey bars; the 
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phosphorylated state of ELRs (P) is represented with blue bars; whereas the de-
phosphorylated state of ELRs (D) is represented with green bars. 
 
Figure 7. RNA quantification of the solutions containing the different smart-ELRs dissolved in 
RNase buffer at 0,5 mg/mL after 15 min of incubation in the darkness at 37 °C. Control: black bar 
(RNase buffer solution without any smart-ELR); grey bars: smart-ELRs in native state (TI-N, TR-N, 
RT-N, TRT-N); blue bars: phosphorylated smart-ELRs (TI-P, TR-P, RT-P, TRT-P); green bars: de-
phosphorylated smart-ELRs (TI-D, TR-D, RT-D, TRT-D). For all the measurements, the absorbance 
was recorded at a wavelength of 688 nm. All experiments were carried out in triplicate and error 
bars show standard deviations (*P<0.05; **P<0.01; ***P<0.001; ****P<0.0001). 
The comparison between the control and all the rest of the conditions showed statistical 
difference with all the smart-ELRs at the different state except for TI-P, RT-D and TRT-D. 
This may be due to the presence of the polymer, that affected by default the 
measurement at 688 nm. In order to make the bar charts clearer, the RNA quantification 
outcomes have been clustered by the smart-ELR type (TI, TR, RT, TRT) in different states. 
The comparison within each group of smart-ELRs has revealed that no difference in RNA 
quantification was recorded between the different states of TI. The same trend was 
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presented by TRT smart-ELR, where no difference in RNA quantification was recorded 
between the native, phosphorylated and de-phosphorylated state. On the other hand, the 
absorbance recorded for the TR-P solution after 15 min of incubation revealed a 
significant decrease in the amount of RNA when compared with TR-N and TR-D. 
Comparing the phosphorylated state (TR-P) with the de-phosphorylated state (TR-D), it 
was recorded a reduction in RNA amount of 17% on average. Moreover, no significant 
difference was recorded between TR-N and TR-D. The RT smart-ELRs presented similar 
values than TR. Indeed, a significant reduction (20%) in RNA amount was recorded for the 
RT-P compared with the RT-D. In addition, no significant difference was recorded 
comparing RT-N and RT-D.  
4. DISCUSSION 
There is a great need of new biomaterials capable to undergo a reversible change in 
response to small variations in solution conditions, showing a fine modulation, such as 
allosteric control (53). The aim of the study was to develop an enzymatic responsive 
smart-ELR with allosteric control of the enzymatic activity, which, allow the 
communication between the biological environment and the material. The allosteric 
control was given by the consensus sequence which, was selectively recognized by Kinase 
and Phosphatase enzymes for phosphorylation/de-phosphorylation. It has already been 
demonstrated that the enzymatic (de-)phosphorylation which, is commonly used in 
biology to alter structural features of proteins, can also modulate the Tt and induce 
gelation of other polymers kind (54-57). Indeed, the change in hydrophobicity is the key 
to the subsequent conformational rearrangements shows by the hydrophobic domains. 
The increase in polarity by phosphorylation moves the frontier of solubility to a higher 
temperature, as the complementary effect of de-phosphorylation moves the frontier 
back. Furthermore, considering that smart-biomaterials are commonly developed as 
enzymatic substrates rather than playing an active role in an enzymatic reaction, RNase A 
was chosen as a single domain protein to confer a catalytic enzyme-responsiveness. As it 
is reported above, the native enzyme was modified at the genetic level by adding at the 
amino or carboxyl end the ELR-counterpart containing (de-)phosphorylation consensus 
sites. Thus, it was obtained an enzymatic responsive smart-ELR with allosteric control of 
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RNAse A activity. Finally, three different variants of smart-ELRs were obtained by DNA 
recombinant techniques (TR, RT, TRT), where the position of RNase A domain change in 
relation to the ELR backbone sequence.  
The first step towards the development of the smart-ELR with allosteric control was to 
verify that TI had complete responsiveness to the Kinase/Phosphatase. Mass 
spectrometry is an excellent method for detecting protein molecular weight and 
quantifying its change. Protein phosphorylation events are detected by increases in 
amino-acid residue mass of +80 Da, which report the addition of HPO3 (58). As shown in 
Table 1, the precise HPLC-HR-MS analysis for TI revealed a difference between TI before 
and after phosphorylation of around 800 Da in molecular weight. The incorporated 
consensus sequence was specifically recognized by the enzyme(s); the phosphorylation 
occurred completely, indeed, ten phosphate groups (which corresponds to 800 Da) were 
transferred above the ten consensus sequences. Also, the (de-)phosphorylation occurred 
completely, indeed the difference between the TI phosphorylated and TI de-
phosphorylated was again of around 800 Da, demonstrating the complete reversibility of 
the ELR state. These results showed optimal accessibility by the enzyme(s) to the 
substrate, due to the adequate exposition by the hydrophilic loop flanking the consensus 
sequence. Furthermore, the same results were obtained for the three smart-ELRs 
containing the RNase A sequence (TR, RT, TRT), where the difference between the 
phosphorylated and the de-phosphorylated state was again around 800 Da. The presence 
of the RNase A domain does not prevent the recognition of the consensus sequence by 
the Kinase/Phosphatase enzyme(s). Moreover, the different position of the RNase A 
domain does not avoid the complete transferral of ten phosphate groups, meaning that 
the consensus sequence keeps optimal accessibility to the enzyme even when linked to 
the RNase A domain. Finally, the complete phosphorylation and de-phosphorylation of 
the smart-ELRs were accomplished in all the cases; indeed, the theoretical number of 
phosphate groups that can be transferred was fulfilled in all the cases, showing a 100% 
effectiveness of the system developed.  
All the smart-ELRs before and after (de-)phosphorylation were further analyzed by 
turbidity (Figure 4). First, it is important to notice that, both reactions were performed at 
a lower temperature (20 °C) than the Tt of the ELRs, in order to guarantee the efficiency 
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of the reactions. Although, the turbidity analysis revealed an evident shift in Tt between 
the smart-ELR before and after the (de-)phosphorylation in all the cases, for TI the Δ Tt 
was slightly higher than for the smart-ELRs (TR, RT, TRT). This is due to the presence of 
RNase A domain, which, increment the size of the protein, reducing the impact of the ten 
phosphates groups over the Tt shift. Moreover, no difference in Δ Tt was recorded 
between TR, RT and TRT, demonstrating that the position of the RNase A sequence does 
not affect the Tt. In any case, the turbidity corroborated the reversibility of the system 
validated by mass spectrometry, showing the capacity of all the smart-ELRs to be driven 
back and forth between association (insolubility) and dissociation (solubility) by selective 
enzymatic activity. The smart-ELR demonstrated to be enzyme-responsive, the allosteric 
domains were able to switch between association and dissociation as a consequence of 
polarity changes caused by post-translational modification (phosphorylation). Moreover, 
also the effect of the saline buffers was observed; in fact, all the smart-ELRs dissolved in 
the phosphorylase buffer showed lower Tt compared to the kinase buffer (Figure 4). The 
effect of saline buffer on the Tt was highlighted by the turbidity analysis performed 
dissolving TI in milliQ (Figure 5A). As it has been extensively studied, an increase in saline 
concentration has a significant effect on the Tt (59). Due to the absence of salts, the 
contribution of the phosphate groups was more evident for the milliQ solution, indeed, 
the Δ Tt recorded in milliQ was much higher than the Tt shift recorded in saline buffer. 
Finally, in all the turbidity curves it can be observed a shoulder for the smart-ELRs around 
15 °C. ELRs formed aggregates with a significant increase recorded at OD 350 nm, due to 
their conformational change and self-organization. This behavior was already reported by 
García-Arévalo et al., where a similar ELR containing Isoleucine as the guest amino acid 
was used (48). These low OD values indicate that neither of the ELRs forms the typical 
coacervate state (60), rather, the small absorbance increase suggests the formation of 
nanoaggregates (23, 61).  
Pattaniak et al., have already demonstrated how the Tt of an ELR could be modulated by 
(de-)phosphorylation; however, they developed a system capable to be only partially 
phosphorylated, showing the effectiveness of 23% (54). In this work, we have developed 
an optimal design for the selective enzyme-responsive smart-ELR, with the ability to be 
completely (de-)phosphorylated, showing the effectiveness of 100%. As it is reported in 
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the literature, the polymer concentration has a significant effect on the altering of Tt (19). 
This correlation was also demonstrated for our system, where decreasing the 
concentration of smart-ELR it corresponded an increase in Tt (Figure 5B). In the light of 
this, a certain concentration was fixed in order to evaluate the modulation of the ELRs 
from the dissolved state (phosphorylated smart-ELR), to aggregate state (de-
phosphorylated smart-ELR) and viceversa at mild conditions.  
The turbidity behaviour for all the smart-ELRs dissolved at 0,5 mg/mL in RNase buffer 
(Figure 6) demonstrated that 37 °C was a temperature in which, smart-ELRs in the native 
and de-phosphorylated state are aggregated, and smart-ELRs in the phosphorylated state 
are dissolved. Moreover, the Δ Tt recorded in RNase buffer is much higher than the one 
recorded in Kinase or Phosphatase buffer. As it has been explained above, this difference 
depends on the concentration of the polymer and on the saline buffer of the solution. 
Moreover, the Tt shift of the smart-ELRs appeared slightly different comparing TR and RT 
with TRT; indeed, the lower concentration of polymers highlighted the small difference in 
self-assembly behavior. Finally, all the smart-ELRs containing RNase A domain showed a 
less sharply curved due to higher MW, especially for the phosphorylated state, which also 
showed higher Tt.  
The formation of aggregates was further corroborated by DLS analysis. These 
measurements showed that smart-ELRs in the native and dephosphorylated state formed 
aggregate at 37 °C, whereas all the smart-ELRs in the phosphorylated state were dissolved, 
indeed no aggregates were recorded. Furthermore, the DLS analysis revealed a decrease 
in volume aggregates between the native TR, RT and TRT and the de-phosphorylated ones; 
this unexpected result can be due to some sort of reorganization after the (de-
)phosphorylation reactions between the RNase A sequence and the ELR backbone, since 
it appeared only for TR, RT and TRT and not for TI (Table 2). A possible explanation for the 
unexpected smaller aggregates after the (de-)phosphorylation could be that there would 
be some ionic rearrangements between the ELRs backbone and the RNase domain during 
the phosphorylation reaction; this new charges interaction favours a tighter aggregation 
when the de-phosphorylation occurred. Finally, the outcomes showed above 
demonstrated that all the smart-ELRs assemblies were responsive to the enzymatic 
activities. Upon the addition of PKA, the multiple-charged ATP molecules were hydrolyzed 
308 
 
into ADP molecules and phosphate groups were transferred to the serine residues. The 
supra-amphiphilic self-assembled aggregates underwent disassembly upon addition of 
PKA. On the other hand, upon the addition of CIP, the phosphate groups were removed 
from the serine residue, causing the supra-amphiphilic self-assembled aggregates. As 
shown above, the system was completely reversible (Figure 2).  
The allosteric control of the RNase A activity was analyzed monitoring the RNA 
quantification of the solutions in mild conditions. These results revealed a different 
behaviour of the smart-ELRs. TI does not contain the RNase A domain; indeed, it has 
shown no RNase A activity. Either the phosphorylated TI (TI-P) or de-phosphorylated TI 
(TI-D) does not have any impact over the RNA quantification, meaning that the state of 
the polymer does not have any cleavage activity over the RNA in the solution. On the other 
hand, the three variants of smart-ELR containing the RNase domain (TR, RT and TRT) 
showed a different RNase A activity comparing the phosphorylated state with the de-
phosphorylated state. Both TR-P and RT-P exhibited a significant reduction in RNA 
quantification, showing a gained catalytic activity due to the selective phosphorylation. 
The conformation changes caused by the phosphorylation distorted the overall 3D 
structure of the hybrid ELR-enzyme altering its efficiency. The complete phosphorylation 
allowed to the TR-P and RT-P to be in its dissolved state, where the RNase A domain 
resulted to be free to active. The reduction in RNA amount of 17% in the case of TR and 
20% in the case of RT demonstrated the capacity of our system to switch from an inactive 
state (de-phosphorylated) to an active state (phosphorylated) by a selective enzymatic 
activity performed by Kinase/Phosphatase. Contrary, TRT exhibited no significant 
difference between the dissolved state (TRT-P) and aggregate state (TRT-D). In this case, 
the RNase A catalytic site remained inactive even when the state of the smart-ELR was 
modulated by Kinase/Phosphatase. This phenomenon could be due to a sort of steric 
hindrance, where the accessibility of the RNA molecule to the catalytic site was blocked 
by the flanked ELR backbone, or perhaps because of the catalytic site of RNase A is 
stretched by the ELR backbone altering the performance of the catalytic site (Figure 8). It 
is well known that, when enzymatic domains are incorporated into polymer assemblies, 
the accessibility of the substrate to the enzyme becomes susceptible to several factors, 
such as the affinity and the permeability of the assemblies to the enzymes, and other 
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factors that can affect the kinetics of the enzyme-responsive behaviour (62-65). In this 
study, the accessibility of the substrate (RNA) to the catalytic site of RNase A is selectively 
regulated by the phosphorylation-responsive behavior. Therefore, we have demonstrated 
that the sequence design of the biomaterial has a crucial influence on the allosteric 
regulation of the enzymatic activity. 
 
Figure 8. Schematic illustration of TR, RT and TRT allosteric control over the RNase A activity. 
 
5. CONCLUSIONS 
In this study, we have developed a smart biomaterial based on Elastin-like 
Recombinamers with allosteric control of RNase A activity. We have obtained an optimal 
design for the Kinase/Phosphatase-responsive behaviour, whereby, the 100% of 
phosphorylation of the smart-ELR was responsible to move the frontier of solubility. This 
system has demonstrated to be completely reversible, moving back and forth between 
association (insolubility) and dissociation (solubility) by (de-)phosphorylation. The 
allosteric regulation of the RNAse A activity was successfully demonstrated; the RNase A 
catalytic activity depended by the assembled state of the biomaterial, which, is selectively 
regulated by the phosphorylation-responsive sites in the assemblies. Moreover, the 
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design principles of phosphatase-involved self-assembling systems can stimulate the 
development of other smart self-assembling systems responding to other important 
enzymes. These designs are interesting by themselves, considering that their varying and 
tailored molecular architectures mean that they can be used in several areas such as thin 
films, hydrogels, micelles, nanofibers, microstructural surfaces. Finally, the allosteric 
control demonstrated for the RNase A activity represents an initial proof-of-concept for a 
new class of responsive macromolecules, which, can be involved in the modulation of 
intracellular signalling activity. 
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SUPPORTING INFORMATION 
 
Figure S1. Purity assessment by SDS-PAGE for TI, TR, RT and TRT. 
 
Figure S2. FTIR of TI. 
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Figure S3. FTIR of TR. 
 
 
Figure S4. FTIR of RT. 
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Figure S5. FTIR of TRT. 
 
Amino acid Theoretical Experimental 
ASP+ASN 30 30.35 
GLU+GLN 11 10.89 
SER 11 9.37 
HIS - - 
GLY 210 210.88 
THR - - 
ARG 30 27.86 
ALA 20 19.73 
TYR - - 
CYS - - 
VAL 130 127.13 
MET 1 1 
TRP - - 
PHE 10 9.37 
ILE 110 112.76 
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LEU 12 12.68 
LYS - - 
PRO 121 124.99 
 
Figure S6. Comparison between the theoretical number of each amino acid and the 
experimental values for TI. 
  TR RT TRT 
Amino acid Theoretical Experimental Experimental Experimental 
ASP+ASN 45 44.33 42.10 46.95 
GLU+GLN 23 19.5 18.10 21.37 
SER 26 18.26 17.87 20.24 
HIS 4 2.85 3.19 3.56 
GLY 213 233.17 238.69 222.38 
THR 10 4.53 5.71 7.22 
ARG 34 35.15 33.07 34.6 
ALA 32 33.91 28.96 33.1 
TYR 6 3.73 3.91 5.03 
CYS 8 8.12 8.32 7.84 
VAL 150 144.27 151.31 143.5 
MET 5 3.8 3.21 4.86 
TRP - - - - 
PHE 13 11.83 11.69 12.3 
ILE 113 122.58 125.04 117.13 
LEU 14 18.87 13.26 16.75 
LYS 9 8.96 10.72 10.3 
PRO 125 123.95 124.85 125.68 
 
Figure S7. Comparison between the theoretical number of each amino acid and the 
experimental values for TR, RT, TRT. 
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Figure S8. HPLC-HR-MS Spectra for TI-N (red spectra), TI-P (blue spectra) and TI-D (green 
spectra). 
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Figure S9. HPLC-HR-MS Spectra for TR-N (blue spectra), TR-P (light green spectra) and TR-D 
(black spectra). 
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Figure S10. HPLC-HR-MS Spectra for RT-N (red spectra), RT-P (green spectra) and RT-D (blue 
spectra).  
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Figure S11. HPLC-HR-MS Spectra for TRT-N (dark green spectra), TR-P (light green spectra) and 
TR-D (purple spectra). 
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CONCLUSIONS AND FUTURE DIRECTIONS 
Genetic engineering, bioproduction and characterization of ELRs   
In this Thesis, it has been shown the development of several ELRs, each one containing 
bioactive sequences for tailored biomedical application. The hyphosesis to generate 
several ELRs comprising diverse combinations of bioactive domains was demonstrated. In 
terms of cell adhesion, RGD and REDV bioactive sequences have been included in the ELRs 
composition. For hydrogel-forming ELRs the amino acid sequences GAGAGS hexapeptide 
found in Bombyx mori silk fibroin was included in the ELR sequence giving stability to the 
hydrogel. Moreover, in the case of ELRs-based hydrogel for osteochondral repair an 
elastase target domain was also included in order to permit the replacement of the 
scaffold for the regenerated tissue. Furthermore, it was developed a series of ELRs 
containing the consensus sequence sensible for the kinase/phosphorylase in combination 
with the RNase A catalytic domain for allosteric domain’s regulation. Characterization 
techniques such as SDS-PAGE and MALDI-TOF confirmed the theoretical MW of the ELRs. 
Moreover, the Tt was assessed through DSC for all the ELRs; confirming that it was below 
the physiological temperature for the ELRs forming hydrogels when injected in vivo. 1H-
NMR and HPLC for amino acid analysis assessed the purity of each batch of the different 
ELRs, while the FTIR analysis showed good agreement of the theoretical composition of 
the ELR with the experimental functional groups analyzed. Finally, the analysis of 
endotoxins ensured the purity of the ELRs for in vivo application. 
 
Development of ELRs-based hydrogel with different gelation 
mechanisms for osteochondral repair  
An important part of this Thesis focusses on the development of bioactive hydrogel for 
Tissue Engineering (TE) application. We hypothesized that the gelation mechanism had a 
crucial influence for the generation of a 3D hydrogel embedded with cells for 
osteochondral repair. Different ELRs-based hydrogels for osteochondral repair having two 
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different gelation mechanisms of hydrogels have been produced, either by chemical 
(covalent bonds) or by physical cross-linking. In both cases, injectable hydrogels were 
obtained. In the case of the chemically cross-linked hydrogel, the ELRs concentration 
selected demonstrated adequate mechanical properties for the osteochondral 
application. In the case of physically cross-linked hydrogels, the pre-annealing treatment 
applied to the Silk Elastin co-Recombinamer has shown to improve the mechanical 
properties of the hydrogel, guarantying fast gelation and the presence of a fibrillary 
structure directly after injection of the hydrogel. For both scenarios, SEM analysis showed 
a homogeneous porous environment with an interconnected structure. Although the ELR-
based hydrogels developed in this Thesis had different gelation mechanisms, in both 
cases, the rheological study demonstrated how the concentration of the hydrogel could 
modulate the mechanical properties. For instance, according to the ELRs composition and 
its MW, the chemically cross-linked hydrogel allows the gelation of the hydrogel at a lower 
concentration than the physically cross-linked hydrogel; this thereby allows the cells 
embedded in the hydrogel matrix to have more space available, and also to play with a 
higher amount of cells for the formation of the 3D matrix. On the other hand, the 
physically cross-linked hydrogel does not contain covalent bonds and considering the 
slower process of gelation, this could provide a better environment for cells embedding.  
In conclusion, both gelation mechanisms demonstrated immediate gelation, conferring 
the benefit of being an injectable scaffold. Moreover, both systems offer tuneable 
features, such as the possibility to choose between a range of hydrogel’s concentration 
and cell’s density, which give the advantage of making the therapy as much tailored as 
possible. For instance, moving forward in the field of Tissue Engineering for osteochondral 
repair, it could be formed a scaffold which comprises both proposed hydrogels; it could 
be designed a double layer hydrogel containing a chemically cross-linked hydrogel for the 
bone area, whereas a physically cross-linked hydrogel could support the regeneration of 
cartilage layer. 
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In vitro, ex vivo and in vivo evaluation of ELRs-based hydrogel for 
osteochondral repair 
The ELRs-based hydrogels containing different bioactive sequences were tested for the 
osteochondral application. The physically cross-linked hydrogel containing the bioactive 
sequence RGD which supports cell adhesion via integrins was embedded with 
chondrocytes. This biomaterial has demonstrated the capacity to form a high cells density 
3D hydrogel and to be delivered into the area of interest. The biocompatibility was proved 
by in vitro study; the addition of the silk allows to make hydrogels with a lower 
concentration, leading to larger pores, which is most likely responsible for better cell 
spreading, and proliferation. The regeneration capacities for cartilage repair were 
evaluated using an ex vivo culture platform. After four weeks of culturing, the hydrogel 
embedded with chondrocytes exhibited remarkable advantages; such as the de novo ECM 
formation, the absence of fibro-cartilage and the production of hyaline cartilage. On the 
other hand, the chemically cross-linked hydrogel was designed in order to contain the 
listed bioactive sequences: RGD and REDV to support cell adhesion via integrins and 
improve the selectivity for endothelial cells, and VGVAPG which provides proteolytic 
sensitivity to the biomaterial. This ELRs-based hydrogel was further embedded with MSCs 
and the biocompatibility was proved by an in vitro study, whereas the regeneration 
properties were evaluated by an in vivo study. Femoral bone defects were created in New 
Zealand rabbits, which were subsequently filled with the hydrogel embedded with MSCs 
and the hydrogel itself; then, after four months the samples were extracted and the 
regeneration was assessed by different methods. This ELR-hydrogel has been 
demonstrated to have an adequate composition; indeed it has shown a right ratio of 
bioactive sequences exhibiting a good balance between the degradation rate and 
adhesion behaviour, allowing for the colonization of chondrocytes with optimal secretion 
of extracellular matrix-collagen type II. Finally, it was demonstrated that the specific 
composition of this hydrogel allowed a faster bone regeneration when embedded with 
rMSCs compared to the injection of the hydrogel alone. On the other hand, the 
comparison of the regeneration between the hydrogel embedded with MSCs and the 
hydrogel itself has shown an excellent cartilage repair without the need for cellular 
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implantation. We demonstrated that the gelation mechanism has a crucial influence for 
the generation of a successful scaffold for osteochondral repair, especially when 
embedded with cells. 
In conclusion, the outcomes collected using the different hydrogel’s compositions with or 
without the cellular contribution open up other possibilities in design and combination of 
hydrogels, perhaps creating a scaffold composed by different layers, each one having its 
own composition, gelation mechanism, and cellular contribution.  
 
Development of a new ELR-peptides hybrid biomaterial 
The hypothesis that the strategy of copper-free click chemistry allows the incorporation 
of non-canonical amino acids and the formation of cyclized peptides on ELRs was 
demonstrated. A new hybrid material comprising the recombinant technique of ELRs and 
the strategy of the synthesis of bicyclic peptides was developed. Indeed, ELRs were 
covalently functionalized with each three high-affinity and selectivity αvβ3- and α5β1-
binding bicyclic RGD peptides and with various integrin-binding benchmark peptides. The 
covalent functionalization was validated by MALDI-TOF analysis, guarantees flexibility and 
minimal steric hindrance for interactions with cellular integrins. Moreover, the objective 
to explore the potentiality of the new hybrid biomaterial for biomedical application was 
achieved; indeed, after the adsorbtion of the ELR-Peptides over tissue culture plate 
surface (TCPS), the adhesion capacity of HUVECs was evaluated. The in vitro studies of 
ELRs have shown that covalent RGD-functionalization of ELRs via copper-free click 
reaction is more efficient for inducing integrin-mediated cell adhesion and proliferation 
than the recombinant synthesis of ELRs comprising RGD as part of their backbone. The in 
vitro studies of ELRs functionalized with high-affinity integrin αvβ3- and α5β1-binding RGD 
bicycles represent an interesting alternative to promote fast cell adhesion on 2D 
biomaterial surfaces compared with well-known linear or monocyclic RGD peptides.  
In conclusion, a new system based on two diametrically opposed strategies was 
developed, demonstrating that combining approaches could be a new manner to explore 
new frontiers. In this case, we believe that ELRs functionalized with integrin-selective 
328 
 
RGD-bicycles have a great potential to evaluate cell-adhesion behavior and tailor high 
integrin peptides for specific biomedical applications.     
 
A new class of smart-ELRs with allosteric domain 
As a final stage of this journey, in this Thesis we have explored a new class of ELRs. A smart 
biomaterial based on ELRs with allosteric control of RNase A activity was developed. 
Firstly, the consensus sequence phosphorylation site was introduced and regularly 
distributed (ten times) along the ELR sequence. The HPLC-HR-MS analysis demonstrated 
the ability to fully phosphorylate/de-phosphorylate the ELRs, and the reversibility of this 
system. Furthermore, the turbidity analysis demonstrated an evident shift in Temperature 
transition (Tt) value due to the transfer/removal of the phosphate groups. Secondly, 
taking advantage of the recombinant technique, the Ribonuclease A catalytic domain 
(RNase A) was fused to the smart-ELR at the genetic level. According to the position of 
RNase A relative to the ELR backbone, three variants of the smart-ELR were produced and 
all of them demonstrated the capacity to fully phosphorylated/de-phosphorylated. The 
DLS and turbidity analysis performed at 37 °C, at the mild condition for a selected 
concentration, showed that the system was completely reversible, moving back and forth 
between association (insolubility) and dissociation (solubility) by (de-)phosphorylation. 
Finally, the RNase A catalytic activity showed dependency by the state of the biomaterial. 
Indeed, the RNase A activity was selectively enhanced by the phosphorylation of the ELR 
consensus sequences. The allosteric regulation of the RNase A activity was successfully 
demonstrated, showing that the design of the sequence has a central role in the activity 
of the selected enzyme. However, a next step would be to find a finer methodology to 
assess the allosteric regulation of the RNase A activity. 
In conclusion, the allosteric control demonstrated for the RNase A activity represents an 
initial proof-of-concept for a new class of responsive macromolecules, the design 
principles of phosphatase-involved self-assembling systems can stimulate the 
development of other smart self-assembling systems responding to other important 
enzymes. 
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Final remarks 
Along this journey towards the discovery of the evolution of ELRs, we have strived to 
explore the potential of ELRs towards the development of tailored solutions for 
Biomedical applications. Across the fulfilment of the objectives of this Thesis, we came 
out with new outstanding biomaterials capable to overcome some limitations of the 
existing ones. However, this is not an ending point; it is rather an ongoing process on 
which we humbly gave our small contribution to scientific discovery. The leitmotiv of this 
Thesis has been described as a sort of journey towards the evolution of Biomaterial 
science. Along with the PhD program, we have learned how important is to address the 
complex problems from different point of views. The final take-home message is about 
the importance of keeping an open mindset considering all the pieces that compose the 
whole picture. We strongly believe that collaboration and cooperation are essentials to 
do “good science”; because it is only combining diverse strengths and skills that we are 
able to break the wall between us and the new discoveries.  
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